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ABSTRACT
Background
A locally adapted comprehensive infection prevention and control programme (IPCP) is
imperative to the management of healthcare associated infections. An IPCP is a
technology cluster made up of a number of elements which are closely inter-related.
IPCPs in high-income countries have demonstrated effective control of infection
transmission in healthcare settings. Relative to the experience of high-income countries,
low- and middle-income (LMI) countries have adopted IPCPs, or parts thereof, with
varying degrees of success.

The country of Kiribati has been most successful in adopting IPCP principles and
practices. The ‘atypical’ case of Kiribati raises many questions, primarily ‘How and
why did it change?’, ‘What has been the process of the change?’ and ‘Could other
countries in the region benefit from the Kiribati experience?’

This study addresses the research questions: How can the success of IPCPs be enhanced
in LMI country healthcare settings? Can the classic Diffusion of Innovations model be
used to explain the level of success?’

Methods
The adoption process of an IPCP in the Republic of Kiribati was investigated with the
findings analysed within the framework of Diffusion of Innovations theory. The case
study investigation involved:
1. Review and analysis of IPCP adoption literature to identify those studies that
have both consciously and unconsciously followed classical Diffusion of
Innovations theory processes. This was to find evidence to support the
suggestion that the theoretical process of Diffusion of Innovations is a key
framework within which to explore and understand the adoption of IPCP in
LMI countries.
2. Evaluation of current IPCP status in Kiribati using adapted National Health
Service (NHS) and World Health Organization (WHO) IPCP audit tools.
3. Survey of healthcare worker knowledge, application and confidence with
infection prevention and control principles and practice using a previously
validated tool.
xii

4. Chronological and thematic analysis of Republic of Kiribati

IPCP

documentation (for example: infection control manuals, infection control
committee minutes) and findings and recommendations of IPCP assessments
performed by Republic of Kiribati staff and external agencies/consultants.
5. Semi-structured interviews with key informants in the Republic of Kiribati and
external agencies (using snow-ball sampling) to explore the key elements that
contributed to the adoption of IPCP.

Findings
The literature review revealed a scarcity of relevant literature examining the adoption of
comprehensive IPCP or associated conceptual frameworks. Only one study was
published which demonstrated the Diffusion of Innovations framework, and it is
discussed in more detail.

The healthcare worker survey and evaluation of the Kiribati IPCP indicated that the
programme had been integrated into healthcare service delivery. The IPCP reached a
level of 75% compliance in accordance with the scoring method of the tool.

Two key activities of the organisational innovation process were identified from the
interviews and the chronological and thematic analysis of the IPCP documentation.
These were: initiation and implementation. The initiation activity included: 1) agendasetting: preparations for severe acute respiratory syndrome (SARS) in 2003 stimulated
the identification of organisational IPCP deficits, and 2) matching: deficits were
identified and the decision to adopt an IPCP innovation package was made.
Implementation included: a) redefining/restructuring: identification of the components
of an IPCP and how they best fit within the local health structure, b) clarifying:
integration of IPCP into the health services and defining an infection control role within
the nursing division and, c) routinising: the IPCP became an ongoing element in health
service delivery.

Conclusions
Exploration of the adoption of the Kiribati IPCP provided an important case study for
other low- and middle-income countries in how they may overcome barriers to the
establishment and integration of a programme into a health service.
xiii

The outcome of the literature review identified a clear need for more research into IPCP
adoption. The availability of relevant literature would be especially important to low
resourced healthcare settings to assist their adoption of comprehensive IPCPs.
Opportunities were identified for future expansion of the Kiribati IPCP through the
healthcare worker survey and IPCP evaluation.

The adoption of the Kiribati IPCP followed the classic Diffusion of Innovations process
for Organisations. The Kiribati case study provides a relevant and useful example of an
IPCP adoption model in low- and middle-income healthcare settings and suggests ways
other LMI countries may utilise opportunities as they occur during an innovation.

It is recommended that other LMI countries should enhance their adoption of IPCP
through applying key components of the Diffusion of Innovations framework to their
endeavours.
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Chapter One
Introduction
This introductory chapter provides a background to the study presented in this
dissertation. It details the location of the study and the history behind the study’s
inception. A brief outline of each chapter of the document is provided, together with a
short commentary on the role of the chapter in addressing the research questions. The
chapter concludes with a summary of the study and its significance.

1.1 Background
Prevention and control of healthcare associated infection (HAI) is an increasingly
important element in the provision of health services globally. It relates to not only
protecting those accessing health services from the spread of infectious or pathogenic
disease but also protecting healthcare workers, their families, and other persons
associated with health services.

At present, resources and expertise in the prevention and control of HAI in low- and
middle-income (LMI) countries is minimal (World Health Organization 2008). LMI
countries are those with a gross national income (GNI) of between
≤$975 USD and
≤$11 905USD per capita, and high income countries are those with a GNI of ≥$11 906
USD, as classified by the World Bank (World Bank 2009).

Most LMI countries are struggling with this issue, having no infection control
guidelines, organisational framework, policy directives or persons responsible for
establishing, implementing and monitoring infection control programmes. These issues
were identified during the rapid preparedness assessments conducted by World Health
Organization (WHO) Infection Control Short Term Consultants, including the
researcher, in 2003 in response to the outbreak of severe acute respiratory syndrome
(SARS).

An infection prevention and control programme (IPCP) is a collection of activities,
resources, policies and procedures designed to control and prevent the transmission of
infectious diseases within the healthcare environment and the community (Farr 2000).
1

Core components of an IPCP have been categorised by the WHO (Informal Network on
Infection Prevention and Control in Health Care 2009) as:
•

Organization of IPCP

•

Technical guidelines

•

Human resources

•

Surveillance of infections and assessment of compliance with infection
prevention and control practices

•

Microbiology laboratory support

•

Environmental minimum requirements

•

Monitoring and evaluation of programmes

•

Links with public health or other relevant services.

Together these core components create a cluster of technologies that can be described as
an innovation, though they are not generally considered to be a new innovation to the
healthcare environment.

The Study on the Efficacy of Nosocomial Infection Control (SENIC) Project, conducted
in the mid-1970s, was the first comprehensive and most influential study of the impact
of IPCPs on HAI incidence in the United States. This study established an association
between intensive IPCPs and reduced rates of HAI and associated healthcare costs. This
was achieved by comparing the incidence of HAI in facilities with IPCPs and those
without (Haley et al. 1985). The findings from SENIC established the essential
requirements of infection prevention and control programmes in the United States to
reduce infection rates. These essential requirements included: 1) an emphasis on
surveillance and control activities; 2) a minimum of one full-time infection control
professional per 250 beds; 3) a trained hospital epidemiologist; and 4) the provision of
feedback on surgical site infection rates to surgeons (Haley et al. 1985). It was found
that hospitals with these programmes in place reduced the incidence of HAI by 32%,
and those without the programmes had an increase in HAI of 18% (Haley et al. 1985).
Infection prevention and control programmes which did not include these requirements
were found to be less effective in reducing HAI (Hospital Infections Program 1992).
Since the SENIC Project, a number of other studies have reinforced the efficacy of
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infection prevention and control programmes in reducing HAI and associated costs,
though not with the thoroughness of the SENIC project.

Understanding the process of adoption of IPCPs is important to assist other countries to
adopt such programmes, particularly those with limited resources. The publication of
the findings of the SENIC Project facilitated the adoption of IPCPs in healthcare
settings in the United States, and subsequently internationally. The core components of
an IPCP have evolved since the 1970s, through to those suggested by the WHO in 2009.

To gain a greater understanding of the process of adoption of IPCPs requires
exploration of the process itself, not just whether selected key components are in place.
The Diffusion of Innovations theory provides a framework through which the adoption
of IPCPs can be examined.

1.2 Diffusion of Innovations and infection prevention and control
Classic Diffusion of Innovations theory describes ‘…the process by which an
innovation is communicated through certain channels over time among the members of
a social system’ (Rogers 2003, p.5). In every diffusion research study, programme or
campaign, four key elements are always present: 1) an innovation; 2) communication
channels; 3) time; and 4) a social system (Rogers 1962, 1983, 2003).

When examining the diffusion of an IPCP in a healthcare environment the innovation 1)
would be the programme, the communication channels 2) are the means by which
information and messages about IPCPs are shared, time 3) includes the rate of adoption,
the innovation-decision process and the innovativeness of the individual or organisation
and the social system 4) is the healthcare environment and infrastructure where the
adoption is to take place.

Rogers also identified a technology cluster as a group of individual components that are
closely inter-related and that can be adopted as a package of technology or an
innovation package (Rogers 2003). The core components of an IPCP are individual but
inter-related, thus they can be considered collectively comprising a specific innovation
package.

3

1.3 The research problem
The efficacy of infection control programmes in reducing the incidence of HAI has been
well established in the literature, particularly in developed or high-income countries
(Haley et al. 1985; Hospital Infections Program 1992). These infection control
programmes are informed by evidence based guidelines and advice developed by
internationally recognised health authorities such as the United States Centers for
Disease Control and Prevention (CDC) and the WHO. Based on such advice many
countries, including LMI countries, have attempted to establish infection control
programmes, with varying degrees of success (Nettleman 1993; Leu 1995; Huskins et
al. 1998).

From the experience of the researcher it appeared that the standards set by these
guidelines and advice were unachievable by LMI countries due to resource limitations,
lack of engagement of healthcare workers and health authorities, lack of expertise and
institutional and priority competition.

The Republic of Kiribati appeared to be an exception to these general findings. In 2003,
the investigator visited Kiribati during a SARS rapid preparedness assessment of
infection prevention and control capacity. The assessment found limited infection
prevention and control programming and activities. The investigator again visited
Kiribati in 2005 during a consultancy with the Secretariat of the Pacific Communities
(SPC) to review infection prevention and control capacity. This 2005 review found
evidence of significant improvements in the overall programme, increased activities and
what appeared to be genuine enthusiasm for infection prevention and control
(Zimmerman 2006). It appeared that there had been a progressive adoption of infection
prevention and control activities that would result in a comprehensive programme. The
extent of these changes was not typical of other LMI countries in the region.

There may have been no intention to adopt individual infection prevention and control
activities, or innovations, and label it an IPCP, but to an experienced Infection Control
Professional (ICP) it was nevertheless evident that the group of activities or innovation
package in Kiribati was developing into an IPCP. What was also interesting in the
Kiribati case was that they appeared to have been able to address issues that often
4

prevented the adoption of IPCP in other LMI countries. It was because of these reasons
that Kiribati was selected as a case study to explore issues of IPCP adoption.

The ‘atypical’ case of Kiribati raised many questions, primarily ‘How and why did it
change?’, ‘What has been the process of the change?’ and ‘Could other countries in the
region benefit from the Kiribati experience?’ These, and many other questions,
warranted further exploration.

1.4 The research aim and purpose
The aim of this research study was to explore and understand a successful
implementation of an IPCP through the analysis of the experience of health
professionals in Kiribati using the classic Diffusion of Innovations model as a frame of
analysis.

The purpose of the study was to provide a holistic understanding of the innovation
process Kiribati experienced in adopting the IPCP innovation package. In line with this
and the research questions, quantitative and qualitative data sources were utilised within
the context of the case study method.

1.5 The researcher
The investigator of this project, an Infection Control Professional (ICP) with 12 years
experience, has acquired experience in a variety of healthcare settings in Australia and
has also had the privilege of working with health authorities in a significant number of
LMI member states of the WHO Western Pacific Region Office. It was through this
experience that interest in the difficulties LMI countries’ experience in relation to
implementation of infection prevention and control activities was first developed.

1.6 The Republic of Kiribati
The Republic of Kiribati is a central western Pacific country of 33 atolls and reef islands
in three main island groups, the Gilbert, Phoenix and Line Islands, as illustrated in
Figure 1. Kiribati has a total land mass of 811 square kilometres spread over 3.5 million
kilometres of ocean. With a GNI of $1 200 USD per capita, Kiribati is considered a
lower middle income country (World Bank 2009).

5

Figure 1: Map of the Republic of Kiribati (Central Intelligence Agency 2011)

Kiribati has a population of approximately 98 989 and an annual population growth rate
of 1.7%. The most populated islands are South Tarawa, North Tarawa and Kiritimati
Island with urban growth rates of 5.2%, 4.8% and 8% respectively (World Health
Organization 2010). Compared to most other Pacific islanders, I-Kiribati have a short
life expectancy with 65 years for males and 70 years for females (World Health
Organization 2010).

The health system of Kiribati is publicly funded with government spending $13.45
million USD in 2008, primarily on curative services, pharmaceuticals and staffing
(World Health Organization 2010). Significant technical and financial assistance is
provided to the Ministry of Health by development partners such as WHO, AusAID,
NZAID, UNICEF, UNFPA, SPC, EU and the governments of Cuba and Taiwan (China)
(World Health Organization 2008). The formal health system is administered by the
central Ministry of Health. Traditional healers provide a parallel service offering local
medicines, massage, antenatal, childbirth and postnatal care. Most people use aspects of
both services though there is no coordination between them. Primary health care is
provided through a network of 92 health centres and dispensaries. Basic hospital
services are available at South Tarawa (Betio), Kiritimati Island and North Tabiteuea.
Secondary care is provided by the national referral hospital in South Tarawa. Patients
requiring tertiary care services may be referred overseas for treatment if they meet the
criteria defined by the Ministry of Health.
6

Environmental factors such as overcrowding of urban areas, particularly in South
Tarawa, are increasing the risk of transmission of infectious disease. Other factors such
as poor water quality, inadequate water supply, inconsistent personal hygiene practices
and poor sanitation, food handling and storage practices contribute to communicable
disease transmission. The incidence of tuberculosis per 100 000 population in Kiribati is
now the second highest in the Pacific (World Health Organization 2009b). The Western
Pacific Regional Office of WHO reports 365/100 000 population in Kiribati compared
with 108/100 000 population in the region (World Health Organization 2009b). In
Kiribati, 70% of reported TB cases are found in Betio, South Tarawa (World Health
Organization 2010). In 2005, diarrhoeal disease and respiratory infections were the
leading causes of morbidity amongst adults and mortality amongst children (World
Health Organization 2008). The WHO has found that non-communicable disease
incidence is increasing, making the severity of communicable diseases potentially worse
for individuals with chronic disease processes. In addition, poor community knowledge
regarding infection prevention practices is likely to be reflected in poor staff practices
within healthcare settings.

1.7 Thesis outline
This thesis is presented as a combination of chapters (introduction, methods, literature
review, and conclusion and recommendations) and manuscripts published/submitted to
peer-reviewed journals, in lieu of results and discussion chapters. The literature review
and methodology chapters are reduced as each manuscript contains a review of the
literature relevant to the research reported and a method section describing the study
undertaken and the research process.

An overview of the methodological approach and design of the research project is
presented in Chapter Two and a detailed description of each method is presented in the
published and submitted manuscripts. Chapter Two outlines the case study
methodology, units of analysis and data sources of the overall project. These include
details of the healthcare worker survey, interviews and IPCP evaluation.

Chapter Three provides a brief literature review of the adoption of IPCP in LMI
countries. This chapter is somewhat shorter than the traditional monograph thesis format
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due to the literature review being fully explored in two of the published and submitted
manuscripts. The literature review in Chapter Three informs and provides further
background to the issues LMI countries have in the adoption of comprehensive IPCP. In
particular, it highlights the need for more research and reporting of the situation of IPCP
in LMI countries.

Chapter Four, “Help or hindrance? Is current infection control advice applicable in
low- and middle-income countries? A review of the literature”, comprises a paper
published in the American Journal of Infection Control. This paper presents a review of
how current infection control guidelines designed for high-income country settings are
utilised by LMI countries and what barriers prevent the adoption of comprehensive
IPCP. The chapter provides the basis for a further review of the literature to explore
how LMI countries adopt comprehensive IPCP. The issues that LMI countries confront
in adopting comprehensive IPCP or their components are identified.

Literature reporting on frameworks that explained the adoption of IPCP, are reviewed in
Chapter Five. “Frameworks that assist adoption of infection prevention and control
programmes. Does the literature exist?” is a paper that has been published in
Healthcare Infection. This literature review identified a paucity of published studies that
report the adoption of comprehensive IPCP and which follow a distinct framework or
model. It is proposed that having a model for adoption of comprehensive IPCP can
assist in mirroring such a process in similar healthcare settings.

Chapter Six, “SARS and Kiribati: Eyes wide open”, is a paper that has been published
in the International Journal of Infection Control. It documents and explores the adoption
stages of an IPCP in a specific case situation, in Kiribati. Rogers’ (2003) Diffusion of
Innovations for Organisations framework has been used to document the process and
this was informed by two sets of data. The first set of data comprised chronological and
thematic analysis of IPCP documentation and assessments performed by local staff and
external agencies/consultants. The second set of data comprised semi-structured
interviews with local key informants and external agencies (using snow-ball sampling).
Thematic analysis of these data identified the process and key events that facilitated the
adoption of the IPCP in the Kiribati case.
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Validation of the presence of the Kiribati IPCP was reported in Chapter Seven,
“Evaluating infection control in the Republic of Kiribati”, a paper currently under
review by the American Journal of Infection Control. This paper describes the
programme’s achievements and areas in need of improvement in relation to infection
control in the Republic of Kiribati. This information will be of particular interest to
other LMI countries who continue to struggle to overcome barriers which prevent
effective infection control.

The findings of Chapters Six and Seven culminate in a further discussion of the research
in Chapter Eight, “Diffusion of Innovations in organisations: A case study of infection
prevention and control programme (IPCP) adoption”, a paper submitted for review to
the International Journal for Quality in Health Care. This chapter provides an
illustration of how a comprehensive IPCP can be adopted in a LMI country setting with
little involvement from external agencies. In examining the Kiribati case, key stimuli,
opportunities and activities were identified that could be similarly adopted and
implemented by other LMI countries that are facing the challenge of developing an
IPCP.

Chapter Nine summarises the conclusions made from the investigation of the research
questions

and

provides

recommendations

based

upon

the

findings.

The

recommendations made focus primarily on the use of theoretical frameworks,
particularly the Diffusion of Innovations model, to assist in the adoption of IPCP. The
chapter goes further to present specific recommendations based upon the documentation
of the Kiribati IPCP and the importance of reporting the LMI country situation in the
literature.

1.8 Conclusion
This study contributes to an understanding of the elements for successful adoption of
IPCP in LMI countries, and hence to improvements in health care and health outcomes
in these less advantaged regions in the world. Surveying the knowledge, application and
confidence of healthcare workers in relation to infection prevention and control
principles and practice, accompanied by a review of the current status of the IPCP,
served to assess the success of the adoption of the IPCP in Kiribati. Exploring the
chronology of IPCP adoption in a LMI country such as the Republic of Kiribati and
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mapping this process within the diffusion of innovation framework provides valuable
insights that can be shared with potential adopters from similar countries who may be
seeking resolutions to their own infection prevention and control issues.

This introductory chapter has described the background to the research detailed in this
thesis and the importance of a comprehensive IPCP in all healthcare provision,
regardless of the economic wealth of a country. It described the unique case of the
Republic of Kiribati and provided the context for the exploration of how a relatively
small Pacific Island country can adopt a comprehensive IPCP in spite of the barriers
similar LMI countries face in this endeavour. The next chapter outlines the
methodology for exploring the Kiribati case.
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Chapter Two
Methodology
This chapter provides a description of the methodology of the overall study, providing
an outline of the case study method, units of analysis and data collection methods. Full
details of each data collection method are separately included in Chapters Four to Eight
as they are presented in article format.

2.1 Introduction
Infection prevention and control research to date has been largely quantitative, focusing
on the surveillance of health care associated infections, the measurement of the use of
infection prevention practices, and clinical trials (Forman et al. 2008). The use of
qualitative data in infection prevention and control has generally been absent, and
because of this, explanations as to why certain infection prevention and control
practices or activities are or are not adopted have not been identified. It has been
suggested that research in the field of infection prevention and control should be a
combination of both quantitative and qualitative data to understand phenomena as well
as measure it (Forman et al. 2008).

Investigating the adoption of an innovation in an organisation similarly involves the use
of quantitative and qualitative data sources. When using the staged model to explore the
adoption of an innovation, described previously, data collection methods have been
generally cross-sectional retrospective surveys, which Wolfe suggested was too limited
to fully explain adoption phenomena (1994). Investigation of the innovation process,
however, has included methods which provided in-depth field studies such as field
observations, interviews, questionnaires and analysis of historical documents such as
reports and archival data, resulting in a combination of quantitative and qualitative data
sources (Wolfe 1994). The use of both sources has assisted to fully explore and
understand the complexity of the innovation process and has not reduced it to “…a few
discrete variables and linear cause-and-effect relationships” (Forman et al., 2008
p.765).
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2.2 Case study design
Case study research is considered one of many ways to explore and study contemporary
phenomena within its real-life context particularly when ‘…the boundaries between
phenomenon and context are not clearly evident’ (Yin 2003, p.13). This research
strategy has been commonly used in education, health care, the military, business and
industry by numerous disciplines such as psychology, sociology, medicine, psychiatry,
law, nursing and education (Mariano 1999).

Case studies have been conducted at various levels of complexity and have used
different levels of analysis: factual, interpretive and evaluative (Lincoln and Guba
1985). Case studies can be exploratory, descriptive, interpretive or explanatory (Stake
1995). Four elements typify case studies: context, boundaries, time and intensity
(Mariano 1999). In case study research the researcher defines the boundaries of the
inquiry, issues and reference points, thus employing an intensive orientation to the
phenomenon under study (Woods and Catanzaro 1988; Mariano 1999; Yin 2003).

The unit of analysis can be a person, family, group, organisation, culture, event,
program or process (Woods and Catanzaro 1988). Case studies can focus on a single
case as the unit of analysis or on multiple cases, which are then compared (Mariano
1999). Single-case design is used when the case represents a typical case, a critical
case, an extreme or unique case or a revelatory case (Yin 2003). It is used to document
and analyse the precise nature of the phenomenon under investigation and to raise
questions for further exploration (Mariano 1999). In multiple-case design, inferences
and interpretations are drawn from a group of cases. This design is appropriate when
the researcher is interested in exploring the same phenomenon across diverse situations
or with a number of individuals. Alternatively, it is used when the researcher wishes to
establish whether a proposed explanation is confirmed across a number of cases
(Mariano 1999).

Particularities and complexities of the case are examined to understand its activity
within important situations. Case study does not generalise, instead it emphasises
uniqueness. That implies knowledge of others that the case is different from, but the
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first emphasis is on understanding the case itself (Yin 2003). Yin further explains that
case study inquiry,
•

Copes with the technically distinctive situation in which there will be
many more variables of interest than data points, …

•

Relies on multiple sources of evidence, with data needing to converge in a
triangulating fashion, …

•

Benefits from the prior development of theoretical propositions to guide
data collection and analysis (2003, p.13-14).

The benefit of the development of theoretical propositions is not required of exploratory
studies, such as the study proposed here, yet a clear purpose is necessary (Yin 2003).

Both Yin (2003) and Stake (1995) argue that case study methodology is well matched
to conducting social science research where people and programs are the areas of
interest. Case studies are generalisable to theoretical propositions rather than
populations or universes (Yin 2003). This research method calls on both qualitative and
quantitative sources of evidence to explore the research questions.

A single case study approach was chosen for this project as it facilitated the exploration,
within a specific context, of the adoption of an IPCP. This study sought to explore
contemporary phenomenon within its real-life context (Yin 2003). This is achieved by
using multiple sources of evidence to enhance rigour (Stake 1995; Yin 2003). Case
study method calls for a triangulating process using multiple sources of evidence, both
qualitative and quantitative to explore the research questions. Triangulation in this study
was achieved through the analysis of multiple sources of data which were each causally
separate.

2.3 Research process
2.3.1 Study aim
To explore and understand the implementation of an IPCP through the analysis of the
experiences of health professionals in Kiribati using the classic Diffusion of Innovations
model as a frame of analysis.
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2.3.2 Purpose
The purpose of the proposed study was to provide a holistic understanding of the
innovation process that Kiribati experienced in adopting the IPCP innovation package,
with a view to enhancing the adoption of IPCP in other LMI country healthcare settings.

2.4 Methods
The methods of inquiry in exploring the research questions included:
Review of the literature
1. Review of the current state of infection prevention and control advice and
barriers to adoption of comprehensive programmes in LMI countries. Full
details of this component of the study are presented in Chapter Four, “Help
or hindrance? Is current infection control advice applicable in low- and
middle-income countries? A review of the literature”
2. Review and analysis of IPCP adoption literature to identify those studies that
have followed a theoretical framework during the process. This is to clarify
the proposition that the Diffusion of Innovations model can assist our
understanding of the adoption of IPCP in LMI countries. Full details of this
component of the study are presented in Chapter Five, “Frameworks that
assist adoption of infection prevention and control programmes. Does the
literature exist?”

Documenting the adoption of IPCP in Kiribati
1. Chronological and thematic analysis of Republic of Kiribati IPCP
documentation (for example: infection control manuals, infection control
committee minutes) and findings and recommendations of IPCP assessments
performed by Republic of Kiribati staff and external agencies/consultants
explored the key elements of the diffusion of innovation process.
2. Semi-structured interviews with key informants in the Republic of Kiribati
and external agencies (using snow-ball sampling) explored the key elements
of the diffusion of innovation process. Full details of this and the above
component of the study are presented in Chapter Six, “SARS and Kiribati:
Eyes wide open”
3. Evaluation of current IPCP status in Kiribati using adapted NHS and WHO
IPCP audit tools with thematic analysis of findings and recommendations –
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identified the current infection prevention and control activities and how
they corresponded with the core components of a comprehensive
programme.
4. Survey of healthcare worker knowledge, application and confidence with
infection prevention and control principles and practice using a previously
validated self-administered tool – identified strengths or deficits in the
education component of the programme. Full details of this and the above
component of the study are presented in Chapter Seven “Evaluating
infection control in the Republic of Kiribati”.

2.5 Units of analysis
2.5.1 Review of IPCP adoption literature
A review of the literature was undertaken to illustrate and research gaps in the current
situation of IPCP adoption in LMI countries in relation to the available expertise and the
barriers faced in programme adoption.

Chapter Three provides a literature review of Diffusion of Innovations and IPCP
adoption which identified an apparent absence of studies which acknowledged the role
of the innovation process in programme adoption. A further review of all available IPCP
adoption studies was undertaken to identify those programmes which were adopted and
unknowingly followed a theoretical framework. The purpose of this review was to
determine support for the suggestion that Diffusion of Innovations was a key framework
within which to explore the adoption of IPCP, particularly in LMI countries.
2.5.2 IPCP documentation analysis
A chronological and thematic analysis was undertaken within the framework of the key
elements and stages of the innovation process. Key data sources were Republic of
Kiribati IPCP documentation (for example: infection control manuals, infection control
committee minutes) and reports on the findings and recommendations of IPCP
assessments performed by Republic of Kiribati staff and external agencies/consultants
Review of the IPCP documentation was conducted by the investigator in country.
Access to these documents required the permission and cooperation of the Ministry of
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Health. This was achieved by following the relevant ethics and study requirements of
the Kiribati Ministry of Health.

Analysis of these documents was performed to provide an illustrative timeline of the
process of IPCP adoption in Kiribati. This served to identify the stages of the innovation
process in the organisation. Text data were subjected to thematic analysis “…as a means
of re-organising the data according to conceptual themes recognised by the researcher”
(Minichello et al. 2000, p.255).
2.5.3 Interviews
Face-to-face interviews were conducted with key stake-holders in the Ministry of
Health, infection prevention and control personnel, and clinicians. Following
consultation with these interviewees, a snow-balling technique was used to identify
other relevant key stakeholders in Kiribati, and additional interviews were sought with
these individuals (Minichello et al. 2000).

The interviews were semi-structured following an interview schedule which explored
the chronology and the aspects of the adoption process of the IPCP (Appendix 1).
Interviews were audio-recorded and transcribed. Data were subjected to thematic
analysis, as detailed in 2.6 below.

Pilot testing of the interview schedule was conducted with infection prevention and
control professionals and clinicians in Queensland, each of whom had work experience
in LMI countries. This step was undertaken to ensure comprehension and language
suitability for the target population in Kiribati. These interviews were held face-to-face,
except one which was conducted over the telephone.
2.5.4 Infection Prevention and Control Programme evaluation
The role of the evaluation of the IPCP in Kiribati was to describe the current infection
prevention and control activities and how they corresponded with the core components
of a comprehensive programme.

Audit and evaluation of IPCPs and their associated activities has been a well recognised
data collection method in the field of Infection Prevention and Control (Bryce et al.
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2007). As part of an IPCP, audits are used to determine the appropriateness of infection
prevention and control policies and the reliability of infection management practices
(Hay 2006).

Audit or evaluation tools reported in the literature to be rigorous and validated through
various research methods have been found to focus on certain infection prevention and
control activities such as hand hygiene (Pittet et al. 2000) and antibiotic stewardship
(Saizy-Callaert et al. 2003). Less available are holistic tools for the evaluation of IPCPs.

In searching the literature for available and validated IPCP audit or evaluation tools
only two documents were considered appropriate to the task, though with some
limitations. The first was the Infection Control Nurses Association Audit tools for
monitoring infection control standards (Infection Control Nurses Association 2004).
This comprised a set of tools that had been validated (Millward et al. 1993, 1995) and
used extensively by the National Health System (NHS) of the United Kingdom for the
standardised monitoring of clinical practice and the healthcare environment. These tools
were not designed to assess the comprehensiveness of an IPCP. Rather they were used
to assess infection prevention and control practice in the clinical healthcare
environment. These tools were also not designed for the LMI country healthcare setting.

The second research tool was the Nosocomial Infection Program Rapid Evaluation
Guide produced by the Pan American Health Organization/Regional Office of the
World Health Organization (Pan American Health Organization 2005). Validation of
this evaluation tool has not been reported in the literature, though Chelenyane and
Endacott (2006, 2008) and Wu et al. (2008) argued that tools created from, and based
upon, the recommendations from systematically and legally established agencies such
as the World Health Organization should be considered as having inherent face and
content validity. This tool was designed to evaluate programmes based on the presence
of indicators of core components of an IPCP, with the LMI country healthcare settings
of the Latin Americas in mind. It was designed to provide a general overview rather
than specifics of the status of IPCPs and it was not intended to provide an evaluation of
the clinical healthcare environment.
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These two tools were combined in this research project to create an evaluation
document, the IPCP evaluation (IPCPE), that was used in this study to assess the status
of the current IPCP and clinical healthcare environment in Kiribati. Assessing the
current status of the IPCP acted to verify the adoption of the activities of the IPCP. The
findings of the assessment were compared to other IPCP documentation and
assessments sourced through the IPCP documentation analysis, and contributed to the
development and understanding of a timeline of the adoption process.

The validity of the IPCPE instrument (Supplement 1) was confirmed by experts in
infection prevention and control with experience in LMI country healthcare settings.
These experts were asked to assess whether the questions and items were valid, readable
and practical. Once the review and adaptation process was complete, the IPCPE was
piloted in healthcare facilities in Fiji by an experienced infection prevention and control
professional. After piloting and making relevant changes, the IPCPE was then used in
the study to assess the IPCP in Kiribati. The IPCPE was conducted in person by the
investigator on visits to Kiribati.
2.5.5 Healthcare worker survey
As part of any evaluation of IPCP adoption it is essential to evaluate the knowledge and
delivery of safe infection prevention and control practices of the healthcare workers
(Bryce et al. 2007). This evaluation assists to identify deficits in the education
component of the programme and serves to provide data on the adoption of the IPCP
innovation in the clinical setting, particularly how successfully it is being implemented.
The results of these self-administered surveys assisted in verifying the adoption of the
IPCP.

Four appropriate survey tools were identified in the published literature. Three of these
referred to the knowledge and practice of universal precautions (Chan et al. 2002; Stein
et al. 2003; Chelenyane and Endacott 2006). Universal precautions are a system of
practices designed to prevent the transmission of infectious diseases from blood and
body fluids (Centers for Disease Control and Prevention 1987). The term, and some
practices of, universal precautions were superseded in 1996 when the CDC produced
new recommendations on the prevention of infection, creating a two-tiered approach
termed standard and additional precautions (Garner 1996). Though these tools were
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designed after 1996, there was no reference to these changes and therefore they were
considered not to reflect current infection control practices.

The fourth relevant instrument had been used to determined Taiwanese nursing
students’ knowledge, application and confidence with standard and additional
precautions (Wu et al. 2008). A content validity index strategy was used to examine the
validity of the tool (Wu et al. 2008). Internal consistency was also established for the
knowledge and confidence scales of the tool. The application scale was not able to be
tested, though the authors maintained, as previously mentioned, that items based upon
recommendations of organisations such as WHO have inherent validity.

The Wu et al self-administered questionnaire was adapted to the culture and
environment of Kiribati (Appendix 2). It was used to assess the knowledge, application
and confidence with infection prevention and control practices of clinicians in the
Kiribati healthcare environment. The target population was clinicians in the hospital of
Betio and the national referral hospital in South Tarawa. The number of surveys
administered was 186. Prior to use in Kiribati, the questionnaire was piloted and tested
for internal consistency with a sample group of clinicians in Fiji. The healthcare worker
survey was conducted in person by the investigator on visits to Kiribati.

Survey data were coded for ease of data entry then collated and entered into SPSS
(Statistical Package for the Social Sciences) Student Version 18 (Pearson Education
2009). The data were then subjected to analysis using descriptive and inferential
statistics.

2.6 Thematic analysis
Thematic analysis involves the search for and identification of common themes
throughout the document reviews and interviews (Morse and Field 1996). This
“…involves reading, overviewing, and annotating the text prior to systematic coding”
(O'Leary 2005, p.196). Data were explored for words used, concepts discussed,
linguistic devices utilised and non-verbal cues identified by the researcher, during the
interview process (O'Leary 2005). To explore word-related themes the text was
systematically searched to find all instances of relevant words and phrases, making note
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of their context and meaning (O'Leary 2005). Livescribe hardware and NVivo9
software were used in the collection and organisation of data for analysis.

Concepts primarily explored were the four components of the Diffusion of Innovations
theory previously described: the innovation, communication channels, time and the
social system (Rogers 2003). Other concepts and themes emerged from the data in
addition to these components, and were analysed in a similar manner.

By investigating and analysing the phenomena in this way, information was gathered to
explore the five stages of the innovation decision process as well as the sequences,
divergent and parallel paths, feedback and feed forward cycles in the process (Wolfe
1994; Rogers 2003). This data collection and analysis also assisted with verification of
the information gathered from the IPCP evaluation and healthcare worker surveys.

2.7 Study issues
2.7.1 Access to the field
The investigator works as an independent consultant. The investigator had previous
work experience with the WHO and the SPC as an Infection Control Technical
Consultant in Kiribati. She also had exposure to, and experience with, a significant
number of health authorities in the LMI countries of the Western Pacific. These prior
experiences assisted in gaining access to the field of investigation. Permission and
assistance was sought from the Ministry of Health of Kiribati in accordance with the
relevant institutional ethics committees (Appendix 3).
2.7.2 Recruitment
Participation was voluntary throughout the study. Participation in the study was sought
and obtained whilst the research was being conducted in Kiribati. This was achieved
with the assistance of Senior Nursing and Medical staff.

2.8 Ethical issues
This study received approval from the University of Wollongong Human Ethics
Committee (Approval number: HE09/386, Appendix 4) and the Ministry of Health of
the Republic of Kiribati (Appendix 3). Particular ethical considerations had been
identified in relation to the design of this study. Each of these is detailed below.
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2.8.1 Security
During data collection and analysis, all information collected, including digital storage
of audio recordings and transcripts of the interviews (master file) were stored in a
locked filing cabinet in the residence of the investigator. A working file, including all
copies of the master file, that were required for the day-to-day work of the study
remained with the investigator or was stored in a locked filing cabinet, separate from
the master file, when not in use. Computer files were password protected. Access to the
data was confined only to the investigator. All data will be kept for the duration
required by the relevant ethics committees, stored in locked filing cabinets at the
School of Health Sciences, University of Wollongong.
2.8.2 Confidentiality
Written information was provided and informed consent obtained from interview
participants by the investigator, before each interview was conducted. Identities of the
interviewees were reported as positions rather than names to help protect identities.
However, this may still pose a potential social risk to the interview participants. This
issue was outlined on the consent form and discussed with participants during their
recruitment to the study and prior to their interview. Interview participants were offered
the opportunity to withdraw consent at any point during the study. Copies of the
consent forms and participant information forms are in Appendix 1 and 2.

2.9 Conclusion
This chapter has provided an overview of the methodology and research process used
throughout the project. It was designed to assist the reader in linking the information
and more detailed methodologies presented in the manuscripts/published papers in
Chapters Four, Five, Six, Seven and Eight, in terms of how they fit together to provide a
comprehensive investigation of the adoption process of a comprehensive IPCP. It also
discussed the traditional research approaches to IPC and the rationale for taking a case
study approach to explore the relevance of the Diffusion of Innovations framework.

The next chapter details a brief literature review of the background to the use of IPCPs
and how the Diffusion of Innovations process in organisations can be used as a
framework for the modelling of the adoption of a comprehensive IPCP. Subsequent
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chapters provide further details of relevant sections of the literature pertinent to the
components of the study reported in published articles of which they are comprised.
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Chapter Three
Literature review
This chapter comprises a brief literature review on the background of IPC in LMI
countries and an introduction to the Diffusion of Innovations process in organisations.
Discussion of the literature identifies the need to further investigate the literature for
reports of comprehensive IPCP adoption and the frameworks that informed them. The
findings presented in this chapter provide the basis of the literature reviews presented in
Chapter Four and Chapter Five.

3.1 Background
It is important to understand the importance of infection and infection control in LMI
countries so as to situate this study’s focus on how a LMI country was able to introduce
an IPCP. This section outlines the current knowledge of IPCP reported in the literature.

The lower the economic status of a given population or nation, the greater is the impact
of infectious diseases and HAI on mortality, and the larger the decrease in quality of life
(Isturiz and Carbon 2000; Starling 2001; World Health Organization 2002; Rosenthal et
al. 2003a; Yalcin 2003). Healthcare facilities in most LMI countries utilise the majority
of public health expenditure and as such are the focus of cost cutting to provide care to
the greater population (Huskins et al. 1998). The quality of health care, including
infection control and prevention, varies across socioeconomic situation. It is commonly
influenced by infrastructure, training of health care workers, patient knowledge and
purchasing power of individuals in each country (Isturiz and Carbon 2000).

The available literature which examines infection prevention and control programmes in
LMI countries consists predominantly of review papers or case study reports, focusing
on the adoption or modelling of individual IPCP components rather than the adoption of
a comprehensive programme. In a series of studies conducted between 2003 and 2005
Rosenthal and colleagues examined the incidence of HAI in specific intensive care units
(ICU) of Argentine hospitals before and after the adoption of globally accepted
infection control and prevention interventions that included staff education,
performance feedback and enhancement of compliance with hand hygiene. The studies
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demonstrated improvement in HAI rates after the adoption of these interventions.
Through conducting these studies however, barriers to implementation of available
guidelines were identified, such as lack of resources, lack of organised IPCP, healthcare
staff unaware of infection prevention methods and lack of institutional support
(Rosenthal et al. 2003a; Rosenthal et al. 2003b; Rosenthal et al. 2004; Rosenthal et al.
2005).

3.2 Barriers to adoption of IPCP in LMI countries
The principles of infection prevention and control remain the same regardless of the
healthcare environment, but how they are implemented depends on a number of factors.
Raza et al. indicated that the United States’ or high income countries’ experience of
infection prevention and control was not applicable to LMI countries due to, ‘…the high
costs involved and local factors such as climate, socioeconomic and demographic
conditions, antibiotic prescription habits and bacterial resistance patterns’ (Raza et al.
2004, p.295). Experiences of LMI countries in their attempts to adopt IPCP were thus
reviewed to identify key factors that impact on successful implementation.

The report of a Project Hope programme that endeavoured to implement an infection
prevention and control programme based upon CDC infection control guidelines in
Indonesia described a number of barriers that were experienced (Rhinehart et al. 1991).
Rhinehart and colleagues reviewed an 11 bed paediatric ICU in a 1200 bed tertiary
facility in Jakarta. They found that literal adoption of CDC guidelines, as would occur
in a high income country, was impossible due to the poor physical environment,
budgetary constraints, unreliable and inappropriate supply of equipment and supplies,
limited microbiological diagnostic facilities, lack of healthcare worker knowledge, local
customs and culture, lack of institutional support and infection control infrastructure and
poor sterilisation capabilities (Rhinehart et al. 1991). Given this situation the project
team reviewed CDC guidelines to adapt them to the local circumstances. This was
performed in collaboration with hospital counterparts. The results of the facility and
CDC guideline review resulted in adapted guidelines for core infection prevention and
control programme components. Though this older study focussed on a very specific
clinical unit, it has provided an important contribution through identification of the
barriers to the successful adoption of IPCP in a LMI healthcare setting.
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A number of review papers echoed the Rhinehart et al. (1991) findings; adoption of
infection control and prevention practices in LMI countries was reported to be often
hindered by a lack of awareness of risk of infection, lack of knowledge, inadequate
supplies of personal protective equipment (PPE) and other equipment, staffing and time,
inconvenience to staff and poor health care system support for safe practice (SagoeMoses et al. 2001; Kermode et al. 2005).

In a cross-sectional survey of health care workers in rural north India, Kermode et al.
(2005) also reported on factors that affected the adoption of infection prevention and
control practices. The principal factors they identified included: length of time in the
job, knowledge of blood borne pathogen transmission, perception of safety climate and
perception of barriers to safe practice. They went on to suggest that promotion of safety
climate factors might be an effective way to assist in implementation of infection
prevention and control advice. However, it was predicted that this cannot be achieved
without structural supports such as a comprehensive IPCP that included those core
components previously mentioned (Informal Network on Infection Prevention and
Control in Health Care 2009), provision of appropriate safety equipment and
commitment from health care leaders (Kermode et al. 2005).

Other studies have identified methods to overcome these barriers, including ensuring
that IPCP was adapted to the local environment and context, making use of available
resources and targeting interventions to those infectious diseases of local importance
(Ponce-de-Leon 1991; Rhinehart et al. 1991; Raza et al. 2004).

Studies of the adoption of IPCP in LMI countries were generally unavailable in the
literature. One reason suggested for this was that such reports were rarely published in
English, particularly studies from Asian countries (Leu 1995). What were available
though, as previously described, were reviews of the general issues related to adopting
IPCP in LMI countries or reviews of individual component adoption, such as
surveillance. Of these reviews the major problems identified were:
•

Most LMI countries have weak or absent IPCP,

•

IPCP are often unidirectional, focusing only on one or a few interventions such
as antibiotic usage,

•

Local studies and local expertise are not utilised in developing an IPCP,
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•

Appropriate resource allocation to the health sector and delivery system is not
addressed,

•

Human resources are not adequately developed to support IPCP adoption, and

•

Equipment and consumable items such as sharps containers, sterilisers,
disinfectants, PPE, running water and electricity have limited availability
(Mortensen 1991; Sobayo 1991; Nettleman 1993; Huskins et al. 1998; Starling
2001; Nyamogoba and Obala 2002).

Given these barriers identified for other LMI countries, Kiribati appeared to have
demonstrated a concentrated effort to adopt infection prevention and control activities
which together created a comprehensive IPCP. Exploring the research questions: ‘How
can the success of IPCP be enhanced in LMI country healthcare settings?’ and ‘Can the
classic Diffusion of Innovations model be used to explain variations in success?’ would
assist in illuminating the adoption process that Kiribati had undertaken to achieve its
current level of IPCP development. In undertaking this discovery, it was first necessary
to further understand classical Diffusion of Innovations theory and its potential role in
understanding IPCP adoption reported in the literature.

3.3 Diffusion of Innovations
Diffusion of Innovations theory has its roots firmly embedded in agriculture and
geography. The concepts central to the classical theory were first described in the 1930s
by researchers studying the adoption of hybrid corn in farming. Whilst observing the
process they noticed patterns of communication and influence amongst the farmers
(Lennarson Greer 1977). Since then, Everett Rogers has been primarily responsible for
the scholarly development of Diffusion of Innovations theory (Rogers 1962; Rogers and
Shoemaker 1971; Rogers and Agarwala-Rogers 1976; Rogers 1983, 2003). Other
scholars who have contributed to the development of the theory include Downs and
Mohr (1976), Brown (1981) and Tornatzky and Fleischer (1990).

Diffusion of Innovations research has produced a substantial body of literature and
publications covering a range of academic disciplines including geography, education,
economics and sociology (Mahajan and Peterson 1985). However, as literature were not
discovered which directly related to the combination of diffusion theory and IPCP, this
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preliminary literature review focuses on Diffusion of Innovations theory as it relates to
the organisation and delivery of health services and IPCP.
3.3.1 Diffusion of Innovations in an Organisation
It has been argued in the literature that classical Diffusion of Innovations theory was
limited in its application to organisational adoption of innovations (Lennarson Greer
1977). It was generally accepted that the classical theory was limited to explaining
adoption of innovations by single individuals. After the first edition of “Diffusion of
Innovations” was published (Rogers 1962), Everett Rogers began exploring innovation
in organisations, resulting in the development of a clear description of how the classic
theory applied to organisations (Rogers and Agarwala-Rogers 1976; Rogers 2003).
Rogers (2003) suggested that the focus of research into innovation in organisations was
on the innovation process itself. This was achieved by using a staged model. The
process specific to organisations was a sequence of five stages, which were divided into
two sub-processes, initiation and implementation.

Initiation involved the information gathering, conceptualising, and the planning of
adoption of the innovation leading up to the point where the decision was made to adopt
the innovation. The implementation was all the events, actions and decisions which
were involved in putting the innovation into use. The decision to adopt was the event
that divided initiation from implementation (Rogers 2003). Other researchers added to
this model, examining sequences in the innovation process, divergent and parallel paths,
and feedback and feed forward cycles (Wolfe 1994). Wolfe suggested investigating the
innovation process in a more meaningful manner by not only examining stages but also
sequences, divergent and parallel paths, feedback and feed forward cycles in the process
(1994).
3.3.2 Diffusion of Innovations theory in IPCP adoption
The adoption of infection prevention and control programmes in healthcare settings has
not figured prominently in Diffusion of Innovations research. To explore the study’s
aim, through the frame of the classic Diffusion of Innovations model, an extensive
search of the literature was performed. The review concentrated on Diffusion of
Innovations theory in relation to infection prevention and control, and searched for
evidence specifically related to the adoption of IPCPs. It was anticipated that the review
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would provide evidence that the classic Diffusion of Innovations model could be used to
explain the success or failure of the adoption of an IPCP.

The search terms used were: infection control, infection prevention, nosocomial
infection control, infection control programme, infection prevention and control
programme, healthcare associated infection and Diffusion of Innovations. The databases
used for the search were Medline, CINAHL, Proquest Central, Academic Onefile,
Academic Research Library, Science Direct, Cochrane, PsycArticles and ERIC. There
were no time parameters included in the search, and results were only sought if they
were written in English. In total, 88 abstracts were found using these search criteria
(Figure 2). Of these 88, most reported or described the adoption of individual IPCP
components not the comprehensive technology cluster. Of the IPCP core components
reported, the majority of the articles focused on the adoption of technical guidelines
(n=17). The other more numerous articles related to the adoption of public health
promotion activities which had a large HIV focus (n=26) and the adoption of evidence
based practice (n=22). Two of the articles had no healthcare delivery relevance at all.

What was absent from the results of this search was literature that addressed the
adoption of a comprehensive IPCP. This absence of literature regarding the adoption of
an IPCP, particularly as it pertained to Diffusion of Innovations theory, suggested three
possible situations:
1. There had been no studies that examined the adoption of an IPCP using
Diffusion of Innovations theory
2. IPCP had been adopted unknowingly following a Diffusion of Innovations
process
3. Studies of IPCP adoption may have been reported in a language other than
English
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Figure 2: Flow chart of preliminary literature search
IPCP Core components
•
Organisation of IPCP
•
Technical guidelines

•
•
•
•

Total
number of
screened
articles
n = 88

Comprehensive
IPCP adoption
n=0

Further
investigation
required Chapter
4 and 5

•
•

n = 26

n=1 (Cryer and Cooper 2008)
n=17 (Abbott et al., 2006, Anderson et al.,
2009, Ball, 1995, Castledine, 2007, Ezedinachi et
al., 2002, Gagliardi et al., 2009, Jessop and
Hausman, Lagercrantz, 2007, Liyanage and
Egbu, 2008, Lubelchek and Weinstein, 2006,
Pittet, 2004, Safdar and Maki, 2006, Saint et al.,
2009, Siegel, 2008, Sproat and Inglis, 1994,
Vandijck et al., 2009, Wilkinson-Brice et al.,
2007)
Human resources
n=2 (Hall, 2003, Sinclair et al., 2002)
Surveillance of infections and assessment of compliance with infection prevention and
control practices
n=2 (Larson 2003; Mabey et al. 2004)
Microbiology laboratory support
n=0
Environmental minimum requirements n=4 ( American College of Clinical
Engineering and Dyro 2004; Baillie 2008; Garvin
1998; Welter and Dyro 2004)
Monitoring and evaluation of programmes
n=0
Links with public health and other relevant services
n=0

Other adoption studies n = 62
•
Public health promotion activities (HIV) n=26 (Bennett, Bennett et al., 1999, Bova,
Collins et al., 2006, Colon et al., 2009, Des
Jarlais et al., 2006, Frajzyngier et al., 2007,
Galavotti et al., 2008, Hamdallah et al., 2006,
Harshbarger et al., 2006, Hays et al., 2003, Hitt et
al., 2006, Ingram et al., 2008, Macauley, 2005,
Miller et al., Miller, 2001, Miller et al., 1998,
Moser and Mosler, 2008, Prather et al., 2006,
Rotheram-borus et al., 2009a, Rotheram-borus et
al., 2009b, Shea et al., 2006, Smith et al., 2006,
Somerville et al., 2006, Villarino et al., 1992,
Wingood and DiClemente, 2006)
•
Evidence based practice
n=22 (Bjerke, 2006, Brinsley et al., 2005,
Callaghan, 1998, Closs and Cheater, 1997,
Cullen, 2006, DeLise and Leasure, 2001, Garrett
and Yasnoff, 2002, Goss, 2007, Grossman and
Bautista, 2002, Kleiber, 2006, Krein et al., 2006,
Larson et al., 2007, Moser and Mosler, 2008,
Murphy and McLaws, 2000, Quiros et al.,
Rebchook et al., 2006, Rutledge and Bookbinder,
2002, Savage et al., 2008, Stone et al., 2007,
Szabo, 2001, Wallin, 2009, Ward, 2000)
•
Health information technology
n=4 (Grey, 2007, Hwang et al., 2008,
Osborne, 2007, Verhoeven et al.)
•
Dental technologies
n=3 (Benjamin, 2003, Dorsey et al., 1991,
Kunzel and Sadowsky, 1993)
•
Quality improvement
n=2 (Plsek 1997; Pronovost et al. 2008)
•
Research methodology
n=2 (Forman et al. 2008; Gilliam 2004)
•
Not healthcare related
n=2 (Lam and Schaubroeck 2000;
Shuttleworth et al. 2008)
•
Patient education
n=1 (Redman et al. 1987)
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3.4 Conclusion
This chapter provided an overview of the current knowledge of IPCPs in LMI countries.
In particular it highlighted an absence of reports of the adoption of IPCPs and/or the
process that this may follow. The findings from this brief review are further explored in
Chapter Four and Chapter Five.

The next two chapters comprise published articles. Chapter Four further examines the
literature regarding IPC in LMI countries. Chapter Five explores the two situations
suggested above, in essence, whether there are conceptual frameworks reported that
have informed the adoption of comprehensive IPCP. Chapter Five reports and discusses
the discovery of a relevant study that had unknowingly followed a Diffusion of
Innovations process, as previously suggested.
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ABSTRACT
Background
High income countries with established infection control programmes have
demonstrated effective control of infection transmission in healthcare settings. The
guidelines and advice underlying these effective control programmes have been
produced by high income countries for their own social, economic and health
environments.

These have also been adopted by low- and middle- income (LMI)

countries but these countries appear to have a limited ability to apply these principles
using the same methods.

Methods
A systematic search for literature published in English was conducted exploring the
relationship between the available infection prevention and control advice and the
capacity of LMI countries to apply this guidance in their healthcare settings. Articles
relevant to this exploration were identified and subsequently informed further search
terms and identified other significant documents.

Results
Infection control guidelines designed for high income countries are being utilised by
LMI countries, with varying degrees of success mainly due to physical, environmental
and socioeconomic factors.

There is a lack of published studies exploring the

implementation of comprehensive infection control advice and programmes, including
the minimal advice which is designed specifically for resource limited settings.

Conclusion
What is evident from the literature is that there is a need for the development of
infection control and prevention guidelines based on evidence but adapted to the
specific needs of healthcare workers in LMI countries. This must be done in
collaboration with those same LMI country healthcare workers. Equally due to finance
and health priorities healthcare facilities should choose those interventions most
relevant to the needs of their population and workers to prevent infection transmission.
Opportunities for further research into application of available infection control advice
in LMI countries are identified. Through such research more appropriate advice may be
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devised to assist with the development of infection control programmes in these
settings.
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4.1 Introduction
The efficacy of infection control programmes in reducing the incidence of healthcare
associated infection (HAI) has been well established in the literature, particularly in
high-income countries. These infection control programmes are informed by evidence
based guidelines and advice developed by internationally recognised health authorities
such as the United States Centers for Disease Control and Prevention (CDC) and the
World Health Organization (WHO). Based on such advice many countries, including
resource limited or low- and middle income (LMI) countries attempt to establish
infection control programmes, with varying degrees of success. This literature review
aims to explore the relationship between the available infection prevention and control
advice and the capacity of LMI countries to apply this guidance in their healthcare
settings.

4.2 Method
The categorisation of LMI countries include those in seven regions, with a few
exceptions, sub-Saharan Africa, India, China, other Asian countries, Latin America and
the Caribbean, the Middle Eastern crescent, and countries that comprise territories
included in the former socialist economies of Europe (Huskins et al. 1998). For the
purpose of the discussion of this paper, LMI countries are those with a gross national
income (GNI) per capita of between $825 USD, or less and $10 065 USD, and high
income countries are those with a GNI of $10 066 USD or more, as classified by the
World Bank (World Bank 2004).

In reviewing the literature a systematic search for literature published in English
available via MEDLINE for the years 1996 through to April 2006 was conducted. The
MEDLINE search was supplemented by a Cumulative Index to Nursing, Allied Health
Literature (CINAHL) search for the years 1982 through 2006. The search terms
included infection control and developing countries, infection control and developing
nations, infection control and limited resources, infection control guidelines, infection
control compliance, infection control efficacy, and infection control implementation.
Identified articles were used to select additional key terms for further searches. Other
relevant articles were identified from the bibliographies of these papers. A search was
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also conducted of the CDC and WHO published documents which focused on infection
control and prevention in healthcare settings.

Articles and documents sought in the review were those that examined the
implementation of comprehensive infection control programmes in LMI countries.
More specifically the search was for examination of programmes which had been based
upon advice and guidelines designed for high income countries, their evaluation and
identification of key elements of success or failure and lessons learnt from the
experience.

4.3 Results
4.3.1 Effectiveness of infection control programmes
Prevention and control of HAI is one of the greatest challenges confronting healthcare
providers around the world. Thorough studies of the impact of HAI in LMI countries
have not been performed but estimates indicate that they pose a substantial public health
problem, with HAI one of the most common adverse outcomes of healthcare (Huskins
et al. 1998). Studies of the United States experience estimate the cost of HAI to
annually exceed $6.5 billion in 2004 dollars (Stone et al. 2005). In dealing with the
potential human and financial costs caused by HAI it is generally recognised that an
effective infection control and prevention programme is the best way to minimise these
costs (Haley et al. 1985; Garner 1996; Herrick and Loos 1996; Huskins et al. 1998;
Scheckler et al. 1998; Farr 2000; Dembrey and Hierholzer 2001; Gulland 2001; Starling
2001; Health Canada 2004).

The Study on the Efficacy of Nosocomial Infection Control (SENIC), conducted in the
mid-1970s, was the first comprehensive, and considered seminal, study of the burden of
HAI in the United States which also established an association between intensive
infection control and surveillance programmes with reduced rates of HAI by 32% and
subsequent healthcare costs (Haley et al. 1985). If an average HAI rate of 8% was
present in the LMI countries of Asia and Africa, with the cost of an infection being
between $50 USD and $500 USD, it is estimated that a 32% reduction in HAI could
result in a saving of $230 million USD to $2.3 trillion USD annually (Nyamogoba and
Obala 2002).
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Since SENIC a number of other studies have reinforced the efficacy of infection control
programmes in reducing HAI and associated costs. This has resulted in health
authorities such as CDC, WHO and professional organizations such as the Society of
Healthcare Epidemiology of America (SHEA), as aforementioned, to continually refer
to infection control and prevention programmes and their activities as essential in the
provision of safe healthcare (Garner 1996; Centers for Disease Control and Prevention
1998; Centers for Disease Control and Prevention and World Health Organization 1998;
Scheckler et al. 1998; Mangram et al. 1999; Centers for Disease Control and Prevention
2001; Dembrey and Hierholzer 2001; Centers for Disease Control and Prevention
2002a, 2002b; World Health Organization 2002; Centers for Disease Control and
Prevention 2003, 2004; Jackson et al. 2004; World Health Organization 2004). This has
consequently encouraged health authorities worldwide to adopt and implement
comparable programmes (Nettleman 1993; Leu 1995; Huskins et al. 1998).
4.3.2 Available infection control advice
The most prolific publisher of evidence based infection control guidelines has been the
Healthcare Infection Control Practices Advisory Committee (HICPAC) of the CDC
(Dembrey and Hierholzer 2001). The guidelines produced by the CDC include topics
such as isolation precautions (Garner 1996), hand hygiene (Centers for Disease Control
and Prevention 2002a), oral health (Centers for Disease Control and Prevention 2003),
protection of healthcare workers (Centers for Disease Control and Prevention and
World Health Organization 1998; Centers for Disease Control and Prevention 2001),
environmental hygiene (Sehulster et al. 2003) and prevention of various types of HAI
(Mangram et al. 1999; Centers for Disease Control and Prevention 2002b, 2004). It is
generally accepted that the guidelines produced by the CDC are designed for healthcare
environments of the United States, to meet regulatory requirements (Simmons and
Gross 2001). Though this may be the case, many other countries, rich and poor, as well
as international health bodies such as the WHO, look to these guidelines and advice to
develop their own programmes and guidelines. This has mainly been due to the
evidence generated from the seminal SENIC study, as described earlier.

The WHO has produced a number of comprehensive infection prevention and control
guidelines not only for healthcare settings but also for community health and specific
infectious diseases (World Health Organization 2002, 2004). These guidelines are again
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based on those produced by the CDC and evidence from high income countries. These
guidelines address the needs for countries with limited resources to some extent but do
not provide assistance on how to adapt them to the local environment. One document
significantly different from these guidelines is the joint WHO and CDC Infection
Control for Viral Haemorrhagic Fevers in the African Health Care Setting which has
been specifically designed as emergency guidelines for resource limited healthcare
settings in African countries during outbreaks of disease such as Ebola haemorrhagic
fever (Centers for Disease Control and Prevention and World Health Organization
1998).

The International Federation of Infection Control (IFIC) has sought to assist LMI
countries in particular by producing an infection control guideline to be used as a
foundation for the development of local policies and procedures, focusing on the very
basic evidence based principles of infection control and prevention. The document is
used extensively in training workshops conducted by IFIC member societies and is
considered a global guideline as it is free from social and cultural restraints of individual
countries (International Federation of Infection Control 2003). However, there have
been no studies that have examined how successful this advice is in the LMI country
setting.

The WHO has also recognised the importance of contextually appropriate infection
control guidelines, particularly for LMI countries. One example of this was the
development of the WHO Regional Office for Africa (AFRO) Infection Control Toolkit
which aims to provide evidence based infection control advice whilst recognising the
resource, infrastructure and educational limitations present in African healthcare
settings (Reid 2001). This toolkit recognises that the principles of infection control and
prevention always remain the same; it is how they are implemented within the context
of a particular healthcare environment which may differ. As with the IFIC guideline,
there have been no studies that have examined how successful this advice is in the LMI
country setting.

38

4.3.3 Implementation of advice and infection control programmes in low- and
middle income countries
For those countries who have equivalent or similar resources to the United States
implementing guidelines similar to that of the CDC or WHO does not appear to be a
problem, however it has been reported in the literature that resource limited countries
appear to have some difficulty implementing these guidelines in their settings
(Nettleman 1993; Huskins et al. 1998; Lim 2001; Starling 2001; Raza et al. 2004).

It is generally recognised that the lower the economic status of a given population or
nation, the greater the significance and impact of infectious diseases and HAI in
mortality and decreased quality of life (Isturiz and Carbon 2000; Starling 2001; World
Health Organization 2002; Rosenthal et al. 2003a; Yalcin 2003). Hence the importance
of infection prevention and control programmes in LMI countries is evident. The
available literature which examines infection control programmes in LMI countries
consists predominantly of review papers or case study reports, focusing on the adoption
or modelling of individual components of an infection control programme rather than
the implementation of a comprehensive plan.

A number of successful model infection control programmes in LMI countries have
been reported in the literature, but these programmes have been located at primarily
academic or well funded urban facilities (Huskins et al. 1998). When reviewing the
literature it is difficult to ascertain the economic situation of those facilities reporting
their findings. Of the literature relevant to this review most papers were from four main
regions: 1) South America (Ponce-de-Leon 1991; Lima et al. 1993; Berg et al. 1995;
Orrett et al. 1998; Rosenthal et al. 2003a; Rosenthal et al. 2003b; Macias et al. 2004;
Rosenthal et al. 2004; Lobo et al. 2005; Rosenthal et al. 2005); 2) Asia (Rhinehart et al.
1991; Leu 1995; Merchant et al. 1998; Lim 2001; Marjadi 2001; Kermode et al. 2005);
3) Africa (Bowen-Jones et al. 1990; Cronin et al. 1991; Foorder 1993; Jepsen et al.
1993; Foorder 1995; Issack 1999; McCarthy et al. 2000; Ansa et al. 2002; Eriksen et al.
2003); and 4) the Middle East (Khuri-Bulos et al. 1999; Askarian et al. 2005a; Askarian
et al. 2005b; Memish et al. 2005). Arguably the most prolific publishing countries from
this selection would generally be considered on the upper end of the LMI scale or even
considered high income in some situations (World Bank 2004).
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Most papers reported on the implementation of individual infection control programme
components, not implementation of comprehensive advice. Approximately half of the
above mentioned articles were reports of surveillance studies to measure the incidence,
causes and consequences of HAI and potential prevention methods (Bowen-Jones et al.
1990; Jepsen et al. 1993; Lima et al. 1993; Berg et al. 1995; Merchant et al. 1998; Orrett
et al. 1998; Khuri-Bulos et al. 1999; Eriksen et al. 2003; Rosenthal et al. 2003a;
Rosenthal et al. 2003b; Macias et al. 2004; Rosenthal et al. 2004; Lobo et al. 2005;
Rosenthal et al. 2005). A number of these utilised CDC guidelines (Garner et al. 1988;
Mangram et al. 1999; Centers for Disease Control and Prevention 2002b; 2004) for case
definitions and surveillance methodology without any alteration, for validity and ease of
comparability with the United States National Nosocomial Infections Surveillance
(NNIS) (Lima et al. 1993; Berg et al. 1995; Khuri-Bulos et al. 1999; Eriksen et al. 2003;
Rosenthal et al. 2003a; Rosenthal et al. 2003b; Rosenthal et al. 2004; Rosenthal et al.
2005). In each of these studies there were no problems reported in applying the CDC
advice on surveillance to the respective healthcare settings, though in comparison with
the NNIS data, generally the LMI countries demonstrated higher rates of HAI (Berg et
al. 1995; Khuri-Bulos et al. 1999; Rosenthal et al. 2003a; Rosenthal et al. 2004; Lobo et
al. 2005). These studies did not provide substantive information as to: 1) what other
infection control programme components were in place; 2) whether there were policies
or practices in place for basic infection prevention; 3) the financial cost of implementing
individual programme components; or 4) what available infection control advice they
may have been based upon.

Perhaps one of the best reviews of infection control programme implementation and
interventions, from available advice and guidelines, found through this literature review
is a series conducted in Argentina (Rosenthal et al. 2003a; Rosenthal et al. 2003b;
Rosenthal et al. 2004; Rosenthal et al. 2005). These studies examined the incidence of
HAI in specific intensive care units (ICU) of Argentine hospitals before and after the
implementation of globally accepted infection control and prevention interventions such
as staff education, performance feedback and enhancement of compliance with hand
hygiene, all key components of an infection control programme, but not indicative of a
comprehensive programme. The studies demonstrated improvement in HAI rates post
interventions in study facility ICUs, resulting in a decrease from 45.94 bloodstream
infections (BSI)/1000 intravascular device (IVD) days to 11.10 BSI/1000 IVD days and
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47.55 HAI/1000 bed days to 27.93 HAI/1000 bed days. It is important to note that the
sites involved with the Argentine studies had infection control teams in place. These
teams had received formal training in infectious disease control and prevention, were
located in Buenos Aires with the ICUs operating at a tertiary care teaching level. This
reflects the previous finding that most programmes and studies have been located at
primarily academic or well funded urban facilities. Even so, through conducting these
studies barriers to implementation of available advice were identified such as lack of
resources, lack of organised infection control programmes, healthcare staff unaware of
infection prevention methods and lack of institutional support (Rosenthal et al. 2003b;
Rosenthal et al. 2005). Similar barriers to implementation of available infection control
advice in LMI countries have been reported in the literature, as shall be described
further.
4.3.4 Barriers to implementation of infection control advice in low- and middle
income countries
It is well recognised that the principles of infection control remain the same regardless
of the healthcare environment, yet how they are implemented depends on a number of
factors (Nettleman 1993; Huskins et al. 1998; Raza et al. 2004). It has been indicated in
a number of papers that the United States or high income experience of infection control
is not applicable to resource limited countries (Nyamogoba and Obala 2002; Raza et al.
2004; Kermode et al. 2005).
Unfortunately much of the Western experience is not applicable to developing
countries owing to the high costs involved and local factors such as climate,
socioeconomic and demographic conditions, antibiotic prescription habits and
bacterial resistance patterns (Raza et al. 2004, p.295).

The report of an endeavour to implement an infection control programme based upon
CDC infection control guidelines in an Indonesian paediatric ICU has also described a
number of barriers in the attempt (Rhinehart et al. 1991), similar to those in the
Argentine setting mentioned previously. It was found that literal adoption of CDC
guidelines, as would occur in a high income country was impossible due to: 1) the poor
physical environment such as absence of hand washing basins and presence of
contaminated tap water; 2) budgetary constraints; 3) unreliable and inappropriate supply
of equipment and supplies including reuse of single use items, poor storage of
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reprocessed items and overuse of expensive disinfection agents; 4) limited
microbiological diagnostic facilities; 5) lack of healthcare worker knowledge
particularly regarding transmission risks associated with poor practice; 6) local customs
and culture including the hierarchical relationship between physicians and nurses; 7)
lack of institutional support from the hospital administration and infection control
infrastructure; and 8) poor sterilisation capabilities (Rhinehart et al. 1991). Given this
situation each CDC guideline was reviewed and adapted to the local circumstances in
collaboration with hospital counterparts.

One of the very important lessons learnt from the Indonesian study was that LMI
countries look to the United States and other high income countries for infection control
advice, but this advice may not be directly applicable in the presence of resource
limitations (Rhinehart et al. 1991). It was found and reported that the CDC guidelines
were not suitable for resource limited settings, their populations, environments or
cultures and that this needs to be taken into consideration in the future, going on to
suggest that additional research must be made into exploring flexible assessment and
delivery methods in LMI countries for infection control (Rhinehart et al. 1991).
Methods to overcome the barriers identified from the review include ensuring that the
available infection control advice is adapted to the local environment and context,
making use of available resources and targeting interventions to those infectious
diseases of local importance (Ponce-de-Leon 1991; Rhinehart et al. 1991; Raza et al.
2004). In achieving this local expertise must be utilised (Rhinehart et al. 1991; Raza et
al. 2004).
Only policies adapted to local conditions, ‘owned’ and practised by local experts
and workers are likely to be sustainable (Raza et al. 2004, p.298).

The published literature indicates the barriers to using unadapted infection control
advice are: most LMI countries do not have or have weak infection control
programmes; infection control programmes are often unidirectional focusing only one
or a few interventions such as surveillance or antibiotic usage; local studies and local
expertise are not utilised in developing infection control programmes; resource
allocation to the health sector and delivery system must be addressed; and human
resources must also be developed (Mortensen 1991; Sobayo 1991; Nettleman 1993;
Huskins et al. 1998; Starling 2001; Nyamogoba and Obala 2002). Other more physical
42

limitations to infection control include a lack of equipment and consumable items such
as sharps containers, sterilisers, disinfectants, personal protective equipment (PPE),
running water and electricity (Sobayo 1991; Nettleman 1993; Starling 2001). In addition
to this other health priorities for LMI countries such as nutrition, high mother and infant
mortality rates and community infectious disease outbreaks take precedence over HAI
and their control (Meers 1988).

4.4 Discussion
An infection control programme is a collection of activities, policies and procedures
designed to control and prevent the transmission of infectious diseases within the
healthcare environment and the community (Farr 2000). This is achieved through
monitoring infections and implementing control measures through education of patients,
employees and visitors in the principles and practices of infection control and
prevention. Essential components of an infection control programme include infection
control policy and procedure development, surveillance, outbreak management,
education, employee health, programme oversight, programme documentation (Herrick
and Loos 1996; Health Canada 2004).
The success or failure of the infection control program is defined by its
effectiveness in achieving its goals (Scheckler et al. 1998, p.48).

An effective infection control programme can only be achieved when all essential
elements are implemented in the context of a specific healthcare environment.
Introducing and conducting individual components such as surveillance of HAI in an
environment where basic infection control policies and practices are absent for patient
and healthcare worker safety is inappropriate.

Quality studies of the comprehensive implementation of high income country-style
infection control programmes are generally unavailable in the literature. One reason for
this is that such reports are rarely published in English, particularly from Asian
countries (Leu 1995; Starling 2001).
The number of papers published in the international literature certainly does not
reflect the level of infection control activities in developing countries. Language
barriers and sometimes other simple obstacles may discourage infection control
professionals from publishing their personal experiences (Starling 2001, p.465).
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What are available though are reviews of the general issues related to implementing
infection control programmes in LMI countries or reviews of individual component
implementation, such as surveillance.

The study from Indonesia is perhaps the most comprehensive published review of the
implementation of an all-inclusive infection control programme, based on original CDC
guidelines which have now been updated, in a LMI country (Rhinehart et al. 1991). This
project identified the key issues which prevent the unadapted adoption of high income
country guidelines in the LMI setting, while establishing a strategy to transform them
into contextually appropriate useful policies and procedures, as outlined in Table 1
(Rhinehart et al. 1991). This strategy could arguably be replicated in other settings.

Table 1: Strategy to adapt available guidelines to the LMI country context
1. Assess the existing situation through interviews, site visits and practice
observation
2. Adopt a flexible approach to implement or reinvigorate infection control
programmes
3. Institute a broadly representative infection control committee with strong
leadership support
4. Appoint and train dedicated health care workers to become infection control
professionals
5. Establish simple surveillance mechanisms where indicated, focusing on high risk
areas
6. In collaboration with local health care workers, review and modify available
guidance, such as that from CDC, to suit local conditions, practice and
resources, using a low technology, low cost approach

Healthcare facilities in LMI countries which experience the previously mentioned
barriers and capacity limitations are in no position to be able to implement the available
infection control advice from the CDC, WHO or IFIC. From this it is evident that there
does appear to be limitations for LMI countries to implement this advice. What is also
evident is there is an opportunity for further research into this area, particularly in the
form of studies of implementation of the available advice in the LMI country setting.
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Infection control in developing countries differs markedly from that in
developed countries. It is important that both local and international authorities
take these differences into account when formulating policies for use in
developing countries (Raza et al. 2004, p.294).

4.5 Conclusion
Is the current infection control advice applicable in LMI countries? Does this advice
help or hinder? What is evident from the literature is that there is a need for the
development of infection control and prevention guidelines based on evidence but
adapted to the specific needs of healthcare workers in LMI countries. This must be done
in collaboration with those same LMI country healthcare workers. Equally due to
finance and health priorities healthcare facilities should choose those interventions most
relevant to the needs of their population and workers to prevent infection transmission.

Evidence based infection control and prevention guidelines and advice is readily
available and their efficacy is well established through the successful implementation
and monitoring of infection control programmes. The advice provided is however
designed for healthcare environments the same as or similar to those in the United
States and other high income countries.

This literature review has highlighted some of the capacity issues that LMI countries
experience when implementing the available advice. The literature identifies resource
limitations in LMI countries which make comprehensive implementation of available
advice either difficult or near impossible. The resource limitations include not only
those of a physical or monetary nature but are also in the form of health priorities and
human resources.
Additional research is needed to refine flexible methods for rapidly assessing the
specific infection control needs of institutions with widely disparate resources,
patient populations, environments and cultures (Rhinehart et al. 1991, p.S213).

This review has also highlighted the opportunity for further research on this topic.
Available studies focus mainly upon the implementation of individual infection control
programme components, such as surveillance rather than the comprehensive adoption of
the available advice, whether designed for high income or LMI settings, and
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measurement of the success of such endeavours. By examining such situations, lessons
may be learnt on how to best adapt the advice to specific healthcare environments or
create resource specific advice, assisting with ease of use in the LMI context.
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Introduction
This chapter consists of a manuscript accepted for publication. It is presented in a form
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imposed as a result of this dissertation style of presentation. This chapter builds on the
investigation and findings of Chapter Three and Chapter Four. The presentation of the
chapter as a stand-alone article, and thus providing a more complete picture of the
available body of knowledge, has resulted in some duplication of the presentation of
information.

The article reports on the component of the overall study that reviewed literature to
identify frameworks used to explain the adoption process of comprehensive infection
prevention and control programmes (IPCP). In the article it has been identified there
was an absence of reports in the literature which examined the adoption of a
comprehensive IPCP whilst using a theoretical framework. The literature reviewed in
this chapter provides evidence to support the case that the diffusion of innovation
process in an organisation is relevant as a framework to examine the adoption of
comprehensive IPCP in healthcare organisations.
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ABSTRACT
The importance of comprehensive infection prevention and control programmes (IPCP)
to prevent healthcare associated infection is well reported in the literature. What is not
as well reported are the conceptual frameworks that guide the adoption of these
comprehensive programmes. By reporting the catalysts and processes associated with
the successful adoption of IPCPs a template for successful programme implementation
may be developed that will assist others in recognising such opportunities, thus allowing
replication. This paper provides stimulus for such adoption and implementation.

A systematic review of the literature was undertaken to identify reports of
comprehensive IPCP adoption and the conceptual frameworks used in the process. The
review activity revealed an absence of relevant literature examining the adoption of
comprehensive IPCP or associated conceptual frameworks. Only one study was
published which demonstrated the Diffusion of Innovations framework, and it is
discussed in more detail. The outcome of this literature review points to a clear need for
more research into IPCP adoption. This is especially important as relevant literature
would assist low resourced healthcare settings in their adoption of comprehensive
IPCPs.
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5.1 Background
Prevention and control of healthcare associated infections is an increasingly important
element in the provision of health services globally (Informal Network on Infection
Prevention and Control in Health Care 2009). It relates to not only protecting those
accessing health services from the spread of infectious or pathogenic disease but also to
protecting healthcare workers, their families, and other persons associated with health
services. A locally adapted comprehensive infection prevention and control programme
(IPCP) is imperative to the management of healthcare associated infections (Informal
Network on Infection Prevention and Control in Health Care 2009).

An IPCP is a collection of activities, resources, policies and procedures designed to
control and prevent the transmission of infectious diseases within the healthcare
environment and the community (Farr 2000). Core components of an IPCP have been
categorised by the World Health Organization (WHO) as:
•

Organization of IPCP

•

Technical guidelines

•

Human resources

•

Surveillance of infections and assessment of compliance with infection
prevention and control practices

•

Microbiology laboratory support

•

Environmental minimum requirements

•

Monitoring and evaluation of programmes

•

Links with public health or other relevant services (Informal Network on
Infection Prevention and Control in Health Care 2009).

IPCPs are a cluster of individual components which are closely inter-related. IPCPs in
high-income countries have demonstrated effective control of infection transmission in
healthcare settings (Haley et al. 1985; Informal Network on Infection Prevention and
Control in Health Care 2009). Relative to the experience of high-income countries,
low- and middle-income (LMI) countries have adopted IPCPs, or parts thereof, with
varying degrees of success (Leu 1995; Huskins et al. 1998). Studies of the adoption of
IPCP in LMI countries are generally unavailable in the literature. What are available are
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reviews of the general issues related to adopting IPCP in LMI countries or reviews of
individual components of adoption, such as surveillance. Of these reviews (Mortensen
1991; Sobayo 1991; Nettleman 1993; Huskins et al. 1998; Starling 2001; Nyamogoba
and Obala 2002) the major problems identified are:
•

most LMI countries have weak or absent IPCP,

•

IPCP are often unidirectional focusing on only one or a few interventions such
as antibiotic usage,

•

local studies and local expertise are not utilised in developing an IPCP,

•

appropriate and sufficient resource allocation to the health sector and delivery
system is not addressed,

•

human resources are not adequately developed to support IPCP adoption,

•

there is a lack of equipment and consumable items such as sharps containers,
sterilisers, disinfectants, PPE, running water and electricity.

To gain a greater understanding of the process of adoption of IPCPs requires
exploration of the process itself, not just whether selected key components are in place.
By reporting the catalysts and processes associated with the successful adoption of
IPCPs, it may be possible to develop a template for successful programme
implementation. This may assist others to recognise such opportunities, thus allowing
replication.

The adoption of knowledge and technological innovations into clinical practice and the
delivery of health services involve appropriate facilitation, such as the insight gained
through the use of conceptual frameworks. A conceptual framework is a group of
concepts or ideas that are broadly described and systematically organized to provide a
focus, a rationale, and a tool for the integration and interpretation of information
(Mosby 2009). It provides a frame within which to understand the process of transfer,
transformation and adoption of policies and practices, such as those in an IPCP
(Donaldson et al. 2004). The reporting of the conceptual frameworks utilised in
adoption processes also assists translation into other clinical contexts (Donaldson et al.
2004).
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The following review seeks to detect the conceptual frameworks that have been utilised
in the adoption of comprehensive IPCPs, regardless of economic well-being, reported in
the literature. The aim of this is to identify how adoption of comprehensive IPCPs can
be facilitated in LMI country settings.

5.2 Methods: A systematic review of the literature
Literature was sought based on three parameters: 1) literature must be published in
English; 2) available on MEDLINE, ERIC, CINAHL or Web of Science, and 3) no time
limits were defined. The initial search terms were: infection control and adoption,
infection control and implementation.

The search was then extended to include

additional search terms based on analysis of the first search yield. These search terms
included: infection control/mt (methods), program implementation and program
adoption. The search was not limited to studies from LMI countries. Other relevant
articles were identified from the bibliographies of these papers.

Articles which

demonstrated a conceptual framework in the adoption or implementation of a
comprehensive IPCP were then selected from this extended sample.

5.3 Results
5.3.1 Theoretical frameworks for IPCP adoption
The initial literature search found 101 articles that described the adoption or
implementation of a comprehensive IPCP. Analysis of these found that 75 made no
reference to any conceptual adoption framework. A further 15 did not have any
relevance to hospital based IPCP though they demonstrated the use of an adoption
framework. The remaining 11 articles demonstrated the application of a conceptual
framework and relevance to aspects of a hospital based IPCP (Leu 1995; Pittet et al.
2000; Misset et al. 2004; Abbott et al. 2006; Vollman 2006; Hall et al. 2007; Harnage
2007; Larson et al. 2007; Muder et al. 2008; Farrell and Petrik 2009; Scales et al. 2011).
However, only one paper reported a study that demonstrated a conceptual framework in
the adoption of a comprehensive IPCP (Leu 1995). The absence of such studies
therefore forced an examination of those studies that identified core IPCP components
and their associated adoption frameworks, each with varying levels of success. Hence,
all 11 articles were included for analysis in this study. Classification of these articles as
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to the programme component and the framework identified within the article is
presented in Table 1.

Table 1: Adoption studies of individual IPCP core components which demonstrate
a theoretical framework.
Article

IPCP component

Framework

1. Introduction of an isolation

•

Technical guidelines

Change leadership (Kotter

policy in paediatric wards (Hall •

Surveillance of infections

1996)

et al. 2007)

and assessment of
compliance with IPC
practices

2. Achieving zero catheter related

•

Technical guidelines

The Model for Improvement

blood stream infections: 15

•

Surveillance of infections

(Langley 2009)

months success in a community

and assessment of

based medical center (Harnage

compliance with IPC

2007)

practices
•

Monitoring and evaluation of
programmes

3. Effectiveness of a hospitalwide programme to improve

•

Technical guidelines

Behavioural theory (Kretzer

•

Surveillance of infections

and Larson 1998)

compliance with hand hygiene

and assessment of

(Pittet et al. 2000)

compliance with IPC
practices
•

Monitoring and evaluation of
programmes

4. Implementation of an industrial •
systems-engineering approach

•

Technical guidelines

Toyota Production System

Surveillance of infections

(Spear and Bowen 1999)

to reduce the incidence of

and assessment of

methicillin-resistant

compliance with IPC

Staphylococcus aureus

practices

infection (Muder et al. 2008).

•

Monitoring and evaluation of
programmes

5. A Multifaceted Intervention for •
Quality Improvement in a

•

Technical guidelines

Continuous quality

Surveillance of infections

improvement

Network of Intensive Care

and assessment of

Units A Cluster Randomized

compliance with IPC

Trial (Scales et al. 2011)

practices
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Article

IPCP component
•

Framework

Monitoring and evaluation of
programmes

6. A continuous qualityimprovement program reduces

•

Technical guidelines

Continuous quality

•

Surveillance of infections

improvement

nosocomial infection rates in

and assessment of

the ICU (Misset et al. 2004)

compliance with IPC
practices
•

Monitoring and evaluation of
programmes

7. Ventilator-associated

•

Technical guidelines

pneumonia and pressure ulcer

Continuous quality
improvement

prevention as targets for quality
improvement in the ICU
(Vollman 2006)
8. Dissemination of the CDC's

•

hand hygiene guideline and

Monitoring and evaluation of

Diffusion of Innovations

programmes

impact on infection rates
(Larson et al. 2007)
9. Infection control. The impact

•

All IPCP core components

Diffusion of Innovations

•

Technical guidelines

Diffusion of Innovations

•

Surveillance of infections

(Rogers 1995)

of US-style infection control
programs in an Asian country
(Leu 1995)
10. Adoption of a ventilatorassociated pneumonia clinical
practice guideline (Abbott et al.

and assessment of

2006)

compliance with IPC
practices
•

Monitoring and evaluation of
programmes

11. Hydration and nosocomial

•

Technical guidelines

Diffusion of Innovations –

pneumonia: killing two birds

Champions (Higgins and

with one stone (a toothbrush)

Howell 1990)

(Farrell and Petrik 2009)

A total of six frameworks were identified through the review of the literature: change
leadership (Hall et al. 2007), the model for improvement (Harnage 2007), behavioural
theory (Pittet et al. 2000), the Toyota production system (Muder et al. 2008) continuous
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quality improvement (Misset et al. 2004; Vollman 2006; Scales et al. 2011) and
Diffusion of Innovations (Leu 1995; Abbott et al. 2006; Larson et al. 2007; Farrell and
Petrik 2009). Continuous quality improvement (n=3) and Diffusion of Innovations
(n=4) were the frameworks more frequently identified.

In relation to the IPCP component that was the focus of the 11 reported interventions,
the adoption of technical guidelines (n=9) was most frequently reported. This was
followed by the adoption of surveillance of infections and assessment of compliance
with IPC practices (n=7) and monitoring and evaluation of programmes (n=7) equally.
In approximately half of the studies, the adoption of technical guidelines occurred with
associated surveillance and monitoring and evaluation components (n=6).

Only one of the 11 studies examined the adoption of all the components of the WHO
defined comprehensive IPCP (Leu 1995). This Taiwanese case described the gradual
adoption of IPCP core components beginning in 1976 and continuing through to 1994;
the paper was subsequently published in 1995. The author identified catalytic incidents,
such as the local staff visiting healthcare facilities in the United States and an outbreak
of salmonellosis, which identified the need for an IPCP, as well as a resolution to a gap
in the provision of care. This was then addressed by seeking assistance from external
sources, training of local staff and the establishment of multi-disciplinary infection
control committees, targeted surveillance programmes and local infection control
manuals suited to the needs of their healthcare environment. Eventually the programme
was accepted by the Department of Health and became part of the routine
administration and accreditation processes of health facilities in Taiwan (Leu 1995).

This one case report, in Taiwan, did not make direct reference to any conceptual
framework, though it clearly followed the initiation and implementation stages of the
Diffusion of Innovations process in organisations, as shall be discussed (Rogers 2003).

5.4 Discussion
From the results it is evident that there is an absence of literature that reports studies
that have applied conceptual frameworks to describe and analyse the adoption of
comprehensive IPCPs within healthcare settings. The frameworks which dominated the
literature focused on continuous quality improvement and Diffusion of Innovations.
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The only study which examined adoption of a comprehensive IPCP clearly
demonstrated the Diffusion of Innovations stages, even though it did not overtly
position the activities within this framework. As the aim of this review was to identify
those studies in the literature which identified frameworks for the adoption of
comprehensive IPCPs, the role of conceptual frameworks with particular reference to
Diffusion of Innovations will be discussed further below. It is from this discussion that
the stages of the Diffusion of Innovations framework can be recognised in the
Taiwanese experience of comprehensive IPCP adoption.
5.4.1 Conceptual frameworks and IPCP
The successful use of conceptual frameworks to translate evidence into practice in
various healthcare disciplines is well recognised in the literature (Donaldson et al. 2004;
Sudsawad 2005; Biron et al. 2007; Danjoux et al. 2007; Gagnon et al. 2007; Kolok et al.
2009; Atun et al. 2010; Drolet and Lorenzi 2011). Unfortunately, this does not appear
to be the case for the adoption of comprehensive IPCP, as it appears there has been
essentially no method for capturing and sharing lessons learned from the process of
adopting IPCPs. Consequently, the adoption of an IPCP may be an unplanned decision
in healthcare organisations, occurring under independent circumstances. This has been
similarly recognised in the adoption of surgical innovation (Martin et al. 2003; Danjoux
et al. 2007).

The reporting of the experiences of IPCP adopters, particularly in LMI countries, could
provide significant guidance to clinicians and administrators who aim to achieve such a
programme (Donaldson et al. 2004; Danjoux et al. 2007).

The importance of

identifying the events and stimuli that influence the adoption of such an innovation is
critical to other healthcare organisations’ abilities to mirror the process (Donaldson et
al. 2004).
5.4.2 Diffusion of Innovations and IPCP
Diffusion of Innovations research has produced a substantial body of literature with
publications covering a range of academic disciplines including geography, education,
economics and sociology (Mahajan and Peterson 1985). The concepts central to
classical theory were first described in the 1930s by researchers studying the adoption
of hybrid corn in farming.

Whilst observing the process they noticed patterns of
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communication and influence amongst the farmers (Lennarson Greer 1977). Since then
Rogers has been responsible for most of the scholarly development of Diffusion of
Innovations theory (Rogers 1962; Rogers and Shoemaker 1971; Rogers and AgarwalaRogers 1976; Rogers 1983, 1995, 2003). Other scholars who have contributed to the
development of the theory include Brown (1981), Downs and Mohr (1976) and
Tornatzky and Fleischer (1990).

More recently a major review conducted by the United Kingdom Department of Health
to explore the use of the Diffusion of Innovations framework in health service
organisations has been reported (Greenhalgh et al. 2005).

Classic Diffusion of Innovations theory describes “…the process by which an
innovation is communicated through certain channels over time among the members of
a social system” (Rogers 1983, p.5). In diffusion research studies, programmes or
campaigns four key elements are consistently present: 1) an innovation; 2)
communication channels; 3) time; and 4) a social system (Rogers 1962, 1983, 2003).

When examining the diffusion of an IPCP in a healthcare environment the innovation 1)
would be the programme, the communication channels 2) are the means by which
information and messages about IPCPs are shared, time 3) includes the rate of adoption,
the innovation-decision process and the innovativeness of the individual or organisation
and the social system 4) is the healthcare environment and infrastructure where the
adoption is to take place.

It has been argued in the literature that classical Diffusion of Innovations theory is
limited in its application to organisational adoption of innovations such as in the
healthcare setting (Lennarson Greer 1977). It was generally accepted that classical
theory was limited to explaining adoption of innovations by single individuals. After the
first edition of “Diffusion of Innovations” was published, Rogers began exploring
innovation in organisations, resulting in the development of a clear description of how
the classic theory is applied to organisations (Rogers 1962; Rogers and AgarwalaRogers 1976; Rogers 2003). Rogers suggests that the focus of research into innovation
in organisations is upon the innovation process (Rogers 2003). This is achieved by
investigation of the implementation process in an organisation using a staged model.
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The process is a sequence of five stages, which are divided into two sub-processes. The
length of time taken to move through these five stages can be significant (Rogers 2003).
The model is illustrated in Figure 1.

Figure 1: Five stages in the innovation process in organisations

THE INNOVATION PROCESS IN AN ORGANISATION

Decision
I. INITIATION

II. IMPLEMENTATION

#1
AGENDASETTING

General
organisational
problems that
may create a
perceived need
for innovation

#2
MATCHING

Fitting a
problem from
the
organisation’s
agenda with
and innovation

#3
REDEFINING/
RESTRUCTURING

The innovation is
modified and reinvented to fit the
organisation, and
organisational
structures are
altered

#4
CLARIFYING

#5
ROUTINISING

The relationship
between the
organisation and
the innovation is
defined more
clearly

The innovation
becomes an ongoing
element in the
organisation’s
activities, and loses
its identity

Initiation involves the information gathering, conceptualising, and the planning of
adoption of the innovation leading up to the point where the decision is made to adopt
the innovation. As described in the Taiwanese case, this can be through identifying gaps
in the IPCP and then sourcing and developing resolutions to the problems (Leu 1995).
The implementation is all the events, actions and decisions which are involved to put
the innovation to use. What is important in this sub-process is involvement of local staff
and the adaption of the innovation to fit the needs of the local healthcare environment,
through consultation and the use of key staff, as described by (Leu 1995). The decision
to adopt (the dotted line in Figure 1) is the event that divides initiation from
implementation.

This contextual nature and dependence on local information and

involvement is also recognised in other studies of the innovation adoption process in
healthcare organisations (Greenhalgh et al. 2005).
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There is an argument that using the staged model of research is limiting, as many
innovations are complex and may originate from within the organisation and the process
may not conveniently fit into stages (Wolfe 1994). It has therefore been suggested that
investigating the innovation process in a more meaningful manner would include not
only examining stages but also sequences, divergent and parallel paths, feedback and
feed-forward cycles in the process (Wolfe 1994; Greenhalgh et al. 2005). The literature
as it stands, specific to the adoption of comprehensive IPCPs, is unable to illuminate
this further, though the successful utilisation of the Diffusion of Innovations framework
in other health service disciplines is well recognised (Greenhalgh et al. 2005).

The use of a conceptual framework, such as Diffusion of Innovations provides a
valuable template for healthcare providers to adopt comprehensive IPCPs. Case reports
of the experience of the adoption of IPCPs particularly in LMI countries would help
managers in other like settings to be able to identify the stages in the innovation process
in an organisation. Such reports would give clear examples as to what type of events or
performance gaps could be exploited to stimulate agenda-setting and matching. Case
reports could assist to identify potential barriers that may prevent the decision to adopt
from occurring and also how to circumvent these hurdles. Examples of how an IPCP
can be redefined to suit the needs of the clinicians and the organisation, and how best to
involve them to routinise practice in health service delivery would be invaluable.
Learning from the experience of others paves the way for ease in the adoption of any
innovation including comprehensive IPCPs. What is needed is the opportunity to learn
from more published case reports.

5.5 Conclusion
There is a lack of literature which examines the conceptual frameworks of
comprehensive IPCP adoption regardless of the economic wealth of a healthcare setting.
Guidance as to how to identify and take advantage of opportunities to adopt and
successfully sustain a programme is important, particularly for low- and middle-income
countries.

The Diffusion of Innovations theory provides an example of a useful

framework to assist LMI countries to match their programme deficits to the IPCP
innovation, make it their own and integrate it into their routine healthcare delivery and
administration. Further research is needed to explore and report the experience of the
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adoption of comprehensive IPCP in low- and middle-income countries and other
frameworks which may assist with understanding these processes.
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Introduction
This chapter consists of a manuscript accepted for publication. It is presented in a form
unaltered from the version accepted for publication, apart from the numbered structure
imposed as a result of this dissertation style of presentation.

The article explores the adoption process of the infection prevention and control
programme (IPCP) in the Republic of Kiribati. It reports on, and discusses, the findings
of the IPCP document analysis and interviews with key informants to the adoption
process.

This article provides evidence that the Diffusion of Innovation process in an
organisation is a relevant framework within which to explore and understand the
adoption of the IPCP in the Republic of Kiribati.
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SUMMARY
A comprehensive infection prevention and control programme (IPCP) is designed to
control and prevent the transmission of infectious diseases within the healthcare
environment and the community. Understanding how an IPCP is introduced within a
health system can inform actions to encourage their adoption in other locations. This
paper explores the adoption stages of an IPCP in a specific case situation of SARS.

Data sources and analysis included: 1) Chronological and thematic analysis of IPCP
documentation

and

assessments

performed

by

local

staff

and

external

agencies/consultants; and 2) semi-structured interviews with local key informants and
external agencies (using snow-ball sampling) with thematic analysis. Analysis was
informed by Everett Rogers’ (2003) Diffusion of Innovations for Organisations
framework.

The two key activities of the organisational innovation process were identified. These
were: initiation and implementation. The initiation activity included: 1) agenda-setting:
preparations for severe acute respiratory syndrome (SARS) in 2003 stimulated the
identification of organisational IPCP deficits; and 2) matching: deficits were identified
and the decision to adopt an IPCP innovation package was made. Implementation
included: a) redefining/restructuring: identification of the components of an IPCP and
how they best fit within the local health structure; b) clarifying: integration of IPCP into
the health services and defining an infection control role within the nursing division
and; c) routinising: the IPCP became an ongoing element in health service delivery.

The adoption of the IPCP followed the classic Diffusion of Innovations Process for
Organisations. The case study described serves as an example of IPCP adoption model
in other low- and middle-income healthcare settings and suggests ways to utilise
opportunities as they present.

Keywords
Infection control, Diffusion of Innovations, adoption framework, low- and middleincome countries
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6.1 Background
An IPCP is a collection of activities, resources, policies and procedures designed to
control and prevent the transmission of infectious diseases within the healthcare
environment and the community (Farr 2000).
6.1.1 The Republic of Kiribati
The Republic of Kiribati is a central western Pacific country of 33 atolls and reef islands
in three main island groups, the Gilbert, Phoenix and Line Islands. Kiribati has a total
land mass of 811 square kilometres spread over 3.5 million kilometres of ocean. It has a
population of approximately 100 000 and an annual population growth rate of 1.7%.
The most populated islands are South Tarawa, North Tarawa and Kiritimati Island with
urban growth rates of 5.2%, 4.8% and 8% respectively (World Health Organization
2010). Compared to most other Pacific islanders, I-Kiribati have a short life expectancy
with 65 years for males and 70 years for females (World Health Organization 2010).

The health system of Kiribati is publicly funded with government spending $13.45
million USD in 2008, primarily on curative services, pharmaceuticals and staffing
(World Health Organization 2010). Significant technical and financial assistance is
provided to the Ministry of Health by development partners (World Health Organization
2008). The formal health system is administered by the central Ministry of Health.
Traditional healers provide a parallel service offering local medicines, massage,
antenatal, childbirth and postnatal care. Most people use both services though there is
no coordination between them. Primary health care is provided through a network of 92
health centres and dispensaries. Basic hospital services are available at South Tarawa
(Betio), Kiritimati Island and North Tabiteuea. Secondary care is provided by the
national referral hospital in South Tarawa. Patients requiring tertiary care services may
be referred overseas for treatment if they meet the criteria defined by the Ministry of
Health.

Environmental factors such as overcrowding of urban areas, particularly in South
Tarawa, are increasing the risk of transmission of infectious disease. Other factors such
as poor water quality, inadequate water supply, inconsistent personal hygiene practices,
poor sanitation, food handling and storage practices contribute to communicable disease
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transmission. The incidence of tuberculosis per 100 000 population in Kiribati is now
the second highest in the Pacific (World Health Organization 2009b). The Western
Pacific Regional Office of WHO reports 365/100 000 population in Kiribati compared
with 108/100 000 population in the region (World Health Organization 2009b). In
Kiribati, 70% of reported TB cases are found in Betio, South Tarawa (World Health
Organization 2010). In 2005, diarrhoeal disease and respiratory infections were the
leading causes of morbidity amongst adults and mortality amongst children (World
Health Organization 2008). The WHO has found that data suggest non-communicable
disease incidence is increasing, making the severity of communicable diseases
potentially worse for individuals with chronic disease processes. In addition, poor
community knowledge regarding infection prevention practices is likely to be reflected
in poor staff practices within healthcare settings.

6.2 Methods
To gain an understanding of the process of adoption of IPCPs requires exploration of
the process itself, not just whether programme components are in place. To assist in
understanding this process, an examination of the evolution of the IPCP in the Republic
of Kiribati was conducted. As this was an exploration of how an IPCP, as a group of
activities and components, had been adopted over time, it was examined through the
Diffusion of Innovations framework (Rogers 2003).

Data which assist in the investigation of the innovation process in an organisation
include the recollections of key participants in the process, written documentation of the
organisation about the adoption decision and process and other data sources (Rogers
2003).

With the co-operation and permission of the Ministry of Health of the Republic of
Kiribati, collaboration was established with the Infection Control Principal Nursing
Officer (ICPNO).

In consultation with the ICPNO, a review of relevant infection

control documentation was performed and a series of seven interviews were conducted
with key stakeholders in the IPCP.
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6.2.1 IPCP documentation analysis
A chronological and thematic analysis of Republic of Kiribati IPCP documentation (for
example: infection control manuals and Infection Control Committee minutes) was
undertaken. This analysis was supplemented with further analysis of the findings and
recommendations of IPCP assessments as performed by Republic of Kiribati staff and
external agencies/consultants. The analysis was guided by the key elements and stages
of the innovation process in organisations (Rogers 2003). The document review was
conducted by the researcher while in Kiribati.

Analysis of these documents was

performed to provide a descriptive timeline of the process of IPCP adoption in Kiribati.
The data were cross referenced against available reports and recommendations of
external agencies/consultants to determine whether changes had occurred after the
provision of technical guidance. This served to identify the stages of the innovation
process.
6.2.2 Interviews
Interviews were conducted with available key stakeholders in the Ministry of Health,
infection prevention and control personnel, senior nursing, medical and laboratory staff.
There were no refusals to participate from the stakeholders approached. From these
interviews a snow-balling technique was used to identify other key stakeholders who
had been involved in the development of the Kiribati IPCP and interviews were sought
with these individuals (Minichello et al. 2000). Each stakeholder was interviewed
individually. The interviews were semi-structured following an interview schedule.
Interviews were audio-recorded and transcribed by the researcher.

The interviews

averaged 40 minutes in length. Data were subjected to thematic analysis.

Piloting of the interview schedule for comprehension and language suitability was
conducted with an infection prevention and control professional from a similarly
resourced IPCP in the Pacific. Written consent for the interviews was sought and
received from all interview participants in accordance with the requirements of the
University of Wollongong Human Research Ethics Committee.
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6.2.3 Thematic analysis
All data were subjected to thematic analysis “…as a means of re-organising the data
according to conceptual themes recognised by the researcher” (Minichello et al. 2000,
p.255).

Thematic analysis involved the search for and identification of common themes
throughout the document reviews and interviews (Morse and Field 1996).

This

involved reading, overviewing, and annotating the text prior to systematic coding
(O'Leary 2005). The data were explored for words that were used, concepts discussed,
linguistic devices utilised and non-verbal cues identified by the researcher during the
interview process (O'Leary 2005). To explore word-related themes the text was
systematically searched to find all instances of a particular word or phrase, making note
of its context or meaning (O'Leary 2005). Livescribe hardware and NVivo9 software
were used in the collection and organisation of data for analysis (Livescribe Inc. 2009;
QSR International 2010).

Concepts that were primarily used to explore the innovation process were the four
components of the Diffusion of Innovations theory: the innovation, communication
channels, time and the social system (Rogers 2003). Other concepts and themes that
emerged from the data in addition to these components were equally analysed.

By investigating and analysing the phenomena in this way it was expected that
information would be gathered to identify the five stages of the innovation decision
process as well as the sequences, divergent and parallel paths, feedback and feed
forward cycles in the process (Wolfe 1994; Rogers 2003).

6.4 Results
The IPCP documentation provided chronological and thematic information covering the
period: 2000 to 2010. Documents analysed during the review process included: reports
from

external

agencies,

Infection

Control

Committee

minutes,

programme

documentation, internal review reports, staff health records, education records, minutes
of other communicable disease committees, strategic plans, implementation plans and
guidelines. This information provided the chronological framework to identify the
significant events which informed the adoption process.
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The interviews (n=7) provided further identification of key points in the innovation
process and personal insights into the other events and actions of individuals, which
were not identifiable from the documentation. Table 1 provides a summary of the key
events and results that shaped the current IPCP in Kiribati.

Table 1: Factors contributing to the development of the Kiribati IPCP
Year

Activities/events

Findings/results

Pre

• Persistent organic pollutants

• Absence of Infection Control

2003
2003

(POPS) review
• SARS Rapid Preparedness

Committee or personnel
• Limited infection control awareness

assessment
• SARS taskforce establishment

and practice
• Absence of an infection control

and activities
2004

• Senior nurse recognises need

programme
• Need for a comprehensive IPCP

for an IPCP
2005

• Proposal made to donor for
assistance to develop IPCP

identified
STC - outcomes of visit:
• Train the trainer workshop for senior

• Short term consultant (STC)
visits

nursing officers
• Nursing based infection control

• Limitations assessment of the
health services performed by

committee established
• Infection control manual written by

senior nursing staff
• Provision of resources,
mentoring to ICC and ICPNO
• Further recommendations

staff
• Training of other health care staff
• IEC development
• Infection Control Principal Nursing

made by STCs to expand the
scope of the IPCP

Officer (ICPNO) role established
• IPCP action plan developed
• Internal risk assessment and audit
• Occupational exposure management
programme established

2006

• Multi-disciplinary ICC
directing national practices

• Work plan implemented
• Recognition of the IPCP by Hospital
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established

Management Committee

• Annual IPCP work plan
• Surveillance plan
• Hepatitis B vaccination
programme proposed
2007

• Annual review of work plan

• Hepatitis B vaccination programme

• Expansion of ICPNO role
• Education programme

implemented
• New education programme developed
and implemented

reviewed
2008

• Annual review of education
programme and work plan

• Hand hygiene initiatives developed
• Targeting of education to specific

• Ministry of Health Clinical

healthcare workers

Service Plan included IPCP
activities for first time
• Infection control manual
reviewed
• Occupational exposure
surveillance data regularly
reported at ICC and senior
management meetings
2009

• H1N1 preparedness activities

• Development and distribution of hand

• Annual review of IPCP

hygiene and occupational exposure

• Syndromic surveillance

IEC to all health facilities

activities
• Direct reporting of

• Further targeting of education
• H1N1 vaccination completed

surveillance activities to the
Ministry of Health
2010

• Baseline survey of infection

• Action plans developed and

control practices

implemented based on survey and

• Waste management and
cleaning plans reviewed

review findings
• Water quality testing implemented

• Surveillance plan to include

based on surveillance findings
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surgical site infections

• HIV specialist medical officer
permanently attached to occupational
exposure management programme

6.4.1 Pre 2003-2005
The documentation review found no reference to any IPCP activities prior to 2003. In
2003, the world experienced the Severe Acute Respiratory Syndrome (SARS) outbreak,
which was focused in the Asia Pacific region. This resulted in a SARS Task force being
established in Kiribati, preparedness training for health staff and an assessment of
public health and infection control preparedness being conducted, as detailed in Table 1.
All interview participants noted SARS as a significant event in the adoption of the
IPCP. One interview participant provides a clear example of this.
P2: “It especially started with the SARS …there was not even a programme of
infection control at that time.”

There was no documentary evidence available for 2004, yet interview participants
identified this was the year that a comprehensive IPCP was first conceptualised by a
senior nursing officer.
P3: “Okay – actually there was one nurse, [name withheld], I think she did her
Masters in [overseas country], and then she came back with the idea of creating
this [IPCP] programme. … I think that’s the first, ... 2004.”

All interview participants identified 2005 as the year the IPCP came into being. This
was supported by a number of IPCP documents. After a proposal was made to a donor
organisation, assistance was provided in the form of a short term consultant (STC) in
May of that year. Six of the seven interviewees identified this as a significant event. A
number of activities stemmed from the involvement from the STC as detailed in Table
1. The events of 2005 ultimately resulted in the beginnings of a comprehensive IPCP.
This included the establishment of an Infection Control Committee at the facility level.
6.4.2 2006-2009
In 2006 the ICC became multi-disciplinary and took on a national role in guiding
practice with the IPCP progressively being implemented in all levels of healthcare. This
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included education, occupational exposure management and hand hygiene initiatives.
These initiatives consisted of IEC materials, training sessions and the introduction of
alcohol based hand hygiene products provided by donor organisations.

The hand

hygiene initiatives were based on resources provided by the STCs and the WHO.

One of the most significant events between 2006 and 2009 was the establishment of a
programme to vaccinate health care workers for hepatitis B as part of the occupational
exposure management initiative. In 2006 a proposal for the vaccination of health care
workers for hepatitis B was developed in consultation with the WHO and UNICEF.
P3: “The end of 2006 they proposed for the more vaccines for hepatitis for
health care workers, and then early May 2007 we started off.”

In 2007 the hepatitis B vaccination programme for health care workers was introduced.
This incorporated immune status testing of staff prior to vaccination for hepatitis B
which was able to be performed in country. This programme was administered and
operationalised by the ICPNO who assumed the role of the occupational exposure coordinator.
6.4.3 2009-present
During this period it was recognised there was a need to identify separate funding for
alcohol based hand rubs and not to rely on donor organisations. Syndromic surveillance
of communicable disease and water availability was added to the IPCP and direct
reporting was established with the Ministry of Health.

6.5 Discussion
The value of reporting the evolution of an IPCP in a low- and middle income country
(LMI) is to identify a model that can explain how it came to be. By identifying such a
model this can then serve to assist similar health environments to exploit opportunities
which may present themselves. In the case of Kiribati this opportunity was created by
SARS.

Based on the outcomes of the interviews and documentation analysis it is clear there
was a staged progression of the IPCP. The Diffusion of Innovations framework is thus
relevant to how the IPCP was adopted in the Republic of Kiribati, as shall be discussed.
71

The IPCP adoption in Kiribati included sequences and response to stimulus from
external and internal sources, consistent with Rogers’ staged process of initiation and
implementation, as shall be discussed and illustrated in Figure 1 (Tornatzky and
Fleischer 1990; Wolfe 1994; Rogers 2003).

Figure 1: Five stages in the innovation process in the Kiribati healthcare
organisation.

THE INNOVATION PROCESS IN AN ORGANISATION

Decision
I. INITIATION

#1
AGENDASETTING
?-2003

General
organisational
problems that
may create a
perceived need
for innovation

II. IMPLEMENTATION

#2
MATCHING
2003-2005

Fitting a
problem from
the
organisation’s
agenda with an
innovation

#3
REDEFINING/
RESTRUCTURING
2005-2006

The innovation is
modified and reinvented to fit the
organisation, and
organisational
structures are
altered

#4
CLARIFYING
2006-2009

The relationship
between the
organisation and
the innovation is
defined more
clearly

#5
ROUTINISING
2009-present

The innovation
becomes an ongoing
element in the
organisation’s
activities, and loses
its identity

Initiation of the IPCP involved both agenda-setting and matching. In Kiribati this
agenda-setting stage appears to have occurred in the years up to and including 2003. It
is in this stage that the identification and prioritisation of needs and problems occurs
resulting in the search within the organisation for innovativeness to meet these problems
(Rogers 2003). Innovations result not from a single incident, though a shock, such as
SARS, can provide the opportunity to address an already known performance gap and
initiate the innovation process. Normally this would occur through a sequence of events
which culminate in a force for change (Schroeder 1986).
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The matching stage within the Kiribati case study emerges in a sequence of events after
the shock of SARS in 2003 and up to and including 2005. This resulted in a decision to
rectify the infection control performance gap with the IPCP innovation. Successfully
matching the problem to the innovation is essential to its success and sustainability,
particularly within healthcare organisations (Goodman and Steckler 1989). It is at the
point, after the matching has occurred, that the decision to proceed with the innovation
occurs and the implementation sub-process can begin.

Implementation of an innovation is considered by Rogers to involve three stages:
redefining/restructuring, clarifying and routinising.

The year 2005 was when the

implementation sub-process began in Kiribati. Through the facilitation of a STC the
IPCP was adapted and changed to suit the needs of the organisation. Structural changes
were also made to the organisation through the introduction of an Infection Control
Committee and an ICPNO. This demonstrated a feedback and feed-forward cycle that
encouraged active participation of individuals in the organisation. Through the
remainder of 2005 and 2006, redefining/restructuring continued. One example was the
change in membership of the Infection Control Committee to be more representative of
the key stakeholders in the IPCP and to adopt a more nationally directed role.

Between 2006 and 2009 the Kiribati healthcare organisation utilised the IPCP to review
and establish education programmes, develop quality indicators to assess compliance
with the programme and provide specialist consultation and advice. The information
gained from these reviews assisted in clarifying the programme and its direction. In
addition, the Infection Control Committee was expanded during this stage.

Its

membership, from the various healthcare disciplines, became champions of the IPCP
and they played a significant role in achieving acceptance of the programme.

In this Kiribati case study, participation of health care workers in the innovation process
was evident and acted to routinise and thus sustain the innovation in the Kiribati health
care environment.

Regular IPCP activities included the assessment of compliance

amongst healthcare workers through the quality indicators and continual review process.
The feedback from these assessments continued to inform the programme and assisted
in its routinisation in the organisation. From 2009 until the present, the activities of the
IPCP continue and are accepted as part of the delivery of healthcare in Kiribati. It has
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now become part of the continuous quality improvement process, a fixture of the
education programme, and a source of advice and information.

6.6 Limitations of the study
The information to support the premise that the Kiribati IPCP followed a Diffusion of
Innovations framework was limited by the availability of documentation and interview
participants. Prior to 2005 there is no documentary evidence of the absence or presence
of an IPCP and thus information is purely dependant on the recollections of the
interview participants. The researcher, though known by the organisation, is not IKiribati which may have had an effect on the desire to disclose by the interviewees.

6.7 Conclusion
The sequence of events and activities in the Kiribati case study clearly follows the
stages of the Innovation Process in Organisations model and provides an opportunity for
lessons to be learnt (Rogers 2003).

Set the agenda: Healthcare workers and

administrators should exploit the opportunities that external stimuli such as shocks to
the health care system can provide, in order to introduce an IPCP; Match the solution to
the problem: Use the resources available both within and external to the healthcare
system to find a suitable solution and move the innovation ahead. Make the solution and
the environment fit each other: Involve key people and healthcare workers themselves
to make the IPCP applicable and unique to their healthcare environment. Let the
relationship evolve: Seek input and feedback through open communication, audits and
marketing of the innovation to administrators and healthcare workers. Identify
champions within the health system who can assist in its integration. Provide practical
ways to demonstrate how the innovation benefits the healthcare worker and the patient.
Let it become routine: Incorporate the IPCP into the day to day work of the healthcare
worker so that it becomes an integral part of health service delivery.

This case highlights the usefulness of considering the adoption of an IPCP in a
healthcare organisation through the lens of a theoretical framework such as the
Diffusion of Innovations model. Practical insights were gained that can serve as an
IPCP adoption model in similar healthcare settings.
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ABSTRACT
Background
This study reviews the status of the comprehensive infection prevention and control
programme (IPCP) established in the Republic of Kiribati in 2005. It identifies
opportunities to continue and expand the integration of the IPCP into health service
delivery.

Methods
The review was conducted in 2010 using two empirical tools: 1) A pilot infection
prevention and control programme evaluation (IPCPE) tool that evaluated the activities
of the programme and its implementation; and 2) a previously validated selfadministered survey assessed healthcare worker knowledge, application and confidence
in infection control principles and practice. The survey was directed to all 186 clinicians
at Tungaru Central Hospital (response rate of 59.7%).

Results
The Kiribati IPCP demonstrated a minimum level of compliance (75%) with the activity
standards set out in the IPCPE. The mean scores achieved in the healthcare worker
survey were: 1) knowledge 62%; 2) application 63%; and 3) confidence 79%.
Significant correlations were found between knowledge, application and confidence.

Conclusions
This evaluation of the Kiribati IPCP provides valuable insight into the status of a
recently adopted comprehensive programme and how it has translated into the
knowledge, application and confidence of healthcare workers in their clinical practice.
The healthcare worker survey provides evidence that the IPCP has translated into
confidence and ability in applying infection prevention practices.
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7.1 Background
The significance and impact of infectious diseases and healthcare associated infection
(HAI) on mortality and quality of life increase as the economic status of a given
population or nation decreases (Isturiz and Carbon 2000; Starling 2001; World Health
Organization 2002; Rosenthal et al. 2003a; Yalcin 2003). The capacities of healthcare
facilities in most low- and middle- income (LMI) countries also are affected by a
number of factors. Health services are commonly the focus of cost cutting (Huskins et
al. 1998). Socioeconomic situations will impact on the quality of health care, including
infection prevention and control.

Healthcare capacity is commonly influenced by

infrastructure, training of health care workers, patient knowledge and purchasing power
of individuals (Isturiz and Carbon 2000).

In 2005, the Ministry of Health of the Republic of Kiribati made inroads into
establishing a comprehensive infection prevention and control programme (IPCP) after
gaps had been identified during the SARS outbreak of 2003 (Pittman and Zimmerman
2003). Since 2005, the IPCP has been adopted and integrated into standard health
service delivery throughout the country. This study explores the status of the current
IPCP and verifies its adoption into the Kiribati healthcare services. It develops and tests
a set of tools that can be adopted by other researchers and practitioners to ensure IPCP
development in LMI settings achieves maximum effectiveness. The tools also guide
operators towards optimum remedial design when design flaws are identified.

The Republic of Kiribati
The Republic of Kiribati is a central western pacific country with a population of
approximately 100 000 and an annual population growth rate of 1.7%. The health
system of Kiribati is publicly funded with government spending $13.45 million USD in
2008 (World Health Organization 2010), and with significant technical and financial
assistance from development partners (World Health Organization 2008).

Basic

hospital services are available together with secondary care provided by a 130 bed
national referral hospital. The healthcare workforce is made up of both locally and
internationally trained individuals.

Infection prevention and control principles and

practices are taught during formal training of healthcare workers, pre and post
commencement of employment as part of the IPCP.
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7.2 Methods
This study explores the status of the current IPCP, based on the World Health
Organization (WHO) core components (Informal Network on Infection Prevention and
Control in Health Care 2009). A pilot study using an IPCP evaluation tool was
conducted, together with a survey of healthcare worker knowledge, application and
confidence of infection control principles. Both tools used in this study are available
upon request.

With the co-operation and permission of the Ministry of Health of the Republic of
Kiribati and in accordance with the requirements of the University of Wollongong
Human Research Ethics Committee, the study was conducted in collaboration with the
Infection Control Committee in Kiribati.

The study was conducted at the Tungaru Central Hospital. All clinical staff employed
in Kiribati rotate through this facility to provide consistency and currency of education
and practice and to maintain a level of quality assurance in the country’s clinical
standards.
7.2.1 IPCP evaluation
Audit and evaluation of IPCPs and their associated activities is a well recognised data
collection method in the field of infection prevention and control (Hay 2006; Bryce et
al. 2007)

Audit or evaluation tools reported in the literature to be rigorous and validated through
various research methods focus on specific infection prevention and control activities,
for example hand hygiene and antibiotic stewardship (Pittet et al. 2000; Saizy-Callaert
et al. 2003). Two validated IPCP audit or evaluation instruments were considered
relevant to the low- and middle-income (LMI) country setting, though each had some
limitations.

The Infection Control Nurses Association’s (ICNA), Audit tools for

monitoring infection control standards (Infection Control Nurses Association 2004) is a
set of validated tools (Millward et al. 1993, 1995) which has been used extensively by
the National Health System (NHS) of the United Kingdom for the standardised
monitoring of clinical practice and the healthcare environment.

80

The second instrument, the Nosocomial Infection Program Rapid Evaluation Guide,
was produced by the Pan American Health Organization/Regional Office of the WHO
(PAHO) for use in LMI countries (Pan American Health Organization 2005). Testing of
this tool has not been reported, though it was considered suitable as it was created from,
and based upon, the recommendations from the WHO and thus should be considered as
having a high degree of inherent face and content validity (Chelenyane and Endacott
2006; Wu et al. 2008).

Each of these tools had specific but complementary deficits, so they were combined to
create a new evaluation document, the IPCP evaluation (IPCPE), which was suitable for
assessment of comprehensive IPCP in LMI countries.

The IPCPE was based primarily on the PAHO tool, which divided the evaluation into
seven specific areas for examination: 1) Organisation; 2) Epidemiological surveillance
of infections; 3) Microbiology; 4) Intervention strategies; 5) Sterilisation and high-level
disinfection; 6) Personnel health; and 7) Hospital environment and sanitation. Specific
aspects of the ICNA tool were included into the Areas of Intervention strategies,
Personnel health and Hospital environment and sanitation to provide details and
observational opportunities for clinical infection prevention and control practice.

Experts in infection prevention and control who have experience in LMI country
healthcare settings and a regional expert from Fiji (also an LMI country) confirmed the
validity of the IPCPE instrument. A pilot of the IPCPE was conducted in person by the
authors in Kiribati. The IPCPE was developed to collect information on a number of
aspects that the WHO identified should be included as core components in an IPCP
(Informal Network on Infection Prevention and Control in Health Care 2009).

The study location, Tungaru Central Hospital (TCH), provides the national population
with general surgery, general medicine, obstetrics, special care nursery, paediatrics, and
tuberculosis services. The IPCPE took nine hours to conduct over three days.

Evaluation of the raw data collected by the IPCPE created a compliance score in seven
areas of IPCP implementation. Scores were derived by aggregating the ‘yes’ answers
and dividing by the total number of questions answered (including all yes and no
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answers), excluding those that were not applicable. These scores were normalised into
percentage scores, which indicated level of compliance with the IPCPE standards. To
produce an overall programme score, the scores for each area were aggregated then
divided by the number of areas assessed, providing an overall evaluation percentage.
The categories of score were: compliant (85% or above); partial (84 to 76%); and
minimal 75% or below. The ICPNO assisting with the evaluation provided further
insight into the specifics of the setting. These details are included in the results.
7.2.2 Healthcare worker survey
Evaluation of the knowledge and delivery of safe infection prevention and control
practices of the healthcare workers (Bryce et al. 2007) assists to identify deficits in the
education component of the programme and provides data on the effectiveness of IPCP
adoption in the clinical setting.

A previously implemented and validated survey instrument used to determine
Taiwanese nursing students’ knowledge, application and confidence with standard and
additional precautions of IPCP was used (Wu et al. 2008). The validity of the tool and
its internal consistency for the knowledge and confidence scales had been established
(Wu et al. 2008). The application scale had not been validated, though the authors
maintained, that items based upon recommendations of organisations such as WHO
have a high degree of inherent validity.

Minor modifications were made to the selected instrument to make it more applicable to
the Kiribati environment and population. The knowledge section contained fifteen
items, eleven yes or no questions and four multiple choice questions. The application
and confidence sections had twelve and eight yes or no questions respectively which
were based on three scenarios related to the care of patients with a suspected diagnosis
of an infectious disease. Prior to use in Kiribati, the questionnaire was piloted and
feedback received for internal consistency with a representative group of clinicians in
Fiji.

A total of 186 healthcare worker surveys were issued to nurses, medical officers,
medical aides, oral health and laboratory staff. One hundred and eleven completed
surveys were returned, a response rate of 59.7%.
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Data were analysed using SPSS v18.0 (Pearson Education 2009). Raw scores were
collated and presented as percentages. The scores for each question were of an equal
weighting. Pearson correlation coefficients were applied to examine the demographics,
including clinical experience and infection control training, in relation to each outcome
variable such as knowledge, application and confidence with infection control principles
and practice, to identify significant relationships. These data were not presumed to be
categorical; in the real world they are not precise measurements. Thus correlation
analyses were considered to provide insights into indicative relationships. The
significance of the tests was set as p < 0.05, 2-tailed.

7.3 Results
7.3.1 Infection Prevention and Control Programme Evaluation
The IPCPE was conducted examining seven key areas of an IPCP. The results for each
of the seven areas reviewed as part of the IPCPE are shown in Table 1. The area
Organisation and Sterilisation and high-level disinfection achieved the highest levels of
compliance. Half of the areas reached a partial level of compliance and two received a
minimal compliance level. Details of the compliance results are provided below.

Table 1: Infection prevention and control programme evaluation scores
Area

Percentage compliance

Compliance level

1. Organisation

100%

Compliant

2. Epidemiological

35.3%

Minimal

3. Microbiology

83.3%

Partial

4. Intervention strategies

76.3%

Partial

5. Sterilisation and high-

87.5%

Compliant

6. Personnel health

78.6%

Partial

7. Hospital environment

60.9%

Minimal

75.0%

Minimal

surveillance of
infections

level disinfection

and sanitation
Overall score
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Compliant
The area of Organisation was compliant as the programme was established in 2005 and
since then has been well integrated into health service delivery through leadership
involvement and a strong education programme both in undergraduate and post-basic
training for healthcare workers. The area of Sterilisation and high-level disinfection
was also found to be compliant, even in the presence of the resource limitations of the
equipment and the environment.

Partial
The area of Microbiology achieved partial compliance due to the unavailability of
diagnostic tools to identify healthcare associated infection agents and their antimicrobial
susceptibility patterns.

Personnel health was identified as an integral area of the

programme with hepatitis B vaccination of staff continuing to be promoted, though it
had not reached the 80% target identified in the tool. A rubella vaccination programme
for susceptible women was also not in place though a childhood programme was active.

Intervention strategies are important areas of the evaluation. The best performing
components of this area were compliance with evidence-based clinical practices and
infection control guidelines and evaluation of these practices. The worst performing
was hand hygiene compliance.

Minimal
The areas which received a minimal compliance assessment, were Epidemiological
surveillance of infections and Hospital environment and sanitation. Lack of compliance
for Epidemiological surveillance of infections was directly related to issues identified in
the Microbiology area, the inability to identify healthcare associated infection agents
and their susceptibility patterns.

Hospital environment and sanitation was found to be of minimal compliance primarily
due to the physical limitations of the environment and climate in Kiribati. The basic
general structural conditions of the facility were found to be difficult to maintain and
improvement was dependant upon input of capital and financial assistance from donor
organisations. Cleaning of patient care equipment was an area in need of improvement,
as was safe waste disposal on removal from the facility. Sharps safety and disposal was
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however found to be exceptional in this area and as an independent standard reached
full compliance 87.5%.
7.3.2 Healthcare Worker Survey
Demographic data
The ages of participants ranged from 21-69 years, with a mean of 35.43 (SD 10.228).
The majority of the participants (75.68%) were female nurses with varying levels of
experience. Almost nine in ten participants (88.9%) reported having some clinical
experience with infectious diseases. Some participants, 38 (35.2%), reporting they had
received some form of post-basic infection control training and the majority of these, 30
(78.95%), spent between one hour and two days undertaking this training. A more
comprehensive breakdown of this demographic data is shown in Table 2.
Table 2: Demographic information relating to participants
Demographic

n

%

Male

16

14.4

Female

95

85.6

Registered nurse

74

66.7

New graduate registered nurse

15

13.5

Senior nursing officer

6

5.4

Medical officer

4

3.6

Laboratory staff

12

10.8

0-4 years

34

31.5

4-8 years

17

15.7

8-12 years

20

18.5

12 years and greater

37

34.3

No

12

11.1

Yes

96

88.9

Sex

Designation

Years worked since basic training

Clinical infectious diseases experience
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Post-basic infection control training
No

70

64.8

Yes

38

35.2

No training

69

64.5

1-4 hours

11

10.3

4-8 hours

6

5.6

1-2 days

13

12.1

2 days - 1 week

0

0

1-2 weeks

7

6.5

2-4 weeks

1

0.9

Time spent on post-basic infection control training

Knowledge of infection prevention and control
Of a possible score of 15 in the knowledge section the results ranged from 0-13, with a
mean knowledge score of 9.23 (SD 1.896). Over 77% of the participants had a score
between 8 and 11. The items that were answered correctly most frequently related to
standard precautions such as the safe disposal of sharps (100%), use of personal
protective equipment to prevent body fluid exposures (98.2%) and use of barriers to
protect non-intact healthcare worker skin (96.1%). The items that were answered most
incorrectly related to additional precautions, particularly how droplet pathogens are
transmitted (23.5%) and how to prevent transmission of droplet and airborne organisms
(31.1%). Overall knowledge of standard precautions was demonstrably better than that
of additional precautions. There was no correlation established between knowledge
scores and demographic variables (Table 3).

Table 3: Correlations between demographics and outcome variables
Variable

Knowledge

Application

Confidence

Age

0.001

0.087

0.047

Gender

-0.060

0.019

0.204*

Clinical infectious disease experience

0.052

-0.043

-0.356**

Post-basic infection control training

-0.016

0.012

-0.142

* Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)
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Application of infection control precautions
The application section of the survey tool had a possible score of 12, with the results
ranging from 0-11, with a mean application score of 7.54 (SD 2.194). Just over 74% of
participants had a score between 7 and 10. For standard precautions the highest scores
were for glove use (96.2%) and hand hygiene (85.7%). Additional precautions were also
well recognised in caring for a patient with scabies with contact precautions applied
(91.5%) and contact and airborne precautions applied for a patient with possible
pandemic influenza or SARS (96.2%). The most frequently incorrect item was related
to a patient under airborne and contact precaution wearing a duckbill mask all the time,
with 59% of participants indicating they would ask the patient to do so. There was no
correlation established between application scores and demographic variables (Table 3).
Pearson correlation analysis did, however, reveal a significant relationship between
knowledge and application abilities as shown in Table 4.

Confidence in infection control precautions
The confidence section of the tool had a possible score of eight, with participants’
responses ranging from 0-8. The mean score was 6.34 (SD 1.956) with just over 79% of
participants scoring between 6 and 8. The items of least confidence were the
participants’ ability to educate the radiographer on additional precautions and only 38%
felt that the radiographer had an invalid reason to not approach a patient with suspected
influenza. High levels of confidence were displayed in educating patients and family
members (96.2%) and in their ability to apply infection control practices in the clinical
setting (93.3%).

Correlation between participants’ gender and clinical infectious disease experience and
their confidence to apply infection control in the clinical setting was demonstrated
(Table 3). Pearson correlation analysis revealed a significant relationship between
knowledge, application and confidence in applying infection control precautions as
shown in Table 4.
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Table 4: Relationship between variable of knowledge, application and confidence
Knowledge

Application

Confidence

Knowledge

-

.241*

.283**

Application

.241*

-

.569**

Confidence

.283**

.569**

-

* Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)

7.4 Discussion
The aim of this IPCP review was to evaluate its adoption into the Kiribati healthcare
environment through a descriptive assessment of the Kiribati IPCP as it stood in 2010. It
provides an assessment of the programme itself and how this has translated into the
knowledge, practice and confidence of healthcare workers within the system. Though
the relationship between the programme evaluation results and the survey scores cannot
be statistically correlated, it is possible to discuss how the presence and performance of
components of the IPCP influence health care workers knowledge of, and application
and confidence in, incorporating infection control principles in practice.
7.4.1 Barriers to achieving compliance
To achieve a rating of ‘compliant’ within the IPCPE tool, a score of at least 85% must
be reached in any given area. The IPCPE identified the areas of Organisation and
Sterilisation and high-level disinfection as being compliant. Both of these areas have
been previously reported in the literature (Mortensen 1991; Sobayo 1991; Nettleman
1993; Huskins et al. 1998; Starling 2001; Nyamogoba and Obala 2002) as being
deficient in LMI countries due to a number of factors. The results of both the IPCPE
and the survey show that the Kiribati IPCP has overcome such issues to some extent.
However, these tools were not designed to explore how this occurred. Other research
into the Kiribati IPCP has demonstrated that these impediments have been overcome
by: 1) adapting the IPCP to the local environment and context; 2) making use of
available resources; 3) involving end users and key stakeholders; 4) identifying and
utilising infection control champions or opinion leaders; and 5) targeting interventions
to those infectious diseases of local importance (Zimmerman et al. 2012). The Kiribati
findings are similarly demonstrated in other LMI country settings (Ponce-de-Leon
1991; Rhinehart et al. 1991; Raza et al. 2004).
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The areas of the IPCPE that received a minimal compliance score were those of
Epidemiological surveillance of infections and Hospital environment and sanitation.
Neither of these areas could be said to be directly related to any of the survey’s results
but are more related to the human resource and physical limitations of the environment,
which is a well recognised concern in LMI countries (Rhinehart et al. 1991; Huskins et
al. 1998; Isturiz and Carbon 2000; Raza et al. 2004).

The results of the evaluation, in conjunction with the findings of the survey, indicate
that there has been a measurable integration and adoption of the IPCP into the Kiribati
healthcare environment. However, compliance was minimal with a score of 75%. The
results of the IPCPE identified there are opportunities to improve the effectiveness of
the IPCP in Kiribati and subsequently will be used to improve compliance of the overall
IPCP.
7.4.2 Knowledge, application and confidence
Within the area of Organisation of the IPCPE is a component for education. The
Kiribati IPCP provides training at both the undergraduate and post-basic healthcare
worker training level. Healthcare worker training and knowledge, particularly of blood
borne pathogen infectious disease risk, transmission routes and prevention methods has
been identified in the literature as essential to the success of an IPCP, particularly in
translating this knowledge into practice (Rhinehart et al. 1991; Raza et al. 2004;
Kermode et al. 2005).

Although their knowledge relating to standard precautions was better than additional
precautions, the participants of the survey demonstrated the confidence and ability to
apply both. This result begs the question as to why these participants were confident and
able to apply these precautions, given the survey’s finding that there is a lack of
knowledge. This issue could be researched further.

Of the participants, two-thirds (64.5%) reported that they had received no post-basic
infection control training. This indicates that there appears to have been adequate
training for most participants at an undergraduate level. However, outcome scores could
be improved if enhanced post-basic training were provided to clinicians and added to
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what is already included in the IPCP (Rhinehart et al. 1991; Sagoe-Moses et al. 2001;
Rosenthal et al. 2003b; Kermode et al. 2005).

Statistically significant correlations were demonstrated between knowledge, application
and confidence, which imply that the education component of the programme has an
impact upon clinicians’ abilities to apply their knowledge and be confident in doing so.
This has implications for the IPCPE area of Intervention strategies, which received a
score of partial compliance; there may be a need to improve the post-basic training of
clinicians. The other areas that received partial compliance were Microbiology and
Personnel health. This was likely to be largely due to resource availability, both human
and financial.

7.5 Limitations
This is a case study of an individual situation. The findings of this study cannot be
generalised to other LMI country situations, though lessons learnt may be valuable.
While the relationship between the programme evaluation results and the survey scores
cannot be statistically correlated, they may be used together to authenticate the
educational component of the programme.

Recommendations for future research include the testing of both the IPCPE and the
survey tool in other settings and other populations to increase the ability to generalise
the findings. It may also be useful to examine the use of written scenarios for evaluation
of healthcare worker knowledge and application of infection prevention and control
principles, as they do not provide visual cues that a clinician may use in practice.

7.6 Conclusion
This evaluation of the Kiribati IPCP provides valuable insight into the status of a newly
adopted comprehensive programme and how it has translated into the knowledge,
application and confidence of healthcare workers in their clinical practice. Kiribati
appears to have demonstrated a concentrated effort to adopt infection prevention and
control activities that together create a comprehensive IPCP with at least minimal
compliance achieved. The healthcare worker survey provides evidence that the IPCP
has translated into confidence and ability in applying infection prevention practices,
though knowledge could be improved. The programme evaluation and healthcare
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worker survey together identify opportunities where expansion and improvement can be
made.

The areas of Microbiology, Personnel health and Hospital environment and sanitation
are largely impacted by barriers such as environmental, financial and human resource
limitations and have been identified in the literature for other LMI countries. The
strength of the Organisation of the IPCP appears to be able to assist this though it may
require additional involvement of healthcare leaders and administration to progress.

Intervention strategies and Epidemiological surveillance of infections are areas that can
be improved through strengthening the education of healthcare workers and adopting
surveillance activities such as practice observation, environmental audits and promotion
of evidence-based clinical guidelines. In addition to this, the IPCPE that was developed
as part of this study and the associated survey provide a baseline measure for the
Kiribati IPCP and have identified areas in need of improvement. These tools can be
used in the future to track the progress of the adoption of the programme.
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ABSTRACT
Objective: To explore the role of the Diffusion of Innovations framework in adopting
infection prevention and control programmes (IPCP) in low- and middle income (LMI)
countries.

Data Sources/Study Setting: The study was set in the healthcare environment of the
Republic of Kiribati.

Study Design: Case study methodology was used to examine and contextualise the
analysis of the Republic of Kiribati’s adoption of the IPCP from 2003-2010. Multiple
sources of data were incorporated in the project.

Data Collection/Extraction Methods: Data were collected from multiple sources
including semi-structured interviews, IPCP documentation, programme evaluation and
healthcare worker survey. Data were subjected to thematic analysis and descriptive
statistics where relevant to the study design.

Principal Findings: The progression of activities and stimuli has resulted in the adoption
of a comprehensive IPCP in the Republic of Kiribati. The process follows the staged
model of the classic Diffusion of Innovations process in organisations described by
Everett Rogers.

Conclusions: This case study provides an illustration of how a comprehensive IPCP can
be adopted in a LMI country setting with little involvement from external agencies. In
examining the Kiribati case key stimuli, opportunities and activities have been
identified which could be similarly adopted and implemented by other LMI countries in
adopting or improving an IPCP.

Keywords:
Infection control, Diffusion of Innovations
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8.1 Background
Prevention and control of healthcare associated infections (HAI) is an increasingly
important element in the provision of health services globally. It relates to not only
protecting those accessing health services from the spread of infectious or pathogenic
disease but also protecting healthcare workers, their families, and other persons
associated with health services.

At present, resources and expertise in the prevention and control of HAI in low- and
middle income (LMI) countries is minimal. Most LMI countries are struggling with
this issue.

Often they lack (or have minimal) infection control guidelines,

infrastructure, policy directives or persons responsible for establishing, implementing
and monitoring infection control programmes.

An infection prevention and control programme (IPCP) is a collection or cluster of
activities, resources, policies and procedures designed to control and prevent the
transmission of infectious diseases within the healthcare environment and the
community (Farr 2000). The core components of an IPCP are individual but interrelated, collectively comprising a specific innovation package. Core components of an
IPCP have been categorised by the World Health Organization (WHO) as:
•

Organisation of IPCP

•

Technical guidelines

•

Human resources

•

Surveillance of infections and assessment of compliance with infection
prevention and control practices

•

Microbiology laboratory support

•

Environmental minimum requirements

•

Monitoring and evaluation of programmes

•

Links with public health or other relevant services (Informal Network on
Infection Prevention and Control in Health Care 2009).

The efficacy of infection control programmes in reducing the incidence of HAI has been
well established in the literature, particularly in developed or high-income countries
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(Haley et al. 1985; Hospital Infections Program 1992).

These infection control

programmes are informed by evidence based guidelines and advice developed by
internationally recognised health authorities such as the United States Centers for
Disease Control and Prevention (CDC) and the WHO.

Based on such advice many countries, including resource limited or LMI countries,
attempt to establish infection control programmes, with varying degrees of success
(Nettleman 1993; Leu 1995; Huskins et al. 1998). From the experience of the first
author it appears that the standards set by these guidelines and advice are unachievable
due to resource limitations, lack of engagement of healthcare workers and health
authorities, lack of expertise, and institutional and priority competition.

The Republic of Kiribati appears to be an exception to these general findings and
experience. In 2003, the first author visited Kiribati during a SARS rapid preparedness
assessment of infection prevention and control capacity. The assessment found limited
infection prevention and control programming and activities. Kiribati was visited again
in 2005 to review infection prevention and control capacity. This 2005 review found
evidence of significant improvements in the overall programme, increased activities and
what appeared to be genuine enthusiasm for infection prevention and control.

A

progressive adoption of infection prevention and control activities was evident and it
appeared that a comprehensive programme would result. The extent of these changes
was not typical to other LMI countries in the region.

8.2 The Republic of Kiribati
The Republic of Kiribati is a central western pacific country of 33 atolls and reef islands
in three main island groups, the Gilbert, Phoenix and Line Islands. Kiribati has a total
land mass of 811 square kilometres spread over 3.5 million kilometres of ocean. It has a
population of approximately 100 000 and an annual population growth rate of 1.7%.
The most populated islands are South Tarawa, North Tarawa and Kiritimati Island with
urban growth rates of 5.2%, 4.8% and 8% respectively (World Health Organization
2010). Compared to most other Pacific islanders, I-Kiribati have a short life expectancy
with 65 years for males and 70 years for females (World Health Organization 2010).
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The health system of Kiribati is publicly funded with government spending $13.45
million USD in 2008, primarily on curative services, pharmaceuticals and staffing
(World Health Organization 2010). Significant technical and financial assistance is
provided to the Ministry of Health by development partners (World Health Organization
2008). The formal health system is administered by the central Ministry of Health.
Traditional healers provide a parallel service offering local medicines, massage,
antenatal, childbirth and postnatal care. Most people use both services though there is
no coordination between them. Primary health care is provided through a network of 92
health centres and dispensaries. Basic hospital services are available at South Tarawa
(Betio), Kiritimati Island and North Tabiteuea. Secondary care is provided by the 130
bed national referral hospital, Tungaru Central Hospital in South Tarawa. Acute care
services include surgery, obstetrics, paediatrics, internal medicine, special care nursery
and tuberculosis treatment. Patients requiring tertiary care services may be referred
overseas for treatment if they meet the criteria defined by the Ministry of Health.

The healthcare workforce is made up of both locally and internationally trained
individuals. The chain of command is hierarchical, with a top down approach to
decision making, though evidence of collaboration and co-operation is evident in the
structure and activities of various committees, particularly the Infection Control
Committee. Senior staff and directors are seen as the decision-makers within the system
as they hold positions of influence based upon their skills, experience and expertise.

8.3 The study: Exploration of the Kiribati case
The ‘atypical’ case of Kiribati raises many questions, primarily: ‘How and why did it
change?’, ‘What has been the process of change?’ and ‘Could other countries in the
region benefit from the Kiribati experience?’

These, and many other questions,

warranted further exploration.

Exploring and identifying the process of successful IPCP adoption is important to assist
other countries in their adoption and implementation of IPCPs. This is particularly
salient where LMI countries are relying on guidance established for use in well
resourced settings, which often provides them with a poor practical fit (Zimmerman
2007). To gain a greater understanding of this process of adoption requires exploration
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of the key elements and stages of the process itself, not just whether selected key
components are in place.

One tool which is appropriate for conducting an exploration of these key elements and
stages in the Classic Diffusion of Innovations theory. Classic Diffusion of Innovations
theory describes “…the process by which an innovation is communicated through
certain channels over time among the members of a social system” (Rogers 2003, p.5).
Diffusion of Innovations theory has its roots firmly embedded in agriculture and
geography. The concepts central to classical theory were first described in the 1930s by
researchers studying the adoption of hybrid corn in farming. Whilst observing the
process they noticed patterns of communication and influence amongst farmers
(Lennarson Greer 1977). Since then Everett Rogers has been primarily responsible for
the scholarly development of Diffusion of Innovations theory (Rogers 1962; Rogers and
Shoemaker 1971; Rogers and Agarwala-Rogers 1976; Rogers 1983, 2003). Other
scholars who have contributed significantly to the development of the theory include
Brown (1981), Downs and Mohr (1976) and Tornatzky and Fleischer (1990).

The classic Diffusion of Innovations theory as it relates to organisations provides a
framework through which the adoption of IPCPs can be examined. In every diffusion
research study, programme or campaign, four key elements are always present: 1) an
innovation; 2) communication channels; 3) time; and 4) a social system (Rogers 1962,
1983, 2003). These elements inform the process, whether for an individual or for an
organisation. It is from this perspective that the Kiribati IPCP adoption process shall be
explored.

When examining the diffusion of an IPCP in a healthcare environment the innovation 1)
would be the programme. The communication channels 2) are the means by which
information and messages about IPCPs are shared. Time 3) includes the rate of
adoption, the innovation-decision process and the innovativeness of the individual or
organisation. The social system 4) is the healthcare environment and infrastructure
where the adoption is to take place. Together, these four elements work to create an
environment and context where the new innovation (the IPCP) is established and
embedded, and conditions emerge which encourage an organic evolution of the
innovation to more directly solve the targeted organisation problems, in this case the
98

prevention of HAI . This organic evolution follows a staged adoption process in an
organisation, such as the Kiribati healthcare organisation. The stages are: 1) agendasetting; 2) matching; 3) redefining/restructuring; 4) clarifying; and 5) routinising
(Rogers 2003). The process is not entirely linear and is responsive to the four key
elements previously mentioned.

To discuss the role of Diffusion of Innovations in IPCP adoption, a case study of the
Republic of Kiribati was developed, identifying the four key elements of the process,
but more importantly exploring and discussing the stages of the innovation process in
the Kiribati healthcare organisation. The specific methodology and findings of the
Kiribati study have been reported elsewhere (Zimmerman et al. 2011; Zimmerman et al.
Accepted 29 Sep 2011; Submitted 14 Dec 2011 American Journal of Infection Control).
This paper discusses the Kiribati case specifically in relation to the Diffusion of
Innovations process in the healthcare organisation.

8.4 Methods
In order to understand the IPCP adoption process in a LMI country setting, a case study
of the Kiribati IPCP was undertaken in 2010. A single case study approach was chosen
for this project as it facilitated the exploration, within a specific context, of the adoption
of an IPCP. This study seeks to explore the contemporary phenomenon within its reallife context (Yin 2003). The case study method calls for a triangulating process using
multiple sources of evidence, both qualitative and quantitative to explore the research
questions to enhance rigour (Stake 1995; Yin 2003). Triangulation in this study was
achieved through the analysis of multiple sources of data which are each causally
separate and have been reported as such elsewhere (Zimmerman et al. 2011;
Zimmerman et al. Accepted 29 Sep 2011; Submitted 14 Dec 2011 American Journal of
Infection Control).
8.4.1 Documenting the adoption of IPCP in Kiribati
To document the adoption of the IPCP in Kiribati an investigation strategy comprising
four components was used: 1) Evaluation of current IPCP status in Kiribati using a pilot
evaluation tool with thematic analysis of findings and recommendations – to identify the
current infection prevention and control activities and how they correspond with the
core components of a comprehensive programme; 2) Survey of healthcare worker
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knowledge, application and confidence with infection prevention and control principles
and practice using a previously validated self-administered tool – to identify strengths or
deficits in the education component of the programme; 3) Chronological and thematic
analysis of Republic of Kiribati IPCP documentation (e.g. infection control manuals,
infection control committee minutes) and findings and recommendations of IPCP
assessments performed by Republic of Kiribati staff and external agencies/consultants
to explore the key elements of the diffusion of innovation process; 4) Semi-structured
interviews with key informants in the Republic of Kiribati and external agencies (using
snow-ball sampling) to explore the key elements of the diffusion of innovation process.

These data sources provide evidence of the four key elements and illustrate the five
stages of the adoption process in an organisation. More specifically the interviews and
the documentation analysis explore the communication channels, social system, the time
it took the innovation to be adopted and the five stages of the adoption process in the
organisation.

The healthcare worker survey and the evaluation of the IPCP more

specifically, provide information on the innovation itself as well as providing evidence
of the clarification and routinising stages of the adoption process.

The healthcare worker survey assessed the knowledge, application and confidence of
staff with infection prevention and control principles and practice using a previously
validated self-administered tool (Wu et al. 2008). This was performed to identify
strengths and deficits in the education component of the programme.

Evaluation of the current IPCP status in Kiribati was achieved using a pilot evaluation
tool, the Infection Prevention and Control Programme Evaluation (IPCPE). This was
performed to identify the current IPCP activities and how they correspond with the core
components of a comprehensive programme.

Using the case study method to explore the innovation process in the Kiribati healthcare
setting provides an opportunity to analyse and critique the applicability of the diffusion
of innovation process for adoption into other healthcare settings. To this end the results
of the study are discussed together, highlighting the stages of the process, providing a
narrative of the organic evolution of the IPCP in the Republic of Kiribati.
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8.5 Discussion of the findings
8.5.1 Diffusion of Innovations in organisations
It has been argued in the literature that classical Diffusion of Innovations theory is
limited in its application to organisational adoption of innovations (Lennarson Greer
1977). It was generally accepted that classical theory was limited to explaining adoption
of innovations by single individuals. After the first edition of “Diffusion of Innovations”
(Rogers 1962) was published, Everett Rogers began exploring innovation in
organisations, resulting in the development of a clear description of how the classic
theory is applied to organisations (Rogers and Agarwala-Rogers 1976; Rogers 2003).
Rogers suggests that the focus of research into innovation in organisations is on the
innovation process itself. This is achieved by using a staged model.

The process

specific to organisations is a sequence of five stages, which are divided into two subprocesses: 1) initiation; and 2) implementation. The model is illustrated in Figure 1.

Figure 1: Five stages in the innovation process in organisations (Rogers 2003)

THE INNOVATION PROCESS IN AN ORGANISATION

Decision
I. INITIATION

#1
AGENDASETTING

General
organisational
problems that
may create a
perceived need
for innovation

II. IMPLEMENTATION

#2
MATCHING

Fitting a
problem from
the
organisation’s
agenda with
and innovation

#3
REDEFINING/
RESTRUCTURING

The innovation is
modified and reinvented to fit the
organisation, and
organisational
structures are
altered
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#4
CLARIFYING

#5
ROUTINISING

The relationship
between the
organisation and
the innovation is
defined more
clearly

The innovation
becomes an ongoing
element in the
organisation’s
activities, and loses
its identity

The initiation sub-process involves the information gathering, conceptualising and the
planning of adoption of the innovation leading up to the point where the decision is
made to adopt the innovation. The implementation sub-process comprises all the events,
actions and decisions which are involved to put the innovation to use. The decision to
adopt, the dotted line, is the event that divides initiation from implementation (Rogers
2003).

Other researchers have added to this model, examining sequences in the innovation
process, divergent and parallel paths, and feedback and feed forward cycles (Tornatzky
and Fleischer 1990; Wolfe 1994). The IPCP adoption in Kiribati appears to have
included sequences in response to stimulus from external and internal sources, yet
followed Rogers’ clearly staged process, as shall be explored further below (Rogers
2003).

8.6 Evolution of the Kiribati programme
The interviews and documentation analysis were essential for the identification of the
stages of the IPCP adoption process. The results from these data sources reveal the
chronological picture of the process, commencing in 2003 and continuing to the present
day. There is no evidence prior to 2003 of any existence of a comprehensive IPCP apart
from the occasional individual activity which identified the lack of a programme. These
events and stimuli are chronologically summarised in Table 1.
Table 1: Summary of activities in Kiribati IPCP adoption process
Year
2003

Key event/stimuli
•

SARS preparation identified lack of infection control awareness and
programme

2004

•

exposure to external infection control consultants

•

Senior nursing staff identifies need for IPCP, after completing a
Masters of Nursing in New Zealand

2005

•

External assistance sought by senior nursing staff and provided to
introduce an IPCP in collaboration with local staff

•

needs assessment performed

•

local nurse lead infection control committee (ICC) and infection
control nurse role established
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•

infection control guidelines, resources and training developed and
disseminated

2006

•

occupational exposure management plan developed and implemented

•

ICC becomes multi-disciplinary with national role, IPCP annual work
plan developed

2007

2008

•

surveillance plan implemented

•

staff hepatitis B vaccination proposed

•

education programmes reviewed and improved

•

hepatitis B vaccination programme implemented

•

IPCP activities included in quality indicators for health

•

reporting of occupational exposure data at ICC and senior
management forums

2009

•

hand hygiene initiatives developed and implemented

•

H1N1 influenza preparation activities coordinated and actioned by
IPCP in collaboration with Public Health

2010

•

direct reporting of surveillance activities to Ministry of Health

•

baseline survey of infection control practices, waste management and
environmental hygiene conducted with action plans developed and
implemented

From this chronology, identification of the stages of the innovation process in the
Kiribati healthcare organisation can be performed and shall be discussed. This serves to
illustrate the impetus to begin and persist with the adoption of an IPCP for other LMI
country settings.

Initiation:
Agenda-Setting
The agenda-setting stage provides the motivation for initiating the innovation process.
This stage may go on for some time, perhaps years. In the case of Kiribati this stage
appears to have occurred in the years up to and including 2003. It is in this stage that
the identification and prioritisation of needs and problems occurs resulting in the search
within the organisation for innovativeness to meet these problems (Rogers 2003).
103

Innovations result not from a single incident, though a shock, such as SARS, can
provide the stimulus to address an already known performance gap and initiate the
innovation process, but rather through a sequence of events which culminate in a force
for change (Schroeder 1986).

Matching
The second stage of initiation involves the performance gap being matched with an
innovation. The responsibility of this matching rests with the organisation’s decision
makers who must ensure that it fits, through its planning and design, within the needs
and capabilities of the organisation (Rogers 2003).

The matching stage within the Kiribati case study emerges in a sequence of events after
the shock of SARS in 2003 and up to and including 2005. This resulted in a decision to
rectify the infection control performance gap with the IPCP innovation. Successfully
matching the problem to the innovation is essential to its success and sustainability,
particularly within healthcare organisations (Goodman and Steckler 1989). It is at the
point, after the matching has occurred that the decision to proceed with the innovation
occurs and the implementation sub-process can begin.

The Decision to Adopt
The decision to adopt appears to have occurred between 2004 and 2005, when the
senior nurse returned from New Zealand and external assistance was sought to improve
the infection control performance gap.

Rogers describes three types of innovation decisions in organisations (Rogers 2003):
1. Optional innovation-decisions are made by an individual independent of the
decisions made by other members of a system
2. Collective innovation-decisions are made by consensus among the members of a
system
3. Authority innovation-decisions are made by relatively few individuals in a
system where these individuals possess power, high social status or technical
expertise.
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Given the social system within the Kiribati healthcare organisation and the role of
hierarchy, the decision to adopt was not undertaken by one person alone, rather a shared
authority of senior staff. The decision to move ahead to reduce the infection control
performance gap was an authority innovation-decision (Rogers 2003).

Implementation:
Redefining/Restructuring
The year 2005 was when the implementation sub-process began in Kiribati.

The

redefining/restructuring stage of the process is the time when the innovation and
organisational structure are modified to assist successful adoption (Van de Ven 1986;
Rogers 2003). It is at this point that the innovation undergoes re-invention to fit the
specific needs and structure of an organisation as it is rare for an innovation to fit an
organisation perfectly (Rogers 2003). Through the facilitation of an external consultant
the IPCP was adapted and changed to suit the needs of the organisation. Structural
changes were also made to the organisation through the introduction of an Infection
Control Committee (ICC) and the establishment of the infection control principal
nursing officer position. This demonstrated a feedback and feed-forward cycle that
encouraged active participation of the individuals in the organisation.

The redefining/restructuring stage continued through the remainder of 2005 and 2006.
These years saw further definition of the IPCP and the organisation with action plans
developed based upon internal reviews of the needs of the organisation. A further
organisational structure change that occurred during this stage was a change in
membership of the ICC to be more representative of the key stakeholders in the IPCP
and provide guidance and co-ordination at a national level.

Clarifying
The clarification stage of the IPCP innovation occurred between 2006 and 2009. This
stage of the process is the beginning of acceptance of the innovation within the
organisation. Following its introduction, it becomes more widely used and is further
adapted to the environment. During this stage, the Kiribati healthcare organisation
utilised the IPCP to establish education programmes, develop quality indicators and
provide specialist consultation and advice.
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Key individuals within the organisation play a significant role in achieving acceptance.
These persons are often referred to as champions (Rogers 2003). Champions are often
well respected within an organisation for their position, knowledge, skills and
interpersonal style. They can help ease an innovation into the organisational structure
because people listen to them (Rogers 2003). The ICC was expanded during this stage,
its membership being champions from the various healthcare disciplines.

Routinising
The routinising of an innovation is the final stage of the process. This is the point when
the innovation has become a part of the everyday operation within an organisation and it
no longer holds a separate identity. For an innovation to become routine it must be
sustainable. An indicator for the sustainability of an innovation is the degree to which
the individuals within the organisation have been involved in the process including its
re-invention to fit the needs of the organisation (Rogers 2003).

A key method for the elimination of barriers in the adoption of an IPCP is the
involvement of key stake holders and opinion leaders. In the Kiribati case, participation
of health care workers in the innovation process was evident. As previously discussed,
broad involvement occurred from the beginning of implementation and was
fundamental in the matching stage of the initiation sub-process. Participation allowed
the identification and adaptation of appropriate resources and tools for the IPCP. This
has assisted in the IPCP being a sustainable innovation in the Kiribati health care
environment. The founding of regular IPCP activities applicable and delivered across
all health services demonstrated the routinising of the programme in Kiribati. From
2009 until the present, the activities of the IPCP continue and are accepted as part of the
delivery of healthcare in Kiribati. It has now become part of the continuous quality
improvement process, a fixture of the education programme, a source of advice and
information. Kiribati is representative of a case where IPCP adoption has been
successful, this however is not always the situation.

Studies of the adoption of IPCP in LMI countries are generally unavailable in the
literature (Leu 1995). What are available though are reviews of the general issues
related to adopting IPCP in LMI countries or reviews of individual component adoption,
such as surveillance. Of these reviews the major problems identified are:
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•

most LMI countries have weak or absent IPCP,

•

IPCP are often unidirectional, focusing only one or a few interventions such as
antibiotic usage,

•

local studies and local expertise are not utilised in developing an IPCP,

•

appropriate resource allocation to the health sector and delivery system is not
addressed,

•

human resources are not adequately developed to support IPCP adoption,

•

limited equipment and consumable items such as sharps containers, sterilisers,
disinfectants, PPE, running water and electricity are available (Mortensen 1991;
Sobayo 1991; Nettleman 1993; Huskins et al. 1998; Starling 2001; Nyamogoba
and Obala 2002).

Given these barriers identified for other LMI countries, Kiribati appears to have
demonstrated a concerted effort to adopt infection prevention and control activities
which together create a comprehensive IPCP. In the context of the classic Diffusion of
Innovations framework, this can also be described as a technology cluster or innovation
package. Rogers identifies a technology cluster, as a group of individual components
that are closely inter-related and that can be adopted as a package of technology or
innovation package (Rogers 2003). In the Kiribati case there is evidence, supported by
the IPCPE and healthcare worker survey, of the adoption of infection prevention and
control activities or innovation package which has evolved into an IPCP.

8.7 Evidence of routinisation of the innovation
The healthcare worker survey and the infection prevention and control programme
evaluation (IPCPE) served to validate the presence and adoption of the IPCP in Kiribati
by verifying the activities that had occurred since 2003. They also served to provide
evidence that the key components of an IPCP, as previously described by WHO
(Informal Network on Infection Prevention and Control in Health Care 2009) were in
existence. The IPCPE tool that was developed as part of the study indicated that the
programme met a minimal level of compliance of 75%, where a score greater than 76%
is required to show at least a partial level of compliance.
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The areas which demonstrated the greatest need for improvement were the
Epidemiological surveillance of infections and Hospital environment and sanitation.
The results of each area examined as part of the IPCPE are detailed in Table 2.

Table 2: Results of the IPCPE
Area

%

Level of compliance

Organisation

100

Compliant

Epidemiological surveillance of infections

35.3

Minimal

Microbiology

83.3

Partial

Intervention strategies

76.3

Partial

Sterilisation and high-level disinfection

87.5

Compliant

Personnel health

78.6

Partial

Hospital environment and sanitation

60.9

Minimal

Ineffective practices

77.8

Partial

Overall

74.56 Minimal

The area Organisation achieved complete compliance. Within this area is the
educational component of the programme which was verified by the healthcare worker
survey. The survey demonstrated that staff had a good knowledge of standard
precautions in comparison to additional precautions and they felt confident in their
ability to apply infection prevention measures in their clinical practice (Zimmerman et
al. Submitted 14 Dec 2011 American Journal of Infection Control).

What is interesting in the Kiribati case is that the healthcare organisation appears to
have been able to address issues that often prevent the adoption of IPCP in other LMI
countries. Methods to overcome these issues include ensuring that IPCP is adapted to
the local environment and context, making use of available resources and targeting
interventions to those infectious diseases of local importance (Ponce-de-Leon 1991;
Rhinehart et al. 1991; Raza et al. 2004). These methods are integral to the Diffusion of
Innovations framework in an organisation.

8.8 Conclusion
The findings demonstrate that the classic Diffusion of Innovations for organisations is a
model that can explain the adoption of the IPCP in the Republic of Kiribati. Given this
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situation it may be useful as a framework for LMI countries to follow in the adoption of
a comprehensive IPCP. The Kiribati case clearly demonstrates the successful and
consistent progression of the innovation process in an organisation through initiation
and implementation, this is demonstrated through application of the staged model of
Diffusion of Innovations for organisations. The routinisation of the programme is
confirmed through the evaluation of the current IPCP and the status of healthcare
worker infection control knowledge and skill and their confidence in applying this in
practice. This case clearly identifies the importance of involving the end users in the
innovation process as well as the particular role of champions in supporting
implementation.

The Kiribati case illustrates how an IPCP can be adopted with little involvement from
external agencies and how important it is to recognise performance gaps to catalyse
change in the healthcare environment. The awareness of staff within the health system
to identify opportunities is paramount as is their ability to motivate change and seek the
resources to enable it.

By presenting a story of successful adoption, other LMI

countries can feel inspired to venture on a similar journey.

Limitations
This is a case study of an individual situation and hence the findings of this study
cannot be generalised to other LMI country situations, though lessons learnt may be
valuable. The findings of this study are applicable to the population and organisation
represented.

Recommendations for future research include the testing of both the

IPCPE and the survey tool in other settings and other populations to increase the ability
to generalise the findings.
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Chapter Nine
Recommendations and conclusions
This study has provided new knowledge that models how LMI countries can improve
their adoption of comprehensive IPCP. Further, the discussion within will assist all
countries in their adoption of the complementary programme components of IPCP. The
case study demonstrated that applying a theoretical framework such as the Diffusion of
Innovations process in an organisation to a comprehensive IPCP, or its componentry,
can lead to successful and sustainable integration into healthcare service delivery, to the
benefit of patients, staff and visitors to that environment.

The study has shown that there is an absence of reported literature to assist LMI
countries to improve the status of IPCP. The need for undertaking in-depth evaluation of
health care practices in LMI countries is established and evident, as they are most at risk
of healthcare associated infection and have negligible resources to deal with such
problems.

Findings from this study provide support for the application of a case study approach to
a real life example. Further, it demonstrates the efficacy in leveraging successful
experience for emulation in similar health care settings. This establishes a connection
between lived experience and remedial action, based on the understanding of IPCP
issues and the adoption of solutions.

This chapter commences with a summary of the overall findings of the study. It draws
together the insights gained from the varied literature and consolidates answers to each
of the research questions. Relevant recommendations to address each of these questions
are also discussed in this section. The limitations of the study design and
implementation are then acknowledged. The chapter concludes with a summary of the
benefits of applying the Diffusion of Innovations process in organisations framework to
gain important insights into LMI country and poorly resourced healthcare settings.
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9.1 Introduction
It is globally recognised that the prevention of healthcare associated infection is an
integral component of the delivery of safe and effective care to patients and clients in
any healthcare environment. Included in this safe delivery is the protection of healthcare
workers and all who visit and are involved in these environments. The goal of the WHO
First Global Patient Safety Challenge is to:
…ensure that infection control is acknowledged universally as a solid and
essential basis towards patient safety and supports the reduction of health careassociated infections and their consequences (World Health Organization
2009a).

It is with this goal in mind that an understanding of how comprehensive infection
prevention and control programmes are essential, and how important it is that they are
adopted in all economic circumstances.

This study set out to explore and understand the successful implementation of an IPCP
through the analysis of the experiences of health professionals in Kiribati, using the
classic Diffusion of Innovations model as a frame of analysis. This model provided a
holistic understanding of the innovation process Kiribati experienced in adopting the
IPCP innovation package. In line with this and the research questions, quantitative and
qualitative data sources were utilised within the context of the case study method.

9.2 The questions, the answers, the recommendations
9.2.1 Research question 1: How can the success of IPCPs be enhanced in LMI
country healthcare settings?
It is generally recognised that the lower the economic status of a given population or
nation, the greater the significance and impact of infectious diseases and HAI in
mortality and decreased quality of life (Isturiz and Carbon 2000; Starling 2001; World
Health Organization 2002; Rosenthal et al. 2003a; Yalcin 2003). Hence, the importance
of infection prevention and control programmes in LMI countries is evident. However,
as detailed in Chapters Three, Four and Five, the available literature which examined
infection control programmes in LMI countries consisted predominantly of review
papers or case study reports, focusing on the adoption or modelling of individual
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components of an infection control programme rather than the implementation of a
comprehensive plan.

Available literature reflected that studies in high-income countries were more prevalent
in available publications and this focus was also more upon the adoption of individual
complimentary components rather than a comprehensive package. This was mainly due
to comprehensive programmes having been established in these settings for significant
periods of time (Raza et al. 2004).

The case study presented in this dissertation explored how a comprehensive IPCP was
adopted in a LMI country setting, using multiple data collection methods to provide
evidence of its presence. Two literature reviews were conducted in conjunction with this
to explore how IPCP adoption could be enhanced in LMI countries. The first, Chapter
Four, identified that available studies focussed mainly upon the implementation of
individual infection control programme components such as surveillance, rather than on
the comprehensive adoption of the available advice, whether designed for high income
or LMI settings, and measurement of the success of such endeavours. By examining
such situations, lessons may be learnt on how to best adapt the advice to specific
healthcare environments or create resource specific advice, assisting with ease of use in
the LMI context.

The Kiribati case study provided a valuable example in the LMI context of how to adopt
an IPCP and subsequently how to enhance adoption in other LMI or resource poor
settings. The documentation of the adoption of the Kiribati IPCP highlighted the
processes that facilitated the development of the present programme. It was clear from
this case study that infection control action followed on from an external key stimulus
(SARS), thus health workers need to able to identify key events (particularly an external
event or review) that may be used to focus their organisation’s attention on the need for
an IPCP. It was also important that health staff in key positions identified gaps in the
current practices, advocated for change and took practical steps toward implementing an
IPCP. As it was the local staff that took action, the infection prevention and control
activities were made relevant to the local needs and available resources of the healthcare
environment. The IPCP process was then consolidated through appropriate
organisational changes in the health services themselves.
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Recommendations:
1. Healthcare workers from LMI settings must be involved with the adaptation of
evidence based infection prevention and control guidelines to assist in the
adoption process (Chapter Four).
2. Infection prevention and control activities chosen for inclusion in a programme
must be relevant to the needs and resources of the healthcare environment
(Chapter Four).

The second review, Chapter Five, was based upon the findings of the first. It identified a
limited literature that explored or described the use of a theoretical framework to inform
the adoption process of an IPCP. The Diffusion of Innovations process in an
organisation (Rogers 2003) was found to be a possible model and one which could be
used to enhance the success of comprehensive IPCP adoption in LMI countries.

Recommendations:
3. Future research is required to investigate and report on theoretical frameworks
that can inform the adoption of infection prevention and control principles and
practices (Chapter Five).
4. Future research is required to investigate and report on the adoption and
implementation of comprehensive IPCP and individual components in LMI
country or healthcare environments, with a view to provide guidance for LMI
countries as to how to identify and take advantage of opportunities to adopt and
successfully sustain a programme (Chapter Four).
9.2.2 Research question 2: Can the classic Diffusion of Innovations model be used
to explain the level of success?
Using the Diffusion of Innovations process in organisations (Rogers 2003) as a
framework for investigation, this case study was conducted to explore the adoption of a
comprehensive IPCP in a LMI country, the Republic of Kiribati. Semi-structured
interviews and a review of the programme’s documentation, as reported in Chapter
Seven, provided a chronological account of the progress of the programme over time up
to the present day. By following the progress of the adoption it was clear that the
activities of the persons and the organisation involved aligned with the initiation and
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implementation sub processes described by Everett Rogers (2003). These processes
identified the use of stimuli, key personnel, champions and organisational restructuring
as being integral to the success of the adoption process.

Recommendations:
5. Healthcare workers and administrators should exploit the opportunities provided
by external stimuli such as shocks to the health care system, in order to
introduce an IPCP (Chapter Six)
6. Key people and healthcare workers themselves need to be involved in order to
make the IPCP applicable and unique to their healthcare environment (Chapter
Six).
7. Input and feedback on the progress of IPCP adoption should be sought through
open communication, audits and marketing of the innovation to administrators
and healthcare workers. Champions within the health system who can assist in
its integration should be identified. Practical ways to demonstrate how the
innovation benefits the healthcare worker and the patient need to be provided
(Chapter Six).
8. The resources available both within, and external to, the healthcare system
should be used to find suitable solutions and move innovations ahead (Chapter
Six).

The evidence of the Kiribati case study provided weight to the argument that a
theoretical framework can assist in the adoption of comprehensive IPCP and associated
individual complementary components. It also suggested that others’ experiences of
adopting an IPCP also may have followed such a diffusion of innovation process but
this may have not been recognised due to lack of similar research.

Recommendations:
9. The IPCP should be incorporated into the day to day work of the healthcare
worker so that it becomes an integral part of health service delivery (Chapter
Six).
10. Chronicling of the adoption process of a comprehensive IPCP to identify the key
stimuli, events and persons responsible for the initiation of the process and
reporting of this within the organisation needs to be explored in future research
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and reported in the literature so that other countries may benefit from such
experiences (Chapter Six).

To confirm the presence of the IPCP in Kiribati, a pilot infection prevention and control
programme evaluation (IPCPE) was developed and carried out in conjunction with a
survey of healthcare worker knowledge, application and confidence with the IPCP that
had been used previously. The findings of these collectively demonstrated that the IPCP
had become routinised into the provision of health service delivery in Kiribati. Though
the IPCPE was a pilot tool, it provided detailed information and baseline data for the
programme, highlighting areas in need of improvement and strengthening. The
healthcare worker survey identified those areas which required further attention in the
training and professional development of clinicians within the organisation.

Recommendations:
11. The adoption of an IPCP should be confirmed and monitored through the use of
evaluation tools such as the IPCPE and healthcare worker surveys of knowledge,
application and confidence. The findings of such monitoring should be
communicated to the participants and the organisation to assist in the routinising
of the programme (Chapter Seven).
12. The findings of IPCP evaluations should be shared with other LMI country and
healthcare settings through publication and conference/meeting attendance
(Chapter Five).

These recommendations point to the value of this study and the need for its
implementation into the larger LMI health care community. The next section discusses
the significance of this study, followed by a presentation of the study’s limitations.

9.3 Significance of this study
This case study of the successful adoption of an IPCP in the Republic of Kiribati
highlighted the elements which can assist in improving health care and health outcomes
in less advantaged regions in the world. Exploring the chronology of IPCP adoption in a
LMI country and mapping this process within the diffusion of innovation framework
provided valuable insight that can be shared with potential adopters from similar
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countries who may be seeking resolutions to their own infection prevention and control
issues.

The Kiribati case was of particular interest as the healthcare organisation appeared to
have been able to address issues that often prevented the adoption of IPCP in other LMI
countries. Methods to overcome these issues included ensuring that IPCP is adapted to
the local environment and context, making use of available resources and targeting
interventions to those infectious diseases of local importance. These methods were
integral to the Diffusion of Innovations framework in an organisation.

It was important that this story was chronicled and shared with other countries and their
health care providers as it evolved. This was achieved through the publication of the
findings of this study and presentations at international forums. In this way the lessons
learnt were disseminated in a timely manner, to maximise the opportunities for other
LMI countries to modify their own practices and achieve more effective and timely
implementation of an IPCP.

9.4 Limitations
The literature reviews performed in this study and reported in Chapters Three, Four and
Five, sourced only articles that were available in English. This was a limitation of the
study as there may have been reports available in languages other than English from
LMI countries. This could be an area of further research for scholars with access to
multi-lingual resources.

The information to support the premise that the Kiribati IPCP followed a Diffusion of
Innovations framework was limited by the availability of documentation and interview
participants, as reported in Chapter Six. Prior to 2005 there was no documentary
evidence of the absence or presence of an IPCP and thus information was purely
dependant on the recollections of the interview participants. The researcher, though
known to the organisation, was not I-Kiribati which may have had an effect on the
interviewees’ desire to disclose. The amount of information gained from these
interviews however did not appear to reflect any reservations on the part of the
participants.
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This was a case study of an individual situation. Hence, the findings of this study cannot
be generalised to other LMI country situations, though lessons learnt may be valuable.
The findings of this study were applicable to the population and organisation
represented. The findings of the healthcare worker survey and IPCPE reported in
Chapter Seven stand alone as a baseline, as there had been no pre-programme
assessment performed. The findings from these tools could be used to reassess its status
in the future. As mentioned in Chapter Seven, the relationship between the programme
evaluation results and the survey scores cannot be statistically correlated, though they
can be used together to authenticate the educational component of the programme.
Recommendations for future research include the testing of both the IPCPE and the
survey tool in other settings and other populations to increase the ability to generalise
the findings.

9.5 Conclusion
The findings have demonstrated that the classic Diffusion of Innovations for
organisations is a model that explains the adoption of the IPCP in the Republic of
Kiribati. It may be concluded that this model is useful as a framework for LMI countries
to follow in the adoption of a comprehensive IPCP. The Kiribati case clearly
demonstrated the successful and consistent progression of the innovation process in an
organisation through initiation and implementation; this was demonstrated through
application of the staged model of Diffusion of Innovations for organisations. The
routinisation of the programme was confirmed through the evaluation of the current
IPCP and the status of healthcare worker infection control knowledge and skill and their
confidence in applying this in practice. This case clearly identified the importance of
involving the end users in the innovation process as well as the particular role of
champions in supporting implementation.

The Kiribati case illustrated how an IPCP can be adopted with little involvement from
external agencies and how important it is to recognise performance gaps to catalyse
change in the healthcare environment. The awareness of staff within the health system
to identify opportunities is paramount, as is their ability to advocate for change and seek
the resources to enable it. By presenting a story of successful adoption, other LMI
countries can feel inspired to venture on a similar journey.
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Appendix 1: Interview participant information sheet and consent form
(printed on UoW letterhead)

PARTICIPATION INFORMATION SHEET FOR INTERVIEWEES
TITLE: Infection prevention and control programme: A Diffusion of Innovations case study in the
Republic of Kiribati.
PURPOSE OF THE RESEARCH: This is an invitation to participate in a study conducted by researchers
at the University of Wollongong. You are invited to participate due to your involvement in infection
prevention and control activities in Kiribati. This project is concerned with exploring how infection
prevention and control programmes are adopted in low- and middle income countries, utilising Kiribati as
a case study.
INVESTIGATORS
Dr Heather Yeatman

Dr Michael Jones

Ms Peta-Anne Zimmerman

Faculty of Health and

Faculty of Commerce

Faculty of Health and

Behavioural Sciences

Behavioural Sciences

+61 (0) 2 4221 3153

+61 (0) 2 4221 4706

+61 (0) 4123 33870

hyeatman@uow.edu.au

mjones@uow.edu.au

papz832@uow.edu.au

METHOD AND DEMANDS ON PARTICIPANTS
If you choose to be included, you will be asked to participate in an interview conducted by a member of
the research team, at a time of your convenience. The researcher will conduct an interview, no longer than
60 minutes, to explore how the infection prevention and control activities have been adopted in Kiribati.
The interview will be audio recorded to ensure accuracy of reporting the data. Typical questions in the
interview include: your role in the Kiribati healthcare system, your role in the infection prevention and
control activities, how the infection prevention and control programme has developed, how long it has
taken for the programme to develop and be adopted, what has influenced the adoption of the infection
prevention and control programme.

POSSIBLE RISKS, INCONVENIENCES AND DISCOMFORTS
Apart from the 60 minutes of your time for the interview, we can foresee no risks for you. Your
involvement in the study is voluntary and you may withdraw your participation from the study at any time
and withdraw any data that you have provided to that point. Confidentiality cannot be assured as your
position, but not your name will be identified in the research, thesis and publications. Refusal to
participate in the study will not affect your relationship with the University of Wollongong or the
researchers.
FUNDING AND BENEFITS OF THE RESEARCH
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This research will provide a basis for improved future infection prevention and control programme
adoption strategies. This research will be included in a Doctor of Public Health Dissertation.
ETHICS REVIEW AND COMPLAINTS
This study has been reviewed by the Human Research Ethics Committee (Social Science, Humanities and
Behavioural Science) of the University of Wollongong. If you have any concerns or complaints regarding
the way this research has been conducted, you can contact the UoW Ethics Officer on (02) 4221 4457.
Thank you for your interest in this study.
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CONSENT FORM FOR
Infection prevention and control programme: A Diffusion of Innovations case study in the
Republic of Kiribati.
Peta-Anne Zimmerman

I have been given information about “Infection prevention and control programme: A Diffusion
of Innovations case study in the Republic of Kiribati”, and discussed the research project with
Peta-Anne Zimmerman who is conducting this research as part of a Doctor of Public Health
program, supervised by Heather Yeatman in the School of Health Sciences at the University of
Wollongong.

I have been advised of the potential risks and burdens associated with this research, which include
the possibility of being identified through the research and have had an opportunity to ask PetaAnne Zimmerman any questions I may have about the research and my participation. I
understand that every attempt will be made to preserve the confidentiality of my identity and the
information that I provide.

I understand that my participation in this research is voluntary, I am free to refuse to participate
and I am free to withdraw from the research at any time. My refusal to participate or withdrawal
of consent will not affect my relationship with the researcher or my relationship with the
University of Wollongong.

If I have any enquiries about the research, I can contact Peta-Anne Zimmerman (+61
412333870), Heather Yeatman (+61 2 4221 3153) and Michael Jones (+61 0 2 4221 4706) or if I
have any concerns or complaints regarding the way the research is or has been conducted, I can
contact the Ethics Officer, Human Research Ethics Committee, Office of Research, University of
Wollongong on +61 2 4221 4457.

By signing below I am indicating my consent to
• an interview of no more than 60 minutes

I understand that the data collected from my participation will be used for thesis completion and
academic papers and I consent for it to be used in that manner.
Signed

.......................................................................

Date

......./....../......

Name (please print)

.......................................................................
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Interview Guide
•

Can you please give a description of your role and position?

•

How long have you held this position?

•

What has been your previous experience in the Kiribati healthcare system?

•

What role do you have in the infection control programme?

•

How long have you been involved in infection control?

•

Can you please give a description of your experience and training in infection control?

The innovation
•

Can you please describe your understanding of the infection control programme?
o

What does it entail?

o

What are the activities of the programme?

o

What staff are associated with the programme?

•

Can you describe how the programme came to be, how did it begin?

•

What factors do you feel contributed to the adoption of infection control activities in Kiribati?
o

Events

o

People/organisations

o

Communication with other bodies, countries

•

What are the future plans for infection prevention and control in Kiribati?

•

What do you see are the future needs for Kiribati in regard to infection control?

Prompts:

Communication channels
•

What, do you think, really started the ball rolling with infection control in Kiribati?

•

How has information about infection control made a difference to the adoption of activities?

•

How was this information made available to you and others involved in infection control?

•

Can you please talk about any published guidelines or input from other organisations that has
been received to assist infection prevention and control implementation in Kiribati/(facility
name)?

Time
•

When, do you think, did things start to change in infection control in Kiribati?

•

Can you think of any events, and when they occurred, that have influenced the adoption of
infection control activities? Can you describe these?

Social system
•

Who has been involved in the adoption of infection control activities in Kiribati?
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•

In your opinion, have there been any key people or groups who have been particularly influential
in adopting infection control activities? Who are they, how have they been influential?

•

Have there been people or groups that have been unhelpful? Who are they, how have they not
been helpful?

•

How have the activities been accepted within the healthcare community?

•

How have the activities been accepted within the Pacific region?

•

Can you describe any problems that have been encountered in the adoption of the activities?

•

Do you foresee any future problems in infection control adoption?
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Appendix 2: Healthcare worker survey and participant information
sheet
(Printed on UoW letterhead)

PARTICIPATION INFORMATION SHEET FOR SURVEY PARTICIPANTS
TITLE: Infection prevention and control programme: A Diffusion of Innovations case study in the
Republic of Kiribati.
PURPOSE OF THE RESEARCH: This is an invitation to participate in a study conducted by researchers
at the University of Wollongong. You are invited to participate due to your involvement in infection
prevention and control activities in Kiribati. This project is concerned with exploring how infection
prevention and control programmes are adopted in low- and middle income countries, utilising Kiribati as
a case study.
INVESTIGATORS:
Dr Heather Yeatman

Dr Michael Jones

Ms Peta-Anne Zimmerman

Faculty of Health and

Faculty of Commerce

Faculty of Health and

Behavioural Sciences

Behavioural Sciences

+61 (0) 2 4221 3153

+61 (0) 2 4221 4706

+61 (0) 4123 33870

hyeatman@uow.edu.au

mjones@uow.edu.au

papz832@uow.edu.au

METHOD AND DEMANDS ON PARTICIPANTS
If you choose to be included, you will be asked to participate in survey of infection control knowledge
and application. The survey is anonymous and should take no longer than 15 minutes to complete. Please
return the completed survey to the designated area in your department.
POSSIBLE RISKS, INCONVENIENCES AND DISCOMFORTS
Apart from the 15 minutes of your time for the survey, we can foresee no risks for you. Your involvement
in the study is voluntary and you may withdraw your participation from the study at any time up until the
survey is returned to the researcher, after that it will not be able to be identified to be withdrawn. Refusal
to participate in the study will not affect your relationship with the University of Wollongong or the
researchers.
FUNDING AND BENEFITS OF THE RESEARCH
This research will provide a basis for improved future infection prevention and control programme
adoption strategies. This research will be included in a Doctor of Public Health Dissertation.
ETHICS REVIEW AND COMPLAINTS
This study has been reviewed by the Human Research Ethics Committee (Social Science, Humanities and
Behavioural Science) of the University of Wollongong. If you have any concerns or complaints regarding
the way this research has been conducted, you can contact the UoW Ethics Officer on (02) 4221
4457.Thank you for your interest in this study.
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Healthcare Worker Survey
Demographic information:
Please write down or tick the appropriate response unless otherwise asked.

1. Age:______________years.

2. Sex:
a.

Male

b.

Female

3. Designation:
a.

Registered nurse

b.

New graduate registered nurse

c.

Senior Nursing Officer

d.

Nurse aide

e.

Medical officer

4. How long have you been working since basic training?
a.

0-4 years

b.

4-8 years

c.

8-12 years

d.

12 years or greater

5. Have you had any experience in caring for patients with infectious disease?
a.

Yes, go to Q6

b.

No, go to Q7

6. What kind of infectious disease did the patient have?
a.

Respiratory tract infections (eg. Influenza, TB, whooping cough)

b.

Bloodborne infections (eg. HIV, hepatitis B, etc)

c.

Skin, wound and eye infections (scabies, conjunctivitis)

d.

gastrointestinal tract infections (Enterovirus)

e.

Urinary tract infections

f.

Not sure
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g.

Others __________________________ (please specify)

7. Have you ever undertaken any post-basic training course or subject or attended
inservice or orientation sessions regarding standard and additional (transmissionbased) precautions?
a.

Yes, please complete Q8

b.

No, go to knowledge section

8. How much time did the training course, session or subject spend on standard and
additional (transmission-based) precautions?
______Months ______Weeks _______Days ________Hours
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Healthcare Worker Survey:

Knowledge
For each of the following questions, please circle “one” answer that best reflects your
opinion. The results of this questionnaire are for research purposes only. Please answer
all questions.

No.

Statements

Answer

1.

Used needles should be disposed of into a sharps container/box

T

F

2.

Standard precautions should apply to situations that might lead to

T

F

T

F

T

F

T

F

T

F

T

F

T

F

contact with vaginal discharge

3.

Masks and goggles are not necessary if procedures and patientcare activities are unlikely to cause splashing of blood or body
fluids

4.

Standard precautions should be applied to all persons regardless
of their infectious status

5.

Gloves are necessary in all procedures when caring for patients
with HIV

6.

Standard precautions should apply to situations that might lead to
contact with tears

7.

Standard precautions should apply to situations that might lead to
contact with saliva

8.

Standard precautions should apply to situations that might lead to
contact with urine or faeces
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9.

Gloves, protective eyewear, and masks should be worn by all

T

F

T

F

T

F

staff assisting with endotracheal intubation

10.

Gowns, gloves, mask, and protective eyewear should be worn
whenever there is potential for splash and/or droplet exposure to
patient’s blood

11.

Staff who have any ‘sores’, or broken skin on hands should be
covered with an occlusive dressing

12.

When you have contact with a coughing patient who does not wear a mask,
what kind of precautions should you apply?

13.

1.

No protective measures required

2.

Only a mask and apron required

3.

Only gloves required

4.

Gloves and mask required

5.

Gloves, mask, apron and protective eyewear required

What should you apply when you have casual contact (no direct physical care)
with patients who do not require additional precautions?

14.

1.

No protective measures required

2.

Only a mask and apron required

3.

Only gloves required

4.

Gloves and mask required

5.

Gloves, mask, and protective eyewear required

What precautions should you apply when you touch non-intact skin?
1.

No protective measures required

2.

Only a mask and apron required

3.

Only gloves required

4.

Gloves and mask required

5.

Gloves, mask, and protective eyewear required

147

15.

Each of the following statements regarding infection control precautions is true,
except……..
1.

Standard precautions are to reduce the risk of transmission of
microorganisms from both recognised and unrecognised sources of
infection

2.

Additional precautions are required to prevent cross-infection

3.

Indirect contact transmission involves contact of a susceptible host
with a contaminated intermediate object, such as sphygmomanometer,
toilet

4.

The microorganisms within the droplets can remain suspended in the
air and transmit by the airborne route

______________________________________________________________
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Healthcare Worker Survey:
Application and Confidence

For each of the scenarios below, please circle a response to each question – 1 for ‘yes’
and 2 for ‘no’.

Scenario 1
Mr A, an ethnic Chinese 45 year old man, walked into the Emergency Department (ED)
with his wife on the morning of 20 May 2003. He complained of fever, chill, fatigue,
cough and shortness of breath. These symptoms started on the 10th May, the day he
returned from mainland China. His temperature was 39.5˚C (oral temperature) and his
chest x-ray was abnormal. He has no history of chronic diseases or surgery, and is not
taking any medications. But he has smoked 20 cigarettes per day since he was 20 years
old. You work in the ED, how would you respond to this situation? What type of
precautions will you implement for managing the case?

No.

Statement

Yes

No

16.

Contact and airborne precautions shall be performed all time when

1

2

I am caring for Mr A

17.

I will ask Mr A to wear a duckbill mask all the time

1

2

18.

It is not necessary to place Mr A in an airborne isolation room

1

2

I shall wear surgical mask, gloves, gowns and eye protection whilst 1

2

before he is confirmed as a patient with a respiratory tract infection

19.

caring for Mr A
20.

Mr A should not be placed in a single bed room with the door

1

2

1

2

1

2

closed
21.

If I have worn gloves to care for Mr A, I do not need to wash my
hands immediately after removal of gloves

22.

I am confident to apply routine practices and infection control
precautions in the clinical setting
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23.

I am confident to educate the reason for infection control

1

2

1

2

precautions to the patient and their family members

24.

I am confident to educate and communicate with other healthcare
workers in relation to infection control issues
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Scenario 2
Mr B is 65 years old. He has a history of myocardial infarction (MI) over 10 years ago
and accepts medications and medical treatment. Two weeks ago he was admitted into
the hospital at midnight due to another MI. He has been in the medical ward for a week
and his condition is improving. However, this morning he complains that he could not
sleep last night because he felt very itchy over his body, especially in the area of his
palms, fingers, armpits, elbows and wrists. When you look at, and try to assess, his skin,
you discover some lesions over these areas; these lesions look like burrow, papules,
pustules and nodules. How will you care for this patient? What strategies and
precautions will you apply to protect both yourself and other staff and patients?

No.

Statement

Yes

25.

Gloves should be put on before entering, and removed after leaving 1

No
2

the patient’s room or dedicated bed space

26.

Conditions such as scabies can only be transmitted through indirect 1

2

contact

27.

Gloves and gowns/aprons should be worn all the time when in

1

2

1

2

1

2

1

2

1

2

contact with Mr B

28.

Personal articles such as slippers or soft toys should be sealed in a
plastic bag for 10 days and removed from the room

29.

Mr B should be nursed in a room on his own until he has been
treated with scabicide

30.

The water from washing him must be disposed of down a special
drain

31.

I am confident to educate patients and their families about dealing
with potential infectious skin conditions
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Scenario 3
Your patient, Mrs C is a 43 year old lady who was admitted to hospital yesterday
morning with a high fever (>39˚C) and she was suspected to be infected with influenza.
In response, she was isolated for treatment and observation in the ward where you work,
which is designated as the isolation area for H1N1 influenza. Mrs C complained that she
felt very unwell with the symptoms of high fever and cough. You tried to contact the
radiographer to perform a mobile chest x-ray and request them to enter the ward. The
radiographer was reluctant to enter the ward and when they did they confined their
movements to the nurses’ station, refusing to see the patient. As you are Mrs C’s careprovider, how would you manage this situation?

No.

Statement

Yes

No

32.

I would be confident to educate the radiographer about additional

1

2

1

2

1

2

1

2

precautions

33.

I have sufficient knowledge and skills in infection control to
reassure the radiographer

34.

I would be confident about protecting myself and my family from
the infection risk in the situation

35.

The radiographer has a valid reason to be afraid of the infection
and not approach the patient

Congratulations!!
You have reached the end of the questionnaire
Thank you for taking the time and effort to complete this questionnaire. Your assistance
on providing information is appreciated. Before you return this survey, please ensure
you have answered all the questions!!
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Appendix 3: Study approval, Ministry of Health of Kiribati, Dr Revite
Kiriton Director of Public Health
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Appendix 4: Ethics approval: Human Research Ethics Committee,
University of Wollongong
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Appendix 5: Letter of acceptance of manuscript for publication –
‘SARS and Kiribati: Eyes wide open’
[IJIC] Editor Decision
Ms Elizabeth Anne Scicluna [elizabeth.scicluna@theific.org]

To:
Peta-Anne Zimmerman
Thursday, 29 September 2011 5:07 PM

You replied on 24/10/2011 8:36 AM.

Ms Peta-Anne Zimmerman,

Thanks for sending us the final clarifications. Your paper has know been
accepted for publication on IJIC.

It will now go through the process of copy editing and type setting and
closer to the date of publication we will send you a pdf file for proof
reading.

regards,

Ms Elizabeth Anne Scicluna
elizabeth.scicluna@theific.org
________________________________________________________________________
International Journal of Infection Control
http://www.ijic.info
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Appendix 6: Letter of permission for manuscript reproduction –‘SARS
and Kiribati: Eyes wide open’
Re: [IJIC] Editor Decision
elizabethific@gmail.com on behalf of Elizabeth Scicluna
[elizabeth.scicluna@theific.org]

To:
Peta-Anne Zimmerman
Monday, 31 October 2011 8:18 PM
Dear Peta-Anne,

You are given permission to reproduce your paper 'SARS and Kiribati: Eyes wide open'
that will be published in the first issue of 2012 of the International Journal of Infection
Control as part of your PhD thesis.

Regards,

Elizabeth Scicluna
Journal Administrator
International Journal of Infection Control
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Appendix 7: Letter of acceptance of manuscript review – ‘Evaluating
infection control in the Republic of Kiribati’
Peta-Anne Zimmerman <petaanne.zimmerman@gmail.com>

Editor handles AJIC-D-11-00547
1 message
"AJIC <ajic@columbia.edu>
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Instructions for Application of the Infection Prevention and Control Evaluation
General Considerations
The purpose of this evaluation is to provide a review of healthcare infection prevention
and control (IPC) activities in a given healthcare facility. It does not, however, consider
the risk of individual patients or specific cases. It is intended as an instrument to provide
assessment of the status of the infection prevention and control programme (IPCP). It
should not be considered an accreditation system. It does not consider other aspects
related to care outside of surveillance, prevention, and control of healthcare associated
infections (HAI). The tool may be used internally as a continuous quality improvement
activity or as an external review tool by appropriately qualified IPC technical
consultants (See Annexe 1).
Description of the Evaluation
This evaluation tool is an adaptation of the “Nosocomial Infection Program Rapid
Evaluation Guide” created by the Pan American Health Organization [1] and the “Audit
Tools For Monitoring Infection Control Standards” from the Infection Control Nurses
Association [2]. To comprehensively evaluate an IPCP it is essential to examine both
theoretical and practical aspects. This tool combines those most essential standards of
an IPCP including how policy and guidelines translate into the healthcare environment
and patient care.

The evaluation provides information on a number of aspects that should be included in
an IPCP. These aspects have been organised in eight areas that include similar topics. In
each area, some components considered being essential in a good programme have been
selected. In each component, standards have been established to best describe an
acceptable component. Then, indicators have been established so that the presence of
the standards could be considered objectively. A single standard may have several
indicators and a single component may have several standards. Space has been provided
for each indicator to enter what source was used to verify its presence. A list of
suggested verifiers is provided in Annexe 2. These simply offer orientation or sources
of information for the evaluator/s that can be used to determine whether a certain
indicator is present. The evaluator/s can use other methods to establish the presence of
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indicators. A glossary is also provided to assist with clarification of terms used (Annexe
3).

According to this tool, evaluation of the IPCP is based solely on the presence of
indicators. Some of these indicators can only be assessed by observation of the clinical
situation.

The only exception to the above is the “INEFFECTIVE PRACTICES” area, in which
the presence of any of the indicators is considered in a comment to the report.
General Instructions
This evaluation is designed for application within a short period of time (i.e.,
approximately 12 person-hours).
•

All actions conducted during an evaluation have a well-defined purpose that
should be made known during the activity.

•

Make written notes of your observations when they occur to you or take digital
photographs. Do not rely on your memory.

•

The written report must be compatible with the oral comments made during the
review.

Indicate whether or not each indicator is present by recording YES, NO or NONAPPLICABLE (N/A) in the evaluation. Whenever NO or N/A is recorded, a brief
written description on the actual status should be provided so that there can be records
for local follow-up. It is not appropriate to enter non-applicable where an improvement
in a standard may be achieved. For example where a requirement exists in the
programme guidelines and it is not being met a non-applicable must not be used, a NO
is more appropriate. This can then be included in the action plan for programme
improvements. It is however appropriate to use non-applicable if a facility is absent or a
practice is not undertaken in a specific area, for example performing hand hygiene after
leaving an isolation room if there is no isolation room available.
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Local initiatives
Wherever there are local initiatives in place to provide solutions to local infection
control issues these must be noted as it demonstrates an understanding of the need to
meet a specific standard although it may not actually be met.
Instructions and Recommendations for Direct Observation
Evaluation of many of the characteristics is based on observation of how activities are
conducted in practice.
•

When direct observation activities are conducted, tell your colleagues what you
expect to find before beginning observation. After completing the activity,
summarize whether what you found was appropriate or the practices did not
meet the requirements.

•

Be cautious about the comments and your reactions to non-compliance of
practices, particularly because the reviews are often accompanied by personnel
who may have a partial or distorted understanding of the practices.

•

If you observe failure to comply with techniques or inappropriate practices, it is
important to take note and possibly mention it in the final report. However, this
does not necessarily mean that it represents a trend unless the practice is
repeated.

Specific Instructions
Some areas have special conditions to be evaluated.
INTERVENTION STRATEGIES and HEALTHCARE ENVIRONMENT AND
SANITATION
These are two of the most important areas of the evaluation. It is also the area in which
there are usually the most comments. The evidence-based concepts used to evaluate the
preventive strategies are only some of the most well-known and least controversial
concepts. Therefore, they should be included in the usual practice of all healthcare
facilities.
INEFFECTIVE PRACTICES
A series of practices have been introduced in healthcare environments in the past to
prevent infections. However, there is currently no basis for maintaining them, as there is
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sufficient evidence that they do not prevent infection. In addition, in some cases, there is
even enough information to consider that it would be advisable to eliminate these
practices since they increase risk.
In this evaluation it is enough to be aware of and verify the presence of an ineffective
measure that increases the risk of infection in order to include a comment about it in the
final interview and the written report. The information on the presence of ineffective
measures may be acquired from multiple sources. It often occurs by chance during
observations in the clinical units.
SCORING
Scoring of the tool can be carried out by adding the total number of yes answers and
dividing by the total number of questions answered (including all yes and no answers)
excluding the non-applicable. Then multiply by 100 to get the percentage. The area
“Ineffective Practices” is not to be scored in this way, but a report of the findings should
be included in the final report.

Formula
total number of yes answers

x 100 = %

total number of yes and no responses

To produce an overall programme score add the scores for each area together then
divide by the number of areas assessed. This will provide an overall all evaluation
percentage. All areas are equally weighted.
Level of compliance
Percentage scores can be allocated a level of compliance using the compliance
categories below. The categories are allocated as follows:
Compliant

85% or above

Partial compliance

76 to 84%

Minimal compliance 75% or below

If when producing an overall programme compliance score one (or more) of the areas
scores less than 85% then there will be a partial compliance result.
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For example:
IPCP evaluation for Hospital X
Organisation

89%

Epidemiological Surveillance of Infections

86%

Microbiology

84%

Intervention Strategies

90%

Sterilisation and High-level Disinfection

86%

Personnel Health

95%

Hospital Environment and Sanitation

85%

Total

615 divided by 7 = 88%

Overall rating will be PARTIAL COMPLIANCE due to one area falling below 85%,
this being the minimum score for compliant.
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Description of Hospital

Name of hospital:

City:

Country:

Administrative status: State

Private

University

Other:

No. beds:

Annual discharges:

Intensive care unit beds:

Number of annual major surgeries:

Surgery
Obstetrics
Paediatrics
Mark the clinical

Internal medicine

services available

Neonatology

with an X

Adult intensive care
Other subspecialties

Name of evaluators:

Date of evaluation:
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1. Area: Organisation
1.1 Component: Leadership
1.1.1 Standard: Infection Prevention and Control Programme (IPCP) oversight has been established and responsibilities have been defined
Yes
1.

No

N/A

Verifier

Local initiative

Comments

There is an official document that designates the
individuals responsible for the IPCP

2.

The tasks described for each of the individuals
responsible are present in position descriptions

3.

Personnel responsible for infection prevention and
control are at a high level in the institution.
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1.1.2 Standard: IPCP functions are directed and evaluated by the highest level of the organisation
Yes
1.

There are annual IPCP goals for the facility

2.

Evidence that decisions are made in order to

No

N/A

Verifier

Local initiative

Comments

Local initiative

Comments

achieve goals
3.

Goals are evaluated and monitored at least once a
year by the hospital management

1.2 Component: IPCP education
1.2.1 Standard: The IPCP is considered to be an integral part of work by all personnel
Yes
1.

No

N/A

Verifier

There is an orientation programme for new
personnel and this programme is followed
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2. Area: Epidemiological surveillance of infection
2.1 Component: Personnel
2.1.1 Standard: The programme has a physician for the activities
Yes
1.

Physician trained in basic epidemiology and IPC

2.

Physician is allocated 10 or more hours per week

No

N/A

Verifier

Local initiative

Comments

N/A

Verifier

Local initiative

Comments

for every 100 beds
2.1.2 Standard: The programme has a nursing professional for IPC
Yes
1.

Full-time professional

2.

Trained in epidemiological surveillance, infection

No

control, and supervision
3.

One full-time professional for every 150 beds
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2.2 Component: Surveillance method
2.2.1 Standard: Surveillance is conducted with active data collection methods
Yes
1.

Standardised definitions of most frequent infections

2.

At least weekly case-finding in risk groups by

No

N/A

Verifier

Local initiative

Comments

reviewing medical records and laboratory data
3.

Case-finding performed by professionals

4.

Standardized definitions of exposed individuals
(denominators of rates) and of how information on
such individuals is collected

Infection Prevention and Control Programme Evaluation

11

2.2.2 Standard: There is a professional microbiologist accessible for the programme
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Access to professional microbiologist

2.2.3 Standard: Epidemiological information is analysed to detect HAI problems and evaluate the impact of intervention
Yes
1.

No

N/A

Verifier

Local initiative

Comments

HAI rates with a monthly frequency of at least 80%
per year for each basic indicator

2.

Annual analysis of antimicrobial drug resistance

3.

Annual analysis of HAI trends that identifies
problems and proposes solutions

4.

Evaluation system (e.g., prevalence) of surveillance
system capacity to detect infections

5.

Identifies epidemic outbreaks and has outbreak
reports
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2.3 Component: Information circulation
2.3.1 Standard: Information is circulated to all personnel affected
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Report with analysis, recommendations, and known
distribution

2.

Up-to-date information is available and known in
all
departments involved in surveillance
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3. Area: Microbiology
3.1 Component: Diagnostic capability
3.1.1 Standard: Hospital has access to identification of the most relevant microbial agents in HAI control
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Identification of aerobic bacteria to species level in
blood cultures

2.

Identification of viral agents: hepatitis, HIV,
adenovirus, influenza, respiratory syncytial virus,
rotavirus

3.

Detection of M. tuberculosis

4.

Identification of Candida
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3.1.2 Standard: Able to routinely identify antimicrobial susceptibility of HAI agents isolated
Yes
1.

No

N/A

Verifier

Local initiative

Comments

No

N/A

Verifier

Local initiative

Comments

Identify susceptibility patterns of most frequent
HAI
agents

2.

Methicillin-resistant Staphylococcus aureus

3.

Vancomycin-resistant Enterococcus

3.2 Component: Specimen collection and shipment standards
3.2.1 Standard: Standardized techniques and procedures
Yes
1.

Specimen collection and shipment manual updated
at least every 3 years and circulated

Infection Prevention and Control Programme Evaluation

15

3.3 Component: Quality control
3.3.1 Standard: Microbiology activities evaluated periodically by internal and external audits

1.

Yes

No

N/A

Verifier

Local initiative

Comments

Yes

No

N/A

Verifier

Local initiative

Comments

Maintain quality control records on identification of
agents and antimicrobial susceptibility studies in
accordance with relevant standards

2.

Submitted to external quality control at least once a
year

3.4 Component: Microbiological information
3.4.1 Standard: Analysis of clinical information

1.

Report on agents responsible for NI according to
the type of specimen and department of origin

2.

Report on antimicrobial susceptibility pattern of
relevant etiologic agents
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4. Area: Intervention strategies
4.1 Component: Interventions to improve IPC
4.1.1 Standard: Hand hygiene will be performed correctly and in a timely manner using a cleansing agent, at the facilities available to reduce the
risk of cross infection
Yes
1.

Liquid soap is available at all hand hygiene sinks

2.

Liquid

soap

must

be

single-use

No

N/A

Verifier

Local initiative

Comments

cartridge

dispensers
3.

Dispenser nozzles are visibly clean

4.

Absorbent single-use towels are available at all
hand hygiene sinks

5.

Wall mounted or pump dispenser hand cream is
available for use

6.

Antibacterial solutions/scrubs are not used for
social hand hygiene

7.

Antibacterial solutions are used for invasive
procedures and surgical scrubs
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4.1.1 cont.
8.

Yes

No

N/A

Verifier

Local initiative

Comments

There are no nail brushes on hand hygiene sinks
in clinical areas

9.

The hand hygiene sinks are free from used
equipment and inappropriate items

10.

Hand hygiene sinks are dedicated for that purpose

11.

Access to hand hygiene sinks is clear

12.

Hand hygiene sinks are clean and intact

13.

Elbow operated taps are available in hand
hygiene sinks in clinical areas

14.

Alcohol hand rub (AHR) is available at
entrance/exits to wards and departments

15.

AHR is directly accessible at the point of care
(one for every four beds)

16.

AHR is portable for clinical procedures

17.

No wrist watches/stoned rings or other wrist
jewellery are worn by staff carrying out patient
care
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4.1.1 cont.
18.

Yes

No

N/A

Verifier

Local initiative

Comments

Staff nails are short, clean, free from nail varnish
or extensions

19.

Posters promoting hand decontamination are
available and displayed in areas visible to staff
before and after patient contact

20.

Staff have received training in hand hygiene
procedure within the last year. (Ask various
disciplines of staff)

21.

Patients are offered hand hygiene facilities after
using the toilet/commode/bedpan

22.

Patients are offered hand hygiene facilities prior
to meals
Observation

23.

Staff use the correct procedure for hand hygiene
(observe practice)

24.

Staff can indicate when it is appropriate to use
alcohol rub
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4.1.1 cont.
25.

Yes

No

N/A

Verifier

Local initiative

Comments

Hand hygiene is performed in the following
circumstances: (Observe practices)

A

Before touching a patient[3]

B

Before clean/aseptic procedures[3]

C

After body fluid exposure/risk[3]

D

After touching a patient[3]

E

After touching patient surroundings [3]

F

Prior to handling food

G

After leaving an isolation room
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4.1.2 Standard: Clinical practices will be based on best practice and reflect infection control guidance to reduce the risk of cross infection to
patients’ whilst providing appropriate protection to staff
NB: This section should be undertaken over a period of time to allow for the observation of as many practice elements as possible
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Sterile and non-sterile gloves (powder free) are fit
for purpose (no splitting etc) are available
in all clinical areas

2.

Gloves are observed to be worn for:

A

Invasive procedures

B

Contact with sterile sites

C

Contact with mucous membranes

D

All activities that have been assessed as carrying
a risk of exposure to body fluids

3.

Gloves are worn as single-use items

4.

Gloves are worn immediately before an episode
of patient contact or treatment, when appropriate,
and removed as soon as the activity is completed
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4.1.2 cont.
5.

Yes

No

N/A

Verifier

Local initiative

Comments

Hand hygiene is performed before donning
gloves and following the removal of gloves

6.

Disposable plastic aprons are worn when there is
a risk that clothing or uniform may become
exposed to body fluids or become wet

7.

Plastic aprons are worn as single-use items for
each clinical procedure or episode of patient care

8.

Full body, fluid repellent gowns are worn where
there is a risk of extensive splashing of body
fluids onto the skin of healthcare practitioners

9.

Facemasks and eye protection are worn where
there is a risk of any body fluids splashing into
the face and eyes

10.

Respiratory protective equipment is available for
use when clinically indicated e.g. particulate
filtration masks for open pulmonary tuberculosis
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4.1.3 Standard: Clinical practices will be based on best practice and reflect infection control guidance to reduce the risk of cross infection to
patients’ whilst providing appropriate protection to staff
NB: This section should be undertaken over a period of time to allow for the observation of as many practice elements as possible
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Urinary catheters and drainage bags are stored in
an appropriate area (not in the sluice)

2.

Indwelling urethral catheters are only inserted
after

considering

alternative

methods

of

management (reason for insertion should be
documented)
3.

There is evidence that the patient’s clinical need
for continuing catheterisation is reviewed and
documented

4.

Catheterisation is performed aseptically (ask a
member of staff to describe the procedure)

5.

A single-use anaesthetic lubricant is used for
insertion for male and females
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4.1.3 cont.
6.

Yes

No

N/A

Verifier

Local initiative

Comments

Indwelling urethral catheters are connected to a
sterile closed urinary drainage system

7.

Catheter bags are positioned below the level of
the bladder and suspended above floor level

8.

Catheters are secured to prevent trauma

9.

The connection between the catheter and the
urinary drainage system is not broken except for
good clinical reasons, e.g., changing the bag in
line with the manufacturers’ recommendations

10.

Hand hygiene is performed before manipulating a
patient’s catheter

11.

When emptying the urinary drainage bag clean
non-sterile disposable gloves, eye protection and
a plastic apron are worn

12.

Hand hygiene is performed after removal of
gloves
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4.1.3 cont.
13.

Yes

No

N/A

Verifier

Local initiative

Comments

When emptying the urinary drainage bag, a
separate and clean container is used for each
patient and contact between the urinary drainage
tap and container is avoided

14.

Night bags are single-use

15.

Meatal cleanliness is maintained only as part of
routine personal hygiene

16.

Catheter specimens of urine (CSU) are only taken
when

clinically

indicated

(e.g.

patient

systemically unwell), or for screening for
antimicrobial resistant organisms if part of local
protocol
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4.1.3 cont.

Yes

17.

CSU specimens are taken aseptically

18.

Bladder irrigation, instillation and washout are

No

N/A

Verifier

Local initiative

Comments

not used for the prevention or treatment of
catheter-associated infection
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4.1.4 Standard: Clinical practices will be based on best practice and reflect infection control guidance to reduce the risk of cross infection to
patients’ whilst providing appropriate protection to staff
NB: This section should be undertaken over a period of time to allow for the observation of as many practice elements as possible
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Insertion of intravascular devices is performed
aseptically

with

hand

decontamination

undertaken on all occasions
2.

Before insertion of a device the skin is disinfected
with a suitable preparation (e.g. alcohol) and is
allowed to dry

3.

Cannulae dressings are changed when they
become damp, loose or soiled

4.

Insertion details relating to the cannulae have
been documented

5.

Sterile dressings are applied to cover cannulae
sites

Infection Prevention and Control Programme Evaluation

27

4.1.4 cont.
6.

Yes

No

N/A

Verifier

Local initiative

Comments

Cannulae and lines should be labelled with a date
or a suitable documentation system is in place to
enable

intravenous

tubing

and

associated

connections to be replaced according to local
policy (e.g. 72 hours)
7.

Injection ports and catheter hubs are disinfected
according to local policy and manufacturers’
instructions before and after using them to access
the system

8.

If blood or lipid emulsions are administered, sets
are changed every 24 hours

9.

Hand hygiene is performed prior to handling or
manipulating intravenous lines

10.

Intravenous fluid bags are single patient use

11.

Intravenous giving set lines used for intermittent
infusions are discarded once disconnected
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4.1.5 Standard: Clinical practices will be based on best practice and reflect infection control guidance to reduce the risk of cross infection to
patients’ whilst providing appropriate protection to staff
NB: This section should be undertaken over a period of time to allow for the observation of as many practice elements as possible
Yes
1.

Isolation facilities are available in inpatient areas

2.

Patients requiring isolation facilities due to

No

N/A

Verifier

Local initiative

Comments

infection have access to them
3.

Where a patient is being isolated for infection
control reasons, the precautions are appropriate
and according to local policy

4.

Protective clothing is readily available upon
entering the isolation room

5.

Hand hygiene facilities are available, accessible
and clean within the room

6.

No inappropriate or unnecessary items are stored
in the isolation room
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4.1.5 cont.
7.

Yes

No

N/A

Verifier

Local initiative

Comments

Where a patient is being isolated for infection
control reasons, the patient is aware of the need
or rationale for this

8.

Clear instructions for staff and visitors are in
place when a patient is in isolation. (e.g.
confidential notice on the door)

9.

Appropriate information leaflets are available to
patients for common infections e.g. MRSA,
C.difficile

10.

Visitors are advised that they do not routinely
need to wear protective clothing

11.

Reusable equipment which may become readily
contaminated is dedicated for the patients use
only (e.g. commode, hoist, sling)

12.

Used linen, waste and crockery have been
removed from the room in a timely manner

13.

Housekeeping staff are aware of the local policy
and procedures for cleaning isolation rooms
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4.1.5 cont.
14.

Yes

No

N/A

Verifier

Local initiative

Comments

Separate colour coded cleaning equipment is in
use for isolation facilities

15.

Isolation precautions are discontinued when no
longer necessary

4.1.6 Standard: Main HAI prevention activities are regulated in accordance with best current knowledge
Yes
1.

Existence of a complete regulatory technical basis

2.

Regulations updated within the last three years

3.

Technical regulation contents and indications are

No

N/A

Verifier

Local initiative

Comments

evidence-based
4.

Infectious foci are eliminated prior to surgery

5.

Surgical site is not shaved with razor blade

6.

Antibiotic prophylaxis administered within two
hours before a surgical procedure

7.

Restricted use of vancomycin

8.

Restricted use of third-generation cephalosporins
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4.1.7 Standard: Compliance with regulations is promoted and evaluated
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Regulations with effective activities
have been circulated to personnel that should
know them

2.

Supervision

of

personnel

compliance

with

regulations is performed
3.

Evidence of compliance with basic regulations
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5. Area: Sterilisation and high-level disinfection
5.1 Component: Sterilisation methods
5.1.1 Standard: Sterilisation processes are controlled in order to guarantee results
Yes

No

N/A

Verifier

Local initiative

Comments

Only sterilisation methods of proven efficacy1 are

1.

used
2.

Standards and procedures have been established
for all sterilisation and disinfection processes

3.

Individual chemical indicators are used

4.

Biological indicators are used at least weekly

5.

Surgical instruments processed are free from
organic matter

6.

All packages are labelled with processing date
and follow event related sterility protocols

1

On the date of preparation of this document: autoclaves, dry heat, ethylene oxide in automated equipment, formaldehyde in automated equipment, hydrogen
peroxide plasma in automated equipment, peracetic acid in automated equipment.
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5.1.1 cont.
7.

Yes

No

N/A

Verifier

Local initiative

Comments

Undamaged containers that are appropriate for
the method 2

8.

Preventive maintenance programme has been
established for sterilisation equipment

2

Fenestrated boxes for use in autoclaves, use of paper packaging without memory in all paper packaging, packaging without cellulose for plasma sterilisation
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5.2 Component: High-level disinfection methods
5.2.1 Standard: High-level disinfection processes are controlled to guarantee results
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Only high-level disinfection methods of proven
efficacy3 are used

2.

Appropriate exposure time is controlled in each
cycle

3.

Chemical indicator of concentration at least
weekly

3

On the date of preparation of this document: 2% glutaraldehyde, peracetic acid, orthophthalaldehyde (OPA). For dialysis filters 4% formaldehyde can be used
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6. Area: Personnel health
6.1 Component: Prevention of infections that can be transmitted between healthcare workers and patients
6.1.1 Standard: Activities to prevent transmission of infections between patients and personnel
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Staff training on prevention of sharps injuries,
splash exposures and immunisation

2.

Written programme for hepatitis B immunisation
of personnel exposed to blood

3.

Hepatitis B programme personnel coverage
= 80% of target population

4.

Written

programme

for

annual

influenza

immunisation of all clinical personnel
5.

Personnel influenza programme coverage = 80%
of target population

6.

Written programme for rubella immunisation of
susceptible women

7.

Personnel rubella programme coverage = 80% of
target population
Infection Prevention and Control Programme Evaluation

36

6.1.1 cont.
8.

Yes

No

N/A

Verifier

Local initiative

Comments

Management of blood and body fluid exposure
caused by sharps injuries with articles used on
patients and splash exposures
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6.1.2 Standard: Personnel infections are monitored and measures are taken to protect exposed personnel and patients
Yes

No

N/A

Verifier

Local initiative

Comments

Management of personnel with communicable 4

1.

infections is supervised and complied with
2.

Occupational

exposure

of

epidemiological 5

importance is monitored
3.

Nurse/clinical manager in charge is aware of the
action required following an inoculation injury.
They

should

include

immediate

first

aid,

informing the manager, occupational health or
ED, completion of an incident form and describe
the action for high risk injuries involving blood
borne

viruses

(Question

the

nurse/clinical

manager in charge)

4

Establish whether personnel with infectious communicable diseases may be in contact with patients or whether they should be absent from work during the
course of each infection.
5
On the date of preparation of this document: exposure to blood and body fluids with high risk of containing HIV, hepatitis B or hepatitis C, and exposure to
Mycobacterium tuberculosis.

Infection Prevention and Control Programme Evaluation

38

6.1.2 cont.
4.

Yes

No

N/A

Verifier

Local initiative

Comments

Staff are aware of the first aid action required
following

an

inoculation

or

splash

injury

(Question a member of staff)
5.

Staff can identify where the safe handling of
sharps policy is located

6.

There is a policy and/or poster available for the
management of a sharps injury or splash exposure
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7. Area: Hospital Environment and sanitation
7.1 Component: Physical plant conditions
7.1.1 Standard: Basic general structural conditions for prevention of infection
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Permanent availability of drinking water with
minimum autonomy of eight hours

2.

Separation of ≥ 1 metre between each bed/cot in
all clinical areas

3.

Participation by IPC team if remodelling or
construction are performed in areas where
activities of clinical importance are conducted

4.

Availability of individual patient isolation room
with operational washbasins, supplies, and closed
doors. If patients with active tuberculosis are
admitted to the hospital, the isolation rooms also
have air extraction towards the outside.
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7.2 Component: Sanitation conditions
7.2.1 Standard: The environment will be maintained appropriately to reduce the risk of cross infection
Yes
1.

No

N/A

Verifier

Local initiative

Comments

The following pieces of equipment are clean and
in a good state of repair:

A

Beds

B

Tables

C

Lockers

D

Chairs and stools

2.

All chairs and stools in clinical areas are covered
in an impermeable material e.g. vinyl

3.

Floors including edges and corners are free of
dust and grit.

4.

All high and low surfaces are free from dust and
cobwebs

5.

Curtains and blinds are free from stains, dust and
cobwebs
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7.2.1 cont.
6.

Yes

No

N/A

Verifier

Local initiative

Comments

There is evidence of an effective pre-planned
programme for curtain changes

7.

Fans are clean and free from dust

8.

Air vents are clean and free from excessive dust

9.

Work station equipment in clinical areas are
visibly clean e.g. phones, computer keyboards
Clean storeroom

10.

There is an identified area for the storage of clean
and sterile equipment

11.

The area is clean and there are no inappropriate
items of equipment

12.

Hand hygiene facilities are available in the
clinical room/clean store

13.

Floors including edges and corners are free of
dust and grit.

14.

All high and low surfaces are free from dust and
cobwebs
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7.2.1 cont.
15.

Yes

No

N/A

Verifier

Local initiative

Comments

Shelves, bench tops and cupboards are clean
inside and out, and are free of dust and spillage

16.

All products are stored above floor level
Bathrooms

17.

Bathrooms/washrooms are clean

18.

There is no evidence of inappropriate storage of
communal items in the bathrooms e.g. single-use
creams, talcum powder

19.

Bathrooms are not used for equipment storage

20.

Baths, sinks and accessories are clean

21.

Bathroom wall tiles and wall fixtures (including
soap dispensers
and towel holders) are clean and free from mould

22.

Bathroom floors including edges and corners are
free of dust and grit.

23.

The toilet, hand hygiene sink, handrails and
surrounding area is clean and free from
extraneous items
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7.2.1 cont.
24.

Yes

No

N/A

Verifier

Local initiative

Comments

Toilet floors including edges and corners are free
of dust and grit

25.

Hand hygiene facilities are available in the toilets
including soap and paper/single-use towels
Dirty utility room

26.

A dirty utility is available

27.

A separate sink is available for decontamination
of patient equipment

28.

A sluice hopper is available for the disposal of
body fluids

29.

The integrity of fixtures and fittings are intact in
the dirty utility room

30.

Separate hand hygiene facilities are available in
the dirty utility room including soap and
paper/single-use towels

31.

The dirty utility room is clean and free from
inappropriate items
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7.2.1 cont.
32.

Yes

No

N/A

Verifier

Local initiative

Comments

The dirty utility room floor is clean and free from
spillage

33.

The dirty utility floors including edges and
corners are free of dust and grit
Cleaners room

34.

Cleaning equipment is colour coded

35.

Mops and buckets are stored according to the
local policy

36.

Mop heads are laundered daily or are disposable
(single-use)

37.

Macerators and bed pan washers are clean and in
working order

38.

Dirty utility shelves and cupboards are clean
inside and out and free of dust, litter or stains
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7.2.1 cont.
39.

Yes

No

N/A

Verifier

Local initiative

Comments

Equipment used by the domestic staff is clean,
well maintained and stored in a locked area

40.

No inappropriate materials or equipment are
stored in the domestic’s room

41.

Products used for cleaning and disinfection
comply with policy and are used at the correct
dilution

42.

Diluted products are discarded after 24 hours

43.

Personal protective clothing is available and
appropriately used

44.

Information on the colour coding system in use is
available in the domestic’s room

45.

Hand hygiene facilities are available for domestic
use
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7.2.2 Standard: Kitchens will be maintained to reduce the risk of cross infection in accordance with legislation
Yes
1.

No

N/A

Verifier

Local initiative

Comments

The floor is free of dust, grit, litter, marks, water
or other liquids

2.

Inaccessible areas (edges, corners and around
furniture) are free of dust, grit, lint and spots

3.

There are no inappropriate items or equipment in
the kitchen

4.

There is no evidence of infestation or animals in
the kitchen

5.

Fly screens are in place where required

6.

There is a policy regarding patient and visitor
access to the kitchen

7.

Cleaning materials used in the kitchen are
identifiable (e.g. colour coded) and are stored
separately to other ward cleaning equipment and
away from food

8.

Hand hygiene sink, liquid soap and disposable
paper/single-use towels are available
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7.2.2 cont.
9.

Yes

No

N/A

Verifier

Local initiative

Comments

Hand hygiene is performed, a clean plastic apron
and hair cover is worn to prepare and serve
patient meals and drinks

10.

Fixtures and fittings are in a good state of repair

11.

Fixtures, surfaces and appliances are free of
grease, dirt, dust, deposits, marks, stains and
cobwebs

12.

Shelves, cupboards and drawers are clean inside
and out and are free from damage, dust litter or
stains and in a good state of repair

13.

Kitchen trolleys are clean and in a good state of
repair

14.

Refrigerators/freezers are clean and free of ice
build up

15.

There is a thermometer in the fridge and freezer
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7.2.2 cont.
16.

Yes

No

N/A

Verifier

Local initiative

Comments

There is evidence that daily temperatures are
recorded and appropriate action is taken if
standards are not met (refrigerator temperature
must be less than 8̊C or as local policy Freezer
temperature –18˚C)

17.

Patient and staff food in the fridge is labelled with
name and date

18.

There are no drugs/blood for transfusion or
pathology specimens in the fridge

19.

Microwaves are visibly clean

20.

Toasters are visibly clean

21.

All food products are within their expiry date

22.

All opened food is covered or stored in containers

23.

Milk is stored under refrigerator conditions

24.

Waste bins are foot operated and in good working
order

25.

Waste bins are clean and labelled ‘for general
waste’
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7.2.2 cont.
26.

Yes

No

N/A

Verifier

Local initiative

Comments

Clean linen or disposable paper is available for
drying equipment and surfaces
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7.2.3 Standard: Linen is managed and handled appropriately to prevent cross infection
Yes
1.

No

N/A

Verifier

Local initiative

Comments

Clean linen is stored in a clean designated area
separate from used linen (not in the sluice or
bathroom)

2.

Clean linen is free from stains (randomly check
linen)

3.

Clean linen store is clean and free from dust

4.

Clean linen store is free from inappropriate items

5.

Linen is segregated in appropriate colour coded
bags according to policy

6.

Bags are less than 2/3 full and are capable of
being secured

7.

Bags are stored correctly prior to disposal

8.

Linen skips and the appropriate bags are taken to
the area required. (Staff are not carrying soiled
linen or leaving it on the floor)

9.

Gloves and apron are worn when handling
contaminated linen
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7.2.3 cont.
10.

Yes

No

N/A

Verifier

Local initiative

Comments

Ward based washing machines are only used with
the agreement of Infection Control

11.

A washing machine if used is situated in an
appropriate designated area

12.

There is written guidance regarding the use of the
washing machine

13.

There is evidence that the guidelines are being
adhered to (question staff and observe use)

14.

If a washing machine is in use a tumble dryer is
also available which is externally exhausted

15.

There is evidence that the washing machine and
tumble dryer are on a pre-planned maintenance
programme

16.

Hand hygiene facilities are available in the
laundry room
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7.2.4 Standard: Waste is disposed of safely without the risk of contamination or injury
Yes
1.

No

N/A

Verifier

Local initiative

Comments

There is an appropriately designated Waste
Officer who has undergone training within the
last two years (check Job Description and training
record)

2.

All clinical waste must be transported in rigid
containers

3.

There is a dedicated compound for the safe
storage of clinical waste, which is under cover
from the elements and free from pests and vermin

4.

All wards/depts should have a clinical waste
storage area away from the public

5.

Waste containers are locked and inaccessible to
the public

6.

The compound is locked and inaccessible to
public

7.

The compound has appropriate signs in the area

8.

Returned containers are clean
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7.2.4 cont.

Yes

9.

Containers are in a good state of repair

10.

Special waste is stored separate to other waste

11.

Special waste storage area is clearly labelled

12.

Special waste storage area/ bin is kept locked

13.

Sharps boxes are correctly sealed

14.

Sharps boxes are correctly labelled

15.

Sharps boxes are safely stored

16.

Biological agents are made safe by autoclaving

No

N/A

Verifier

Local initiative

Comments

before leaving the laboratory for final disposal
17.

There are no inappropriate items in the household
or recycling bins

18.

Spill kit and heavy duty gloves or alternative are
available

19.

There is no storage of inappropriate items in the
waste compound

20.

The area is clean and tidy (there are cleaning
facilities)
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7.2.4 cont.
21.

Yes

No

N/A

Verifier

Local initiative

Comments

There is no storage of waste in corridors,
inside/outside

the

hospital

whilst

awaiting

collection
22.

There is a system for transporting the waste
through the hospital (i.e. which avoids manual
handling of
waste)

23.

Clinical waste is segregated from other waste for
transportation

24.

All waste containers used for transport are clean

25.

All waste containers are in a good state of repair

26.

Clinical waste posters and/or a waste policy
identifying waste segregation are available in all
areas

27.

All bags are tied, labelled and secured before
leaving the place of generation (e.g. ward)

28.

All waste bins are enclosed to minimise the risk
of injury
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7.2.4 cont.
29.

Supplies

Yes
of

"Household",

bins

labelled

“Hazardous”

as
or

No

N/A

Verifier

Local initiative

Comments

"Clinical",
“Glass

and

Aerosol” are available
30.

Staff are aware of waste segregation procedures
(Randomly question a staff member)

31.

All waste bins are visibly clean

32.

All waste bins in the area are foot operated,
lidded and in good working order

33.

Staff are using correct waste bags for household,
glass, aerosols, batteries and clinical/hazardous
waste (Visibly check bin contents)

34.

All prescription only medicines must be disposed
of as hazardous/special waste and the bin labelled
accordingly
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7.2.4 cont.
35.

Yes

No

N/A

Verifier

Local initiative

Comments

Glass and aerosol boxes are not used for
prescription only medicine bottles

36.

Waste bags are removed at least daily

37.

There is no transfer of clinical waste from one
bag to another

38.

There are no overfilled bags. Bags are no more
than 2/3 full

39.

Waste bags are not tied onto containers/trolleys

40.

Suction waste must be disposed of in a manner
which prevents spillage e.g. canisters/liners are
disposed of into rigid leak-proof containers or
suction waste has been solidified with a gelling
agent

41.

Rigid burn bins are available for disposal of body
parts, equipment etc

42.

Staff have attended a training session which
includes the correct and safe disposal of clinical
waste
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7.2.4 cont.
43.

Yes

No

N/A

Verifier

Local initiative

Comments

Internal storage is inaccessible to the public or
locked

44.

Tied bags waiting disposal are not observed in
corridors. They are stored in an appropriate
holding area
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7.2.5 Standard: Sharps will be handled safely to prevent the risk of needlestick injury
Yes
1.

The bins in use comply with national standards

2.

Bins have not been filled above the fill line

3.

Bins are free from protruding sharps

4.

All bins have been assembled correctly

5.

All sharps bins are labelled and signed according

No

N/A

Verifier

Local initiative

Comments

to hospital policy
6.

Sharps bins are stored safely, away from the
public and out of reach of children

7.

Bins are stored appropriately off the floor

8.

Sharps bins are used in accordance with
ergonomic manual handling principles i.e. using
brackets

9.

Once full the bin aperture is sealed or locked

10.

Sealed and locked bins are stored in a locked
room, cupboard or container, away from public
access
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7.2.5 cont.
11.

Yes

No

N/A

Verifier

Local initiative

Comments

An empty sharps bin is available on the cardiac
arrest trolley

12.

The sharps bin on the cardiac arrest trolley is
stored safely

13.

Sharps trays in use are visibly clean

14.

Sharps are disposed of directly into a sharps bin
at the point of use (i.e. medicine trolleys and
laboratory equipment)

15.

Inappropriate re-sheathing of needles does not
occur. Observe or question a member of staff.

16.

Needles and syringes are discarded into a sharps
bin as one unit
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7.2.6 Standard: There is a system in place that ensures as far as reasonably practicable that all reusable equipment is properly decontaminated
prior to use and that the risks associated with decontamination facilities and processes are adequately managed
NB: All decontamination must be undertaken in accordance with local policy and manufacturers’ instructions
Yes
1.

No

N/A

Verifier

Local initiative

Comments

A written comprehensive decontamination policy,
approved by the ICC is available to all staff

2.

Staff are aware of the need to contact infection
control

for

advice

when

purchasing

new

equipment
3.

Manufacturers’ instructions are available for the
decontamination of newly purchased equipment

4.

Staff can state the procedure for decontamination
of commonly used patient care equipment e.g.
commodes, mattresses, IV stands

5.

Local decontamination of reusable surgical
instruments is not undertaken in clinical areas.
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7.2.6 cont.
6.

Yes

No

N/A

Verifier

Local initiative

Comments

Used instruments are safely stored in an
appropriate container prior to collection for
decontamination in CSSD

7.

The responsibility for the cleaning of dedicated
patient equipment is clearly defined, e.g., bed
frames, IV stands, commodes

8.

The following general equipment is visibly clean:

A

IV stands

B

IV pumps/syringe drivers

C

Cardiac monitors

D

Dressing trolleys

E

Blood pressure cuffs

F

Pillows

G

Mattresses

H

Cot sides

I

Wheelchairs and cushions

J

Oxygen saturation probes
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7.2.6 cont.
9.

Patient

Yes

wash

bowls

are

No

N/A

Verifier

Local initiative

Comments

decontaminated

appropriately
between patients and are stored clean dry and
inverted
10.

Standard mattress covers are in a good state of
repair

11.

Disposable paper towel or reusable linen on
couches/trolleys is changed between each patient
use

12.

Medications

on

the

resuscitation

trolley/resuscitaire are within their expiry date
and all items are visibly clean (free from dust and
body fluids)
13.

Single-use ambu bags are used or filters to ambu
bags are changed between patient use

14.

Laryngoscope covers or blades are single-use
alternatively the blades are sent back to CSSD for
decontamination between each patient use
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7.2.6 cont.
15.

Yes

No

N/A

Verifier

Local initiative

Comments

Laryngoscope handles if not disposable are
decontaminated following each use

16.

Suction equipment is clean and dry (including
canister)

17.

Catheter is not attached (clean cover acceptable in
some emergency situations)

18.

Disposable suction liners are used and changed
between patient use

19.

Respiratory equipment is changed according to
local policy and manufacturers’ instructions,
check

A

Oxygen masks/nasal cannulae

B

Wall humidifiers

C

Nebulisers

20.

Humidifiers

are

managed

according

to

manufacturers’ instructions and local policy
21.

Ventilator tubing is protected by filters –
expiratory

22.

Ventilator is protected by a filter – inspiratory
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7.2.6 cont.
23.

Yes

No

N/A

Verifier

Local initiative

Comments

Ventilator equipment is on a pre-planned
maintenance programme

24.

Ventilator equipment is visibly clean

25.

Catheter stands are available clean and in a good
state of repair

26.

Appropriate facilities are available and in
working order, to ensure correct disposal (or
disinfection)

of

bedpans

and

urinals

e.g.

macerator or washer disinfector
27.

Washer/disinfectors reach a temperature of 87˚C

28.

Bedpans/potties,

slipper

pans/bedpan

holders/urinals
are visibly clean
29.

Bedpans/bedpan

holders/urinals

are

stored

inverted on racks
30.

If reusable jugs are in use for emptying catheter
bags (i.e. during irrigation) appropriate washing
and disinfection facilities are available

31.

Raised toilet seats are clean and ready for use
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7.2.6 cont.
32.

Yes

No

N/A

Verifier

Local initiative

Comments

Commodes are clean and ready for use (check
underside)

33.

Commodes are in a good state of repair

34.

Medical imaging check the following:

A

Ultra sonic probes are decontaminated according
to
local policy and manufacturers’ instructions
between each patient use

B

Gels are single patient use or dispensed in a
manner to
avoid contamination

C

Sand bags are intact and covered

D

Sand bags are visibly clean

E

Foam supports are covered with wipeable covers

F

X-ray cassettes are decontaminated according to
local policy and manufacturers’ instructions
between patient use

G

Mobile X-ray machines are visibly clean

H

Scanners are visibly clean
Infection Prevention and Control Programme Evaluation

66

8. Area: Ineffective Practices
The following practices have been established in the past in order to prevent
infections.
At present, there are no foundations to recommend maintaining them.
Practices recognized as ineffective that increase risk 6
Yes
1.

No

Comments

Processing with quaternary ammonium
for high-level disinfection or sterilisation

2.

Syringes or needles used in more than one
patient (e.g., anaesthesia)

3.

Use of flash sterilisation as routine
method of instrument sterilisation

4.

Surgical site is shaved with razor blade

5.

Use of immersion in chemical agents for
sterilisation

6.

Environmental

disinfection

with

formaldehyde
7.

Sterilisation with formaldehyde tablets

8.

Sterilisation of materials in plastic bags
and ethylene oxide ampoules

9

Recycling of disposable peripheral venous
infusion material

10.

Use of air conditioning without filter in
operating room

11.

Chemical

decontamination

of

contaminated material

6

These concepts are based on well-designed studies that have led to the conclusion that they do not
prevent infections. Rather, they increase the risk of infection.
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Costly practices recognized as ineffective 7
Yes
1.

No

Comments

Routine culture of personnel that are
carriers 8

2.

Use of topical antiseptic on open wounds

3.

Continuation of antibiotic treatment after
operation concludes

4.

Routine culture of vascular catheter tips

5.

Disinfection of hospital waste (except for
Microbiology laboratory)

6.

Use of footwear covers in all areas of
hospital (not Operating Room/Theatre)

7.

Routine environmental cultures (e.g., air,
surfaces, or soap)

7

These concepts are based on well-designed studies that have led to the conclusion that they do not
prevent infections. Although they do not increase risk, they
often cause unnecessary expenses.
8
These cultures are not useful unless there is an epidemic with evidence that carriers should be
considered as a risk factor.
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Annexe 1: Instructions for External Technical Consultants
Instructions and Recommendations for External Evaluators
Interviews
This process includes three main types of interviews:
Initial interview: This interview is usually with the hospital director, who may or may
not be accompanied by other people. The objectives are as follows:
•

Introduction to the local authority

•

Meet the people who will accompany the evaluators during the activity

•

Become familiar with the general characteristics of the hospital

•

Explain which activities will be conducted in the hospital during the evaluation

•

Set a time for the final meeting

•

Confirm that the local authority has consented to the activity

Technical interviews: These interviews are with professionals who perform
different activities in the hospital. The objective is to obtain specific information related
to the guide. In order to make the most of these interviews, the following is
recommended:
•

You should always be accompanied by a professional from the hospital

•

Interview the person in charge of the unit or activity. A meeting with personnel
working under them should be held only with their consent.

•

Introduce yourself and explain the reason for the interview

•

Tell them what information is required

Final interview: This interview is usually with the hospital director, accompanied by
other people. The objectives of this interview are as follows:
•

Report the main findings of the observations.
o Briefly summarize each area, highlighting aspects that are partially or
fully acceptable as well as those that can be improved. Use clear
examples. Avoid going into detail.

•

Compile any information that was not included previously

•

Receive comments and clarifications on your observations
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•

Thank the facilities and the appropriate individuals for having participated in the
activity

It is strongly recommended that the team of evaluators meet alone for a few minutes
before the final interview and agree on the points that will be dealt with.
Document Review
Some of the information will be obtained from documents that directly or indirectly
contribute data that can be used as a basis for determining compliance with the
characteristics in the guide. Document review tends to be a long and complex process.
For document review:
•

Focus the document review on the objectives of the guide.

•

Request that your local contacts show where the information is found in the
documents.

•

Review by a person unfamiliar with the local documentation system may be
tedious and fruitless. Be explicit about your needs.

•

Avoid requesting a particular document. It is preferable to request
documentation for the activities. Each hospital has its own form of
documentation. For example: In order to find out about training activities, avoid
requesting “committee minutes” since the information needed may not be found
there. However, if you request a list of training activities performed, there may
be different types of documentation (e.g., annual summaries of activities and
specific training reports).

Instructions and Recommendations for Direct Observation
Evaluation of many of the characteristics is based on observation of how activities are
conducted in practice.
•

When direct observation activities are conducted, tell your contacts what you
expect to find before beginning observation. After completing the activity,
summarize whether what you found was appropriate or the practices did not
meet the requirements.

•

Be cautious about the comments and your reactions to non-compliance of
practices, particularly because the visits are often accompanied by personnel
who may have a partial or distorted understanding of the practices.
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•

If you observe failure to comply with techniques or inappropriate practices, it is
important to take note and possibly mention it at the meeting. However, this
does not necessarily mean that it represents a trend unless the practice is
repeated.

Specific Instructions
Some areas have special conditions to be evaluated.
INTERVENTION STRATEGIES and HEALTHCARE ENVIRONMENT AND
SANITATION
These are two of the most important areas of the evaluation. It is also the area in which
there are usually the most comments. The evidence-based concepts used to evaluate the
preventive strategies are only some of the most well-known and least controversial
concepts. Therefore, they should be included in the usual practice of all healthcare
facilities.
INEFFECTIVE PRACTICES
A series of practices have been introduced in healthcare environments in the past to
prevent infections. However, there is currently no basis for maintaining them, as there is
sufficient evidence that they do not prevent infection. In addition, in some cases, there is
even enough information to consider that it would be advisable to eliminate these
practices since they increase risk.

In this evaluation it is enough to be aware of and verify the presence of an ineffective
measure that increases the risk of infection in order to include a comment about it in the
final interview and the written report. The information on the presence of ineffective
measures may be acquired from multiple sources. It often occurs by chance during
observations in the clinical units.
Written Report
INSTRUCTIONS AND RECOMMENDATIONS FOR PREPARATION OF THE
REPORT
•

When the field activities have been completed, a final written report should be
prepared.
Infection Prevention and Control Programme Evaluation

72

•

It is recommended that the report be written on the same day as the evaluation
was made, particularly if more than one healthcare facility has been evaluated
that day.

•

This is an activity that should be performed by the entire team. If more than one
facility has been evaluated on the same day, it is recommended that the facilities
be analysed one at a time.

Individuals to Interview

• Facility Director
• Infection Control Committee or Programme Director
• Infection Control Professional
• Physician-Epidemiologist
• Microbiologist
• Sterilisation Supervisor
• Heads of Department: Intensive Care, Paediatrics, and Surgery
• Director of Nursing
• Personnel Health Supervisor

Infection Prevention and Control Programme Evaluation

73

Proposed Programme

Activity

Initial interview

Estimated time

Number of

(min)

evaluators

40

All

Objective

Introduction,
arrange final
meeting

Meet with Infection Control

90-120

All

Committee

Review
information,
documents,
evaluate
organisation and
monitoring

Sterilisation

30-45

1

Evaluate
sterilisation

Laboratory

30-45

1

Evaluate
microbiology

Intensive

30-45

1

care unit

Evaluate
intervention

Paediatrics

30-45

1

Surgery

30-45

1

Medicine

30-45

1

strategies

Integrate

Visit

Others

programme into

departments

based on

routine practice

time
available

Aspects of
physical plant
and
environmental
sanitation

Identify
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ineffective
practices
Meet with Personnel Health

30-40

1

Supervisor

Evaluate
personnel health

Meet with Governing body

30-60

All

Oral report on
findings

Write report

120-180

All

Prepare report
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Annexe 2: Suggested verifiers
Verifiers offer orientation of sources of information for the evaluator/s that can be used
to determine whether a certain indicator is present. This list is not exhaustive; the
evaluator/s can use other methods to establish the presence of indicators.
Area

Suggested verifiers:

1. Organisation

•

Documentation signed by local authority

•

Official documents of the institution (programme,
plans or annual report)

•

Minutes, reports or intervention programmes

•

Annual reports

•

Written

education

programme

that

includes

healthcare associated infection (HAI) standards
•

Education programme compliance reports

2. Epidemiological

•

Interviews

Surveillance of

•

Certificates of training

Infections

•

Local documentation

•

Surveillance record sheets

•

Local procedures

•

Various reports

•

Information bulletins/reports and distribution list

•

Interviews

•

Various reports

•

Reference laboratory report

•

Manuals

4. Intervention

•

Standards

strategies

•

Guides

•

Manuals

•

Direct observation

•

Interviews

5. Sterilisation and

•

Interviews

High-Level

•

Standards

3. Microbiology

Disinfection
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•

Direct observation

•

Manuals

•

Record forms

•

Maintenance programme record forms

•

Care records and plan

•

Programme documentation

•

Records

•

Standards

7. Hospital

•

Direct observation

Environment and

•

Meeting minutes

Sanitation

•

interviews

6. Personnel Health
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Annexe 3: Glossary
Glossary
access

In this document it is the condition by which a hospital provides a
service that is not provided directly by it. For example, a hospital
may not have a Microbiology Department. Rather, the appropriate
services are provided by an external laboratory when required. In
this case, the hospital has “access” to microbiology.

immunisation

Proportion of vaccinated individuals out of the total number

coverage

planned. In this guide, evaluation of immunological response to
the vaccine is not considered.

disinfection

Procedure designed to eliminate pathogenic agents from articles
and other patient care equipment in order to decrease the risk of
infection. Microbial spores are not usually eliminated. A
distinction is made between different levels using Spaulding’s
classification. High-level disinfection is considered to be of
interest.

official

Document that satisfies local requirements to be considered in

document

compulsory compliance or knowledge. It must be signed by at
least the hospital management.

sterilisation

Procedure designed to eliminate all forms of microbial life from
articles and other patient care equipment in order to decrease the
risk of infection.

programme

A specific, stable unit that includes the individuals responsible for

oversight

the safety of clinical activities (department or unit chiefs). In
addition to the individuals themselves, it includes their method of
communication and the hierarchical structure of the organisation.

evidence

Certainty derived from studies on a certain subject that are
currently considered to be conclusive. This usually means, but is
not limited to, several controlled clinical trials with similar
findings.

Infection Prevention and Control Programme Evaluation

78

guide

Document with recommendations for action on a specific subject.
The subjects are usually technical, and they are not compulsory.

basic healthcare

Minimum ongoing information that a hospital should have in order

associated

to determine the infection status. The following are considered to

infection

be minimum: central venous catheter-related sepsis, catheter-

indicators

associated urinary tract infections, mechanical ventilationassociated pneumonia, surgical site infections by type of
operation, and puerperal endometritis by type of delivery. These
indicators may be different if a hospital has other frequent highrisk procedures.

nosocomial

Infection that occurs during or as a result of hospitalization, and

infection

was not present or incubating at the time of patient admission.
This definition does not distinguish between severe and minor
infections, nor preventable and non-preventable infection.

invasive

Clinical procedure that leads to mechanical interruption of the

procedure

body’s barriers of defence (e.g., skin perforation or insertion of
catheters that change the usual fluid flow).

manual

Reference

document

that

organizes

and

summarizes

the

regulations, instructions, procedures, or any other type of
information, usually operational, on a specific subject.
goals

Quantifiable objectives that are expected to be achieved. They are
usually stated numerically in ratios, rates, proportions, or other
indicators of this type

standard

Guideline that must always be fulfilled

professional

Worker with a university education and degree

immunisation

Activities designed to vaccinate a given population that establish

programme

who should be vaccinated, which vaccines will be used, dosage,
route, frequency, and all other specifics of this objective.

programme

Organized set of resources and activities to attain a known end. It
also includes the objectives, goals, and individuals responsible.
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orientation

Organized training activities to ensure that recently hired

programme

personnel are familiar with the hospital’s technical and
administrative procedures.

routine

Customary practice without a rationale that is performed
according to current practice.

supervision

Observation process to measure compliance with standards,
instructions, care procedures, or other parameters in daily practice.

epidemiological

Ongoing information system on diseases (usually infectious

surveillance

diseases) in the population in order to determine their frequency,
risk factors, morbidity, mortality, and early detection of
epidemics.
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